EX-10.1



 Exhibit 10.1 
  

 
  

CREDIT AND SECURITY AGREEMENT (TERM LOAN) 

dated as of June 30, 2015 

by and among 

ENDOCHOICE HOLDINGS, INC. 

ENDOCHOICE, INC. 
 ROBERT
S. SMITH, M.D., INC. 
 and any additional borrower that hereafter becomes party hereto, each as Borrower, and 

collectively as Borrowers, 

and 
 MIDCAP FINANCIAL
TRUST, 
 as Administrative Agent, 

and 
 THE LENDERS

 FROM TIME TO TIME PARTY HERETO 
  

 
 



 
  
  

 







 CREDIT AND SECURITY AGREEMENT 

THIS CREDIT AND SECURITY AGREEMENT (as the same may be amended, supplemented, restated or otherwise modified from time to time, the
“Agreement”) is dated as of June 30, 2015 by and among ENDOCHOICE HOLDINGS, INC. (“Holdings”), ENDOCHOICE, INC., ROBERT S. SMITH, M.D., INC., and any additional borrower that may hereafter
be added to this Agreement (individually as a “Borrower”, and collectively with any entities that become party hereto as Borrower and each of their successors and permitted assigns, the “Borrowers”), MIDCAP
FINANCIAL TRUST, a Delaware statutory trust, individually as Agent, and the financial institutions or other entities from time to time parties hereto, each as a Lender. 

RECITALS 
 Borrowers have
requested that Lenders make available to Borrowers the financing facilities as described herein. Lenders are willing to extend such credit to Borrowers under the terms and conditions herein set forth. 

AGREEMENT 
 NOW,
THEREFORE, in consideration of the premises and the agreements, provisions and covenants herein contained, Borrowers, Lenders and Agent agree as follows: 

ARTICLE 1 - DEFINITIONS 

Section 1.1 Certain Defined Terms. The following terms have the following meanings: 

“Acceleration Event” means the occurrence of an Event of Default (a) in respect of which Agent has declared all
or any portion of the Obligations to be immediately due and payable pursuant to Section 10.2, and/or (b) pursuant to either Section 10.1(e) and/or Section 10.1(f). 

“Account Debtor” means “account debtor”, as defined in Article 9 of the UCC, and any other obligor in
respect of an Account. 
 “Accounts” means, collectively, (a) any right to payment of a monetary
obligation, whether or not earned by performance, (b) without duplication, any “account” (as defined in the UCC), any accounts receivable (whether in the form of payments for services rendered or goods or equipment sold, rents,
license fees or otherwise), any “health-care-insurance receivables” (as defined in the UCC), any “payment intangibles” (as defined in the UCC) and all other rights to payment and/or reimbursement of every kind and description,
whether or not earned by performance, (c) all accounts, “general intangibles” (as defined in the UCC), Intellectual Property, rights, remedies, Guarantees, “supporting obligations” (as defined in the UCC),
“letter-of-credit rights” (as defined in the UCC) and security interests in respect of the foregoing, all rights of enforcement and collection, all books and records evidencing or related to the foregoing, and all rights under the
Financing Documents in respect of the foregoing, (d) all information and data compiled or derived by any Borrower or to which any Borrower is entitled in respect of or related to the foregoing, and (e) all proceeds of any of the
foregoing. 







 “Acquisition” means any transaction or series of related transactions for the
purpose of or resulting, directly or indirectly, in (a) the acquisition of all or substantially all of the assets of a Person, or of any business of division of a Person, (b) the acquisition of in excess of fifty percent (50%) of the
equity interest of any Person or otherwise causing any Person to become a Subsidiary of a Borrower, or (c) a merger or consolidation or any other combinations with another Person. 

“Agent” means MCF, in its capacity as administrative agent for itself and for Lenders hereunder, as such capacity is
established in, and subject to the provisions of, Article 11, and the successors and assigns of MCF in such capacity. 

“Affiliate” means, with respect to any Person, (a) any Person that directly or indirectly controls such Person,
(b) any Person which is controlled by or is under common control with such controlling Person, and (c) each of such Person’s (other than, with respect to any Lender, any Lender’s) officers or directors (or Persons functioning in
substantially similar roles) and the spouses, parents, descendants and siblings of such officers, directors or other Persons. As used in this definition, the term “control” of a Person means the possession, directly or indirectly, of the
power to vote ten percent (10%) or more of any class of voting securities of such Person or to direct or cause the direction of the management or policies of a Person, whether through the ownership of voting securities, by contract or
otherwise. 
 “Affiliated Credit Agreement” that certain Credit and Security Agreement (as the same may be
amended, restated, supplemented or otherwise modified from time to time), among MCF, as Agent and a lender, the other lenders party thereto and the Borrowers pursuant to which such Agent and lenders have extended a revolving credit facility to the
Borrowers. 
 “Affiliated Financing Agent” means the “Agent” under and as defined in the Affiliated
Credit Agreement. 
 “Affiliated Financing Documents” means the “Financing Documents” as
defined in the Affiliated Credit Agreement.  
 “Affiliated Obligations” means all “Obligations”,
as such term is defined in the Affiliated Financing Documents. 
 “Amegy Account” means each of
Borrower’s accounts at Amegy Bank, N.A. set forth on Schedule 5.14 on the Closing Date. 
 “Anti-Terrorism
Laws” means any Laws relating to terrorism or money laundering, including, without limitation, Executive Order No. 13224 (effective September 24, 2001), the USA PATRIOT Act, the Laws comprising or implementing the Bank Secrecy
Act, and the Laws administered by OFAC. 
 “Applicable Interest Rate” has the meaning set forth in Section
2.1(a)(iv). 

  
 2 

MidCap / EndoChoice / Term Credit and Security Agreement 








 “Asset Disposition” means any sale, lease, license, transfer, assignment
or other consensual disposition by any Credit Party of any asset. 
 “Bank Services” are any products,
credit services, and/or financial accommodations previously, now, or hereafter provided to Borrower or any of its Subsidiaries by any Lender or any Affiliate of a Lender, including, without limitation, any letters of credit, cash management services
(including, without limitation, merchant services, direct deposit of payroll, business credit cards, and check cashing services), interest rate swap arrangements, and foreign exchange services as any such products or services may be identified in
such Lender’s various agreements related thereto (each, a “Bank Services Agreement”). 

“Bankruptcy Code” means Title 11 of the United States Code entitled “Bankruptcy”, as the same may be
amended, modified or supplemented from time to time, and any successor statute thereto. 
 “Base
Rate” means a per annum rate of interest equal to the greater of (a) one half percent (0.5%) per annum and (b) the rate of interest announced, from time to time, within Wells Fargo Bank, National Association (“Wells
Fargo”) at its principal office in San Francisco as its “prime rate,” with the understanding that the “prime rate” is one of Wells Fargo’s base rates (not necessarily the lowest of such rates) and serves as the basis
upon which effective rates of interest are calculated for those loans making reference thereto and is evidenced by the recording thereof after its announcement in such internal publications as Wells Fargo may designate; provided, however,
that Agent may, upon prior written notice to Borrower, choose a reasonably comparable index or source to use as the basis for the Base Rate. 

“Blocked Person” means any Person: (a) listed in the annex to, or is otherwise subject to the provisions of,
Executive Order No. 13224, (b) owned or controlled by, or acting for or on behalf of, any Person that is listed in the annex to, or is otherwise subject to the provisions of, Executive Order No. 13224, (c) with which any Lender
is prohibited from dealing or otherwise engaging in any transaction by any Anti-Terrorism Law, (d) that commits, threatens or conspires to commit or supports “terrorism” as defined in Executive Order No. 13224, or (e) that
is named a “specially designated national” or “blocked person” on the most current list published by OFAC or other similar list or is named as a “listed person” or “listed entity” on other lists made under any
Anti-Terrorism Law. 
 “Borrower” and “Borrowers” has the meaning set forth in the
introductory paragraph hereto.  
 “Borrower Representative” means EndoChoice Holdings, Inc., in its capacity
as Borrower Representative pursuant to the provisions of Section 2.9, or any successor Borrower Representative selected by Borrowers and approved by Agent. 

“Borrowing Base” means the “Borrowing Base” under and as defined in the Affiliated Credit Agreement. 

  
 3 

MidCap / EndoChoice / Term Credit and Security Agreement 








 “Business Day” means any day except a Saturday, Sunday or other day on
which either the New York Stock Exchange is closed, or on which commercial banks in Washington, DC and New York City are authorized by law to close. 

“CERCLA” means the Comprehensive Environmental Response, Compensation and Liability Act of 1980, 42 U.S.C.A. §
9601 et seq., as the same may be amended from time to time. 
 “Change in Control” means any of
the following events: (a) any Person or two or more Persons acting in concert shall have acquired beneficial ownership, directly or indirectly, of, or shall have acquired by contract or otherwise, or shall have entered into a contract or
arrangement that, upon consummation, will result in its or their acquisition of or control over, voting stock of any Borrower (or other securities convertible into such voting stock) representing 40% or more of the combined voting power of all
voting stock of any Borrower or (b) Holdings ceases to own, directly or indirectly, 100% of the capital stock of any of its Subsidiaries (or such lesser portion as may be owned by Holdings as of the date hereof) (with the exception of any
Subsidiaries permitted to be dissolved or merged to the extent otherwise permitted by this Agreement). As used herein, “beneficial ownership” shall have the meaning provided in Rule 13d-3 of the Securities and Exchange Commission under the
Securities Exchange Act of 1934.  
 “Closing Date” means the date of this Agreement. 

“CMS” means the federal Centers for Medicare and Medicaid Services (formerly the federal Health Care Financing
Administration), and any successor Governmental Authority. 
 “Code” means the Internal Revenue Code of 1986,
as amended from time to time. 
 “Collateral” means all property, now existing or hereafter acquired, mortgaged or
pledged to, or purported to be subjected to a Lien in favor of, Agent, for the benefit of Agent and Lenders, pursuant to this Agreement and the Security Documents, including, without limitation, all of the property described in
Schedule 9.1 hereto. 
 “Commitment Annex” means Annex A to this Agreement. 

“Commitment Expiry Date” means June 30, 2020. 

“Compliance Certificate” means a certificate, duly executed by a Responsible Officer of Borrower Representative,
appropriately completed and substantially in the form of Exhibit B hereto. 
 “Consolidated
Subsidiary” means, at any date, any Subsidiary the accounts of which would be consolidated with those of “parent” Borrower (or any other Person, as the context may require hereunder) in its consolidated financial statements if
such statements were prepared as of such date. 
 “Contingent Obligation” means, with respect to any Person,
any direct or indirect liability of such Person: (a) with respect to any Debt of another Person (a “Third Party 

  
 4 

MidCap / EndoChoice / Term Credit and Security Agreement 








 
Obligation”) if the purpose or intent of such Person incurring such liability, or the effect thereof, is to provide assurance to the obligee of such Third Party Obligation that such
Third Party Obligation will be paid or discharged, or that any agreement relating thereto will be complied with, or that any holder of such Third Party Obligation will be protected, in whole or in part, against loss with respect thereto;
(b) with respect to any undrawn portion of any letter of credit issued for the account of such Person or as to which such Person is otherwise liable for the reimbursement of any drawing; (c) under any Swap Contract, to the extent not yet
due and payable; (d) to make take-or-pay or similar payments if required regardless of nonperformance by any other party or parties to an agreement; or (e) for any obligations of another Person pursuant to any Guarantee or pursuant to any
agreement to purchase, repurchase or otherwise acquire any obligation or any property constituting security therefor, to provide funds for the payment or discharge of such obligation or to preserve the solvency, financial condition or level of
income of another Person. The amount of any Contingent Obligation shall be equal to the amount of the obligation so Guaranteed or otherwise supported or, if not a fixed and determinable amount, the maximum amount so Guaranteed or otherwise
supported. 
 “Controlled Group” means all members of any group of corporations and all members of a group of
trades or businesses (whether or not incorporated) under common control which, together with any Borrower, are treated as a single employer under Section 414(b), (c), (m) or (o) of the Code or Section 4001(b) of ERISA.

 “Correction” means repair, modification, adjustment, relabeling, destruction or inspection (including patient
monitoring) of a product without its physical removal to some other location. 
 “Credit
Exposure” means, at any time, any portion of the Term Loan Commitment and of any other Obligations that remains outstanding; provided, however, that no Credit Exposure shall be deemed to exist solely due to the existence of
contingent indemnification liability, absent the assertion of a claim, or the known existence of a claim reasonably likely to be asserted, with respect thereto. 

“Credit Party” means any Guarantor under a Guarantee of the Obligations or any part thereof, any Borrower and any
other Person (other than Agent, a Lender or a participant of a Lender), whether now existing or hereafter acquired or formed, that becomes obligated as a borrower, guarantor, surety, indemnitor, pledgor, assignor or other obligor under any Financing
Document, and any Person whose equity interests or portion thereof have been pledged or hypothecated to Agent under any Financing Document; and “Credit Parties” means all such Persons, collectively. 

“DEA” means the Drug Enforcement Administration of the United States of America, any comparable state or local
Government Authority, any comparable Government Authority in any non-United States jurisdiction, and any successor agency of any of the foregoing. 

“Debt” of a Person means at any date, without duplication, (a) all obligations of such Person for borrowed money,
(b) all obligations of such Person evidenced by bonds, debentures, notes or other similar instruments, (c) all obligations of such Person to pay the deferred purchase  

  
 5 

MidCap / EndoChoice / Term Credit and Security Agreement 








 
price of property or services, except trade accounts payable in the Ordinary Course of Business, (d) all capital leases of such Person, (e) all contingent or non-contingent obligations
of such Person to reimburse any bank or other Person in respect of amounts paid under a letter of credit, banker’s acceptance or similar instrument, (f) all equity securities of such Person subject to repurchase or redemption other than at
the sole option of such Person (and other than transactions where the consideration is paid solely in equity securities), (g) all obligations secured by a Lien on any asset of such Person, whether or not such obligation is otherwise an
obligation of such Person (other than Liens permitted under clause (c) or (f) of the definition of Permitted Liens), (h) “earnouts”, purchase price adjustments, profit sharing arrangements, deferred purchase money amounts
and similar payment obligations or continuing obligations of any nature of such Person arising out of purchase and sale contracts, (i) all Debt of others Guaranteed by such Person and (j) off-balance sheet liabilities and/or Pension Plan
or Multiemployer Plan liabilities of such Person. Without duplication of any of the foregoing, Debt of Borrowers shall include any and all Loans. 

“Default” means any condition or event which with the giving of notice or lapse of time or both would, unless cured or
waived, become an Event of Default. 
 “Deposit Account” means a “deposit account” (as defined in
Article 9 of the UCC), an investment account, or other account in which funds are held or invested for credit to or for the benefit of any Borrower. 

“Deposit Account Control Agreement” means an agreement, in form and substance satisfactory to Agent, among Agent, any
Borrower and each financial institution in which such Borrower maintains a Deposit Account, which agreement provides that (a) such financial institution shall comply with instructions originated by Agent directing disposition of the funds in
such Deposit Account without further consent by the applicable Borrower, and (b) such financial institution shall agree that it shall have no Lien on, or right of setoff or recoupment against, such Deposit Account or the contents thereof, other
than in respect of usual and customary service fees and returned items for which Agent has been given value, and containing such other terms and conditions as Agent may require. 

“Deposit Account Restriction Agreement” has the meaning set forth in the Affiliated Credit Agreement. 

“Distribution” means as to any Person (a) any dividend or other distribution (whether in cash, securities or
other property) on any equity interest in such Person (except those payable solely in its equity interests of the same class), (b) any payment of cash or cash equivalents by such Person on account of (i) the purchase, redemption,
retirement, defeasance, surrender, cancellation, termination or acquisition of any equity interests in such Person or any claim respecting the purchase or sale of any equity interest in such Person, or (ii) any option, warrant or other right to
acquire any equity interests in such Person, (c) any management fees, salaries or other fees or compensation to any Person holding an equity interest in a Borrower or a Subsidiary of a Borrower (other than compensation of directors, officers
and other employees of the Borrower or any Subsidiary and advances and reimbursement to the same, and payment of benefits of the same, all to the extent not contrary to the directives of the compensation 


  
 6 

MidCap / EndoChoice / Term Credit and Security Agreement 








 
committee and (i) paid in the Ordinary Course of Business or (ii) expressly approved by the compensation committee of the Board of Directors of Holdings), or (d) repayments of or
debt service on loans or other indebtedness held by any Person holding an equity interest in a Borrower or a Subsidiary of a Borrower, an Affiliate of a Borrower or an Affiliate of any Subsidiary of a Borrower unless permitted under and made
pursuant to a Subordination Agreement applicable to such loans or other indebtedness. 
 “Dollars” or
“$” means the lawful currency of the United States of America. 
 “Environmental Laws” means
any present and future federal, state and local laws, statutes, ordinances, rules, regulations, standards, policies and other governmental directives or requirements, as well as common law, pertaining to the environment, natural resources,
pollution, health (including any environmental clean up statutes and all regulations adopted by any local, state, federal or other Governmental Authority, and any statute, ordinance, code, order, decree, law rule or regulation all of which pertain
to or impose liability or standards of conduct concerning medical waste or medical products, equipment or supplies), safety or clean-up that apply to any Borrower and relate to Hazardous Materials, including, without limitation, the Comprehensive
Environmental Response, Compensation and Liability Act of 1980 (42 U.S.C. § 9601 et seq.), the Resource Conservation and Recovery Act of 1976
 (42 U.S.C. § 6901 et seq.), the Federal Water
Pollution Control Act (33 U.S.C. § 1251 et seq.), the Hazardous Materials Transportation Act (49 U.S.C. § 5101 et seq.), the Clean Air Act (42 U.S.C. § 7401 et
seq.), the Federal Insecticide, Fungicide and Rodenticide Act (7 U.S.C. § 136 et seq.), the Emergency Planning and Community Right-to-Know Act (42 U.S.C. § 11001 et seq.), the
Occupational Safety and Health Act (29 U.S.C. § 651 et seq.), the Residential Lead-Based Paint Hazard Reduction Act (42 U.S.C. § 4851 et seq.), any analogous state or local
laws, any amendments thereto, and the regulations promulgated pursuant to said laws, together with all amendments from time to time to any of the foregoing and judicial interpretations thereof. 

“ERISA” means the Employee Retirement Income Security Act of 1974, as the same may be amended, modified or
supplemented from time to time, and any successor statute thereto, and any and all rules or regulations promulgated from time to time thereunder. 

“ERISA Plan” means any “employee benefit plan”, as such term is defined in Section 3(3) of ERISA (other
than a Multiemployer Plan), which any Borrower maintains, sponsors or contributes to, or, in the case of an employee benefit plan which is subject to Section 412 of the Code or Title IV of ERISA, to which any Borrower or any member of the
Controlled Group may have any liability, including any liability by reason of having been a substantial employer within the meaning of Section 4063 of ERISA at any time during the preceding five (5) years, or by reason of being deemed to
be a contributing sponsor under Section 4069 of ERISA. 
 “Event of Default” has the meaning set forth
in Section 10.1. 
 “FDA” means the Food and Drug Administration of the United States of America, any
comparable state or local Government Authority, any comparable Government Authority in any non-United States jurisdiction, and any successor agency of any of the foregoing. 

  
 7 

MidCap / EndoChoice / Term Credit and Security Agreement 








 “FDCA” means the Federal Food, Drug and Cosmetic Act, as amended, 21
U.S.C. Section 301 et seq., and all regulations promulgated thereunder. 
 “Financing Documents” means
this Agreement, any Notes, the Security Documents, any separate fee letter, any subordination or intercreditor agreement pursuant to which any Debt and/or any Liens securing such Debt is subordinated to all or any portion of the Obligations and all
other documents, instruments and agreements related to the Obligations and heretofore executed, executed concurrently herewith or executed at any time and from time to time hereafter, as any or all of the same may be amended, supplemented, restated
or otherwise modified from time to time. 
 “GAAP” means generally accepted accounting principles set forth
from time to time in the opinions and pronouncements of the Accounting Principles Board and the American Institute of Certified Public Accountants and statements and pronouncements of the Financial Accounting Standards Board (or agencies with
similar functions of comparable stature and authority within the United States accounting profession), which are applicable to the circumstances as of the date of determination. 

“General Intangible” means any “general intangible” as defined in Article 9 of the UCC, and any
personal property, including things in action, other than accounts, chattel paper, commercial tort claims, deposit accounts, documents, goods, instruments, investment property, letter-of-credit rights, letters of credit, money, and oil, gas or other
minerals before extraction, but including payment intangibles and software. 
 “Good Manufacturing Practices”
means current good manufacturing practices, as set forth in 21 C.F.R. Parts 210 and 211. 
 “Governmental
Authority” means any nation or government, any state, local or other political subdivision thereof, and any agency, department or Person exercising executive, legislative, judicial, regulatory or administrative functions of or pertaining to
government and any corporation or other Person owned or controlled (through stock or capital ownership or otherwise) by any of the foregoing, whether domestic or foreign. 

“Guarantee” by any Person means any obligation, contingent or otherwise, of such Person directly or indirectly
guaranteeing any Debt or other obligation of any other Person and, without limiting the generality of the foregoing, any obligation, direct or indirect, contingent or otherwise, of such Person (a) to purchase or pay (or advance or supply funds
for the purchase or payment of) such Debt or other obligation (whether arising by virtue of partnership arrangements, by agreement to keep-well, to purchase assets, goods, securities or services, to take-or-pay, or to maintain financial statement
conditions or otherwise), or (b) entered into for the purpose of assuring in any other manner the obligee of such Debt or other obligation of the payment thereof or to protect such obligee against loss in respect thereof (in whole or in part),
provided, however, that the term Guarantee shall not include endorsements for collection or deposit in the Ordinary Course of Business. The term “Guarantee” used as a verb has a
corresponding meaning. 

  
 8 

MidCap / EndoChoice / Term Credit and Security Agreement 








 “Guarantor” means any Credit Party that has executed or delivered, or
shall in the future execute or deliver, any Guarantee of any portion of the Obligations. 
 “Hazardous
Materials” means petroleum and petroleum products and compounds containing them, including gasoline, diesel fuel and oil; explosives, flammable materials; radioactive materials; polychlorinated biphenyls and compounds containing them; lead
and lead-based paint; asbestos or asbestos-containing materials; underground or above-ground storage tanks, whether empty or containing any substance; any substance the presence of which is prohibited by any Environmental Laws; toxic mold, any
substance that requires special handling; and any other material or substance now or in the future defined as a “hazardous substance,” “hazardous material,” “hazardous waste,” “toxic substance,” “toxic
pollutant,” “contaminant,” “pollutant” or other words of similar import within the meaning of any Environmental Law, including: (a) any “hazardous substance” defined as such in (or for purposes of) CERCLA, or
any so-called “superfund” or “superlien” Law, including the judicial interpretation thereof; (b) any “pollutant or contaminant” as defined in 42 U.S.C.A. § 9601(33); (c) any material now defined as
“hazardous waste” pursuant to 40 C.F.R. Part 260; (d) any petroleum or petroleum by-products, including crude oil or any fraction thereof; (e) natural gas, natural gas liquids, liquefied natural gas, or synthetic gas usable for
fuel; (f) any “hazardous chemical” as defined pursuant to 29 C.F.R. Part 1910; (g) any toxic or harmful substances, wastes, materials, pollutants or contaminants (including, without limitation, asbestos, polychlorinated biphenyls
(“PCB’s”), flammable explosives, radioactive materials, infectious substances, materials containing lead-based paint or raw materials which include hazardous constituents); and (h) any other toxic substance or contaminant
that is subject to any Environmental Laws. 
 “Healthcare Laws” means all applicable Laws relating to the
procurement, development, provision, clinical and non-clinical evaluation or investigation, product approval or clearance, manufacture, production, analysis, distribution, dispensing, importation, exportation, use, handling, quality, reimbursement,
sale, labeling, advertising, promotion, or postmarket requirements of any drug, medical device, clinical laboratory service, food, dietary supplement, or other product (including, without limitation, any ingredient or component of, or accessory to,
the foregoing products) subject to regulation under the Federal Food, Drug, and Cosmetic Act (21 U.S.C. et seq.), Clinical Laboratory Improvement Amendments of 1988 (42 U.S.C. §263a et seq) and its implementing regulations (42 C.F.R.
Part 493) and similar state or foreign laws, controlled substances laws, pharmacy laws, consumer product safety laws, Medicare, Medicaid, and all laws, policies, procedures, requirements and regulations pursuant to which Regulatory Required Permits
are issued, in each case, as the same may be amended from time to time. 
 “Holdings” has the meaning
assigned thereto in the preamble to this Agreement. 
 “Instrument” means “instrument”, as defined
in Article 9 of the UCC. 
 “Intellectual Property” means all copyright rights, copyright applications,
copyright registrations and like protections in each work of authorship and derivative work, whether published or unpublished, any patents, patent applications and like protections, including improvements, divisions, continuations, renewals,
reissues, extensions, and continuations-in-part of the same, trademarks, trade names, service marks, mask works, rights of use of any name,  

  
 9 

MidCap / EndoChoice / Term Credit and Security Agreement 








 
domain names, or any other similar rights, any applications therefor, whether registered or not, know-how, operating manuals, trade secret rights, clinical and non-clinical data, rights to
unpatented inventions, and any claims for damage by way of any past, present, or future infringement of any of the foregoing. 

“Intercreditor Agreement” means that certain Intercreditor Agreement dated as of the date hereof between Agent and the
Affiliated Financing Agent, as the same may be amended, restated, supplemented or otherwise modified from time to time. 

“Inventory” means “inventory” as defined in Article 9 of the UCC. 

“Investment” means, with respect to any Person, directly or indirectly, (a) to purchase or acquire any stock or
stock equivalents, or any obligations or other securities of, or any interest in, any Person, including the establishment or creation of a Subsidiary, (b) to make or commit to make any acquisition (including through licensing) of (i) of
all or substantially all of the assets of another Person, or (ii) any business, Product, business line or product line, division or other unit operation of any Person or (c) make or purchase any advance, loan, extension of credit or
capital contribution to, or any other investment in, any Person. 
 “IP Proceeds” means, collectively, all
cash, Accounts, license and royalty fees, claims, products, awards, judgments, insurance claims, and other revenues, proceeds or income, arising out of, derived from or relating to any Intellectual Property of any Credit Party, and any claims for
damage by way of any past, present or future infringement of any Intellectual Property of any Credit Party (including, without limitation, all cash, royalty fees, other proceeds, Accounts and General Intangibles that consist of rights of payment to
or on behalf of a Credit Party and the proceeds from the sale, licensing or other disposition of all or any part of, or rights in, any Intellectual Property by or on behalf of a Credit Party).  

“Joinder Requirements” has the meaning set forth in Section 4.11(d). 

“Laws” means any and all federal, state, provincial, territorial, local and foreign statutes, laws, judicial
decisions, regulations, ordinances, rules, judgments, orders, decrees, codes, injunctions, permits, governmental agreements and governmental restrictions, whether now or hereafter in effect, which are applicable to any Credit Party in any particular
circumstance. “Laws” includes, without limitation, Healthcare Laws and Environmental Laws. 

“Lender” means (a) each Person party hereto in its capacity as a lender hereunder, (b) each other Person
that becomes a party hereto as Lender pursuant to Section 11.17, and (c) the respective successors of all of the foregoing, and “Lenders” means all of the foregoing.  

“Lien” means, with respect to any asset, any mortgage, lien, pledge, charge, security interest or encumbrance of any
kind, in respect of such asset. For the purposes of this Agreement and the other Financing Documents, any Borrower or any Subsidiary shall be deemed to own subject to a Lien any asset which it has acquired or holds subject to the interest of a
vendor or lessor under any conditional sale agreement, capital lease or other title retention agreement relating to such asset. 

  
 10 

MidCap / EndoChoice / Term Credit and Security Agreement 








 “Litigation” means any action, suit or proceeding before any court,
mediator, arbitrator or Governmental Authority. 
 “Loan Account” has the meaning set forth in
Section 2.6(b). 
 “Loan(s)” means the Term Loan and each and every advance under the Term Loan. All
references herein to the “making” of a Loan or words of similar import shall mean, with respect to the Term Loan, the making of any advance in respect of a Term Loan. 

“Market Withdrawal” means a Person’s Removal or Correction of a distributed product which involves a minor
violation that would not be subject to legal action by the FDA or which involves no violation, e.g., normal stock rotation practices, routine equipment adjustments and repairs, etc.  

“Material Adverse Effect” means with respect to any event, act, condition or occurrence of whatever nature (including
any adverse determination in any litigation, arbitration, or governmental investigation or proceeding), whether singly or in conjunction with any other event or events, act or acts, condition or conditions, occurrence or occurrences, whether or not
related, a material adverse change in, or a material adverse effect upon, any of (a) the condition (financial or otherwise), operations, business or properties of the Credit Parties taken as a whole, (b) the rights and remedies of Agent or
Lenders under any Financing Document, or the ability of any Credit Party to perform any of its obligations under any Financing Document to which it is a party, (c) the legality, validity or enforceability of any Financing Document, (d) a
material impairment of the prospect of repayment of any portion of the Obligations, (e) the existence, perfection or priority of any security interest in any material Collateral granted in any Financing Document, or (f) the value of any
material Collateral.  
 “Material Contracts” means, with respect to any Credit Party, (a) the Operative
Documents and (b) each agreement, contract or other instrument to which such Credit Party or its Subsidiaries is a party that (i) involves aggregate consideration payable to or by such Credit Party or its Subsidiary of $5,000,000 or more
in any year, or (ii) the termination of which could reasonably be expected to result in a Material Adverse Effect.  

“Material Intangible Assets” means all of (i) Borrower’s Intellectual Property and (ii) license or
sublicense agreements or other agreements with respect to rights in Intellectual Property, in each case, the loss or impairment of which would reasonably be expected to have a Material Adverse Effect, as determined by Agent in its reasonable
discretion. 
 “Material Permits and Rights” has the meaning set forth Section 8.1(c) 

“Maximum Lawful Rate” has the meaning set forth in Section 2.7. 

“MCF” means MidCap Financial Trust, a Delaware statutory trust, and its successors and assigns. 

  
 11 

MidCap / EndoChoice / Term Credit and Security Agreement 








 “Medicaid” means the medical assistance programs administered by state
agencies and approved by CMS pursuant to the terms of Title XIX of the Social Security Act, codified at 42 U.S.C. 1396 et seq. 

“Medicare” means the program of health benefits for the aged and disabled administered by CMS pursuant to the terms of
Title XVIII of the Social Security Act, codified at 42 U.S.C. 1395 et seq. 
 “Minimum Liquidity” means
the sum of Revolving Loan Availability plus unrestricted cash and cash equivalents that are (a) owned by any Borrower, (b) not subject to any Lien other than a Lien in favor of Agent, (c) held in a Deposit Account
or Securities Account that is subject to a Deposit Account Control Agreement or Securities Account Control Agreement, as applicable, and (d) not pledged to or held by Agent to secure a specified Obligation. 

“Multiemployer Plan” means a multiemployer plan within the meaning of Section 4001(a)(3) of ERISA to which any
Borrower or any other member of the Controlled Group (or any Person who in the last five years was a member of the Controlled Group) is making or accruing an obligation to make contributions or has within the preceding five plan years (as determined
on the applicable date of determination) made contributions. 
 “Notes” has the meaning set forth in
Section 2.3. 
 “Notice of Borrowing” means a notice of a Responsible Officer of Borrower
Representative, appropriately completed and substantially in the form of Exhibit D hereto. 

“Obligations” means all obligations, liabilities and indebtedness (monetary (including, without limitation, the
payment of interest and other amounts arising after the commencement of any case with respect to any Credit Party under the Bankruptcy Code or any similar statute which would accrue and become due but for the commencement of such case, whether or
not such amounts are allowed or allowable in whole or in part in such case) or otherwise) of each Credit Party under this Agreement, any other Financing Document or any Bank Services Agreement, in each case howsoever created, arising or evidenced,
whether direct or indirect, absolute or contingent, now or hereafter existing, or due or to become due.  

“OFAC” means the U.S. Department of Treasury Office of Foreign Assets Control. 

“OFAC Lists” means, collectively, the Specially Designated Nationals and Blocked Persons List maintained by OFAC
pursuant to Executive Order No. 13224, 66 Fed. Reg. 49079 (Sept. 25, 2001) and/or any other list of terrorists or other restricted Persons maintained pursuant to any of the rules and regulations of OFAC or pursuant to any other applicable
Executive Orders. 
 “Operative Documents” means the Financing Documents, Subordinated Debt Documents, and
any documents effecting any purchase or sale or other transaction that is closing contemporaneously with the closing of the financing under this Agreement. 

  
 12 

MidCap / EndoChoice / Term Credit and Security Agreement 








 “Ordinary Course of Business” means, in respect of any transaction
involving any Credit Party, the ordinary course of business of such Credit Party, as conducted by such Credit Party substantially in accordance with past practices. 

“Organizational Documents” means, with respect to any Person other than a natural person, the documents by which such
Person was organized (such as a certificate of incorporation, certificate of limited partnership or articles of organization, and including, without limitation, any certificates of designation for preferred stock or other forms of preferred equity)
and which relate to the internal governance of such Person (such as by-laws, a partnership agreement, joint venture agreement or an operating, limited liability company or members agreement), including any and all shareholder agreements or voting
agreements to which such Person is party relating to the capital stock or other equity interests of such Person. 

“Payment Account” means the account specified on the signature pages hereof into which all payments by or on behalf of
each Borrower to Agent under the Financing Documents shall be made, or such other account as Agent shall from time to time specify by notice to Borrower Representative. 

“PBGC” means the Pension Benefit Guaranty Corporation and any Person succeeding to any or all of its functions under
ERISA. 
 “Pension Plan” means any ERISA Plan that is subject to Section 412 of the Code or Title IV of
ERISA. 
 “Perfection Certificate” means the Perfection Certificate delivered to Agent as of the Closing
Date, together with any amendments thereto required under this Agreement. 
 “Permit” means all licenses,
certificates, accreditations, product clearances or approvals, provider numbers or provider authorizations, supplier numbers, marketing authorizations, drug or device authorizations and approvals, other authorizations, franchises, qualifications,
accreditations, registrations, permits, consents and approvals of a Credit Party issued or required under Laws applicable to the business of Borrower or any of its Subsidiaries or necessary in the manufacturing, importing, exporting, possession,
ownership, warehousing, marketing, promoting, sale, labeling, furnishing, distribution or delivery of goods or services under Laws applicable to the business of Borrower or any of its Subsidiaries. Without limiting the generality of the foregoing,
“Permit” includes any Regulatory Required Permit. 
 “Permitted Acquisition” means any Acquisition
by Borrower to the extent that each of the following conditions shall have been satisfied: 
 (a) to the extent the Acquisition will be
financed in whole or in part with the proceeds of any Loan, the conditions set forth in Section 7.2 shall have been satisfied; 

  
 13 

MidCap / EndoChoice / Term Credit and Security Agreement 








 (b) Borrower shall have notified Agent and Lenders of such proposed Acquisition at least twenty
(20) days prior to the consummation thereof and furnished to Agent and Lenders as soon as available, but at least ten (10) days prior to the consummation thereto: 

(i) an executed term sheet and/or letter of intent (if any) setting forth in reasonable detail the terms and conditions of such
Acquisition and, at the request of Agent, such other information and documents that Agent may reasonably request, including, without limitation, at such time that such documents are available, executed counterparts of the respective agreements,
documents or instruments pursuant to which such Acquisition is to be consummated (including, without limitation, any related management, non-compete, employment, option or other material agreements), any schedules to such agreements, documents or
instruments and all other material ancillary agreements, instruments and documents to be executed or delivered in connection therewith, each reasonably acceptable to Agent; 

(ii) pro forma financial statements of Borrowers and their consolidated Subsidiaries after giving effect to the consummation of
such Acquisition; 
 (iii) a true and accurate copy attached to such certificate of a statement of the sources and uses of
the funding of such Acquisition; 
 (iv) a certificate of a Responsible Officer of Borrower demonstrating in reasonable
detail acceptable to the Agent that, on a pro forma basis, Borrower will be in compliance with the covenants set forth in Article 6 both immediately prior to and immediately after the consummation of such Acquisition; and 

(v) copies of such other agreements, instruments and other documents as Agent shall reasonably request. 

(c) following the consummation of such Acquisition, each Borrower remains a surviving legal entity and the Borrowers and their Subsidiaries
(including any new Subsidiary) shall execute and deliver the agreements, instruments and other documents required by Section 4.11 and, to the extent permitted under the applicable acquisition agreement, Agent shall have received, for the
benefit of the Lenders, a collateral assignment of the seller’s representations, warranties and indemnities to the Borrowers or any of their Subsidiaries under the acquisition documents; 

(d) a certificate of a Responsible Officer of Borrower, as of the date of the consummation of such Acquisition, that (i) no Default or
Event of Default shall have occurred and be continuing or would result from such Acquisition, (ii) all material approvals required in connection therewith shall have been obtained, and (iii) the conditions set forth in this definition have
been satisfied; 
 (e) such Acquisition shall not be hostile and shall have been consummated pursuant to a negotiated acquisition agreement
provided to Agent and Lenders, which has been approved by the board of directors or other applicable governing body of the seller or entity to be acquired, and no material challenge to such Acquisition (excluding the exercise of appraisal rights)
shall be pending or threatened by any shareholder or director of the seller or entity to be acquired; 

  
 14 

MidCap / EndoChoice / Term Credit and Security Agreement 








 (f) on the date of the consummation of such Acquisition, Borrower shall have delivered to Agent
executed counterparts of the respective agreements, documents or instruments pursuant to which such Acquisition was to be consummated (including any related management, non-compete, employment, option or other material agreements), any schedules to
such agreements, documents or instruments and all other material ancillary agreements, instruments and documents to be executed or delivered in connection therewith without material changes from those delivered pursuant to clause (b)(i), above; 

(g) no Debt or Liens are assumed or created (other than Permitted Liens) in connection with such Acquisition; and 

(h) the total consideration paid or payable (including without limitation, all deferred purchase price, seller notes and other liabilities
incurred, assumed or to be reflected on a consolidated balance sheet of the Borrowers and their Subsidiaries after giving effect to such Acquisition) for all Acquisitions consummated during any twelve (12) month period shall not exceed
$5,000,000 in the aggregate for all such Acquisitions. 
 “Permitted Asset Dispositions” means the following Asset
Dispositions, provided, however, that at the time of such Asset Disposition, no Default or Event of Default exists or would result from such Asset Disposition: (a) dispositions of Inventory in the Ordinary Course of
Business and not pursuant to any bulk sale, (b) dispositions of real property and personalty in the Ordinary Course of Business that the applicable Borrower or Subsidiary determines in good faith is no longer used or useful in the business of
such Borrower and its Subsidiaries, (c) dispositions consisting of Permitted Licenses, (d) disposition of Intellectual Property by any Borrower to any other Borrower, (e) dispositions of obsolete or worn out property, whether now
owned or hereafter acquired, in the Ordinary Course of Business, (f) dispositions of assets, other than assets constituting Collateral that is part of the Borrowing Base, with an aggregate fair market value of all such assets so sold not to
exceed $2,000,000 in the aggregate during the term of this Agreement, and (g) dispositions approved by Agent.  

“Permitted Contest” means, with respect to any tax obligation or other obligation allegedly or potentially owing from
any Borrower or its Subsidiary to any governmental tax authority or other third party, a contest maintained in good faith by appropriate proceedings promptly instituted and diligently conducted and with respect to which such reserve or other
appropriate provision, if any, as shall be required in conformity with GAAP shall have been made on the books and records and financial statements of the applicable Credit Party(ies); provided, however, that
(a) compliance with the obligation that is the subject of such contest is effectively stayed during such challenge; (b) Borrowers’ and its Subsidiaries’ title to, and its right to use, the Collateral and its Intellectual Property
is not adversely affected thereby and Agent’s Lien and priority on the Collateral are not adversely affected, altered or impaired thereby; (c) Borrowers have given prior written notice to Agent of a Borrower’s or its Subsidiary’s
intent to so contest the obligation; (d) the Collateral, its Intellectual Property, or any part thereof or any interest therein shall not be in any danger of being sold, forfeited or lost by reason of such contest by Borrowers or its
Subsidiaries; (e) Borrowers have given Agent notice of the commencement of such contest and upon request by Agent, from time to time, notice of the status of such contest by Borrowers and/or confirmation of the continuing satisfaction of this
definition; and (f) upon a final determination of such contest, Borrowers and its Subsidiaries shall promptly comply with the requirements thereof. 

  
 15 

MidCap / EndoChoice / Term Credit and Security Agreement 








 “Permitted Contingent Obligations” means (a) Contingent Obligations
arising in respect of the Debt under the Financing Documents; (b) Contingent Obligations resulting from endorsements for collection or deposit in the Ordinary Course of Business; (c) Contingent Obligations outstanding on the date of this
Agreement and set forth on Schedule 5.1 (but not including any refinancings, extensions, increases or amendments to the indebtedness underlying such Contingent Obligations other than extensions of the maturity thereof without any other
change in terms); (d) Contingent Obligations incurred in the Ordinary Course of Business with respect to surety and appeal bonds, performance bonds and other similar obligations not to exceed $500,000 in the aggregate at any time outstanding;
(e) Contingent Obligations arising under indemnity agreements with title insurers to cause such title insurers to issue to Agent mortgagee title insurance policies; (f) Contingent Obligations arising with respect to customary
indemnification obligations in favor of purchasers in connection with dispositions of personal property assets permitted under Section 5.6; (g) so long as there exists no Event of Default both immediately before and immediately after
giving effect to any such transaction, Contingent Obligations existing or arising under any Swap Contract, provided, however, that such obligations are (or were) entered into by Borrower or an Affiliate in the Ordinary Course of
Business for the purpose of directly mitigating risks associated with liabilities, commitments, investments, assets, or property held or reasonably anticipated by such Person and not for purposes of speculation; (h) Contingent Obligations with
respect to any undrawn portion of any letter of credit issued (i) in connection with the lease of real property by a Credit Party and (ii) for the account of such Credit Party, or as to which such Credit Party is otherwise liable for the
reimbursement of any drawing, in an amount not to exceed $1,000,000 in the aggregate with respect to all such letters of credit at any time outstanding; and (i) other Contingent Obligations not permitted by clauses (a) through
(h) above, not to exceed $500,000 in the aggregate at any time outstanding.  
 “Permitted Debt” means:
(a) Borrowers’ and its Subsidiaries’ Debt to Agent and each Lender under this Agreement and the other Financing Documents; (b) Debt incurred as a result of endorsing negotiable instruments received in the Ordinary Course of
Business; (c) purchase money Debt not to exceed $2,000,000 at any time (whether in the form of a loan or a lease) used solely to acquire equipment used in the Ordinary Course of Business and secured only by such equipment; (d) Debt
existing on the date of this Agreement and described on Schedule 5.1 (but not including any refinancings, extensions, increases or amendments to such Debt other than extensions of the maturity thereof without any other change in terms);
(e) Debt in the form of insurance premiums financed through the applicable insurance company; (f) trade accounts payable arising and paid in the Ordinary Course of Business and which do not remain unpaid more than one hundred and eighty
(180) days past the invoice date; (g) Subordinated Debt; (h) Permitted Contingent Obligations; (i) Borrowers’ and its Subsidiaries’ Debt under the Affiliated Financing Documents, and (j) subject in all cases to the
Borrowers’ compliance with the provisions of Section 4.11, Debt consisting of intercompany loans and advances made by any Credit Party to any other Credit Party in an aggregate principal amount not to exceed $15,000,000 outstanding at any
time, provided that in the case of Debt owed by a Borrower to a Credit Party that is not a Borrower, the obligations of the Borrower under such intercompany 

  
 16 

MidCap / EndoChoice / Term Credit and Security Agreement 








 
loan shall be evidenced by a promissory note or other written instrument, which shall be in form and substance satisfactory to Agent and contain express provisions subordinating the Debt
evidenced thereby to the Obligations of the Credit Parties hereunder or under the other Financing Documents in a manner satisfactory to Agent. 

“Permitted Distributions” means the following Distributions: (a) dividends by any Subsidiary of any Borrower to such
parent Borrower or by any Subsidiary of EndoChoice Holdings, Inc. to EndoChoice Holdings, Inc.; (b) dividends payable solely in common stock; and (c) repurchases of stock of former employees, directors or consultants pursuant to stock
purchase agreements or any stock option or other incentive plan so long as an Event of Default does not exist at the time of such repurchase and would not exist after giving effect to such repurchase, provided, however, that the amount of
such repurchases (paid other than in equity securities) does not exceed $1,000,000 in the aggregate per fiscal year. 
 “Permitted
Investments” means: (a) Investments shown on Schedule 5.7 and existing on the Closing Date; (b) cash and cash equivalents; (c) Investments consisting of the endorsement of negotiable instruments for deposit
or collection or similar transactions in the Ordinary Course of Business; (d) Investments consisting of (i) travel advances and employee relocation loans and other employee loans and advances in the Ordinary Course of Business, and
(ii) loans to employees, officers or directors relating to the purchase of equity securities of Borrowers or their Subsidiaries pursuant to employee stock purchase plans or agreements approved by Borrowers’ Board of Directors (or other
governing body), but the aggregate of all such loans outstanding may not exceed $50,000 at any time; (e) Investments (including debt obligations) received in connection with the bankruptcy or reorganization of customers or suppliers and in
settlement of delinquent obligations of, and other disputes with, customers or suppliers arising in the Ordinary Course of Business; (f) Investments consisting of notes receivable of, or prepaid royalties and other credit extensions, to
customers and suppliers who are not Affiliates, in the Ordinary Course of Business, provided, however, that this subpart (f) shall not apply to Investments of Borrowers in any Subsidiary; (g) Investments consisting of the Amegy
Accounts, the PNC Accounts (so long as, in each case, Borrower is compliance with the provisions of Section 7.4) or deposit accounts in which Agent has received a Deposit Account Control Agreement; (h) Investments by any Borrower in any
Subsidiary now owned or hereafter created by such Borrower, which Subsidiary is organized under the laws of the United States, a state thereof, or the District of Columbia, which Subsidiary is a Borrower or has provided a Guarantee of the
Obligations of the Borrowers which Guarantee is secured by a Lien granted by such Subsidiary to Agent in all or substantially all of its property of the type described in Schedule 9.1 hereto and otherwise made in compliance with
Section 4.11(d); (i) Investments of cash and cash equivalents in a Restricted Foreign Subsidiary but solely to the extent that the aggregate amount of such Investments with respect to all Restricted Foreign Subsidiaries does not, at any
time, exceed $10,000,000; provided that the aggregate amount of Investments made in any Restricted Foreign Subsidiary shall not exceed the amount necessary to fund the current operating expenses of such Subsidiary (taking into account their revenue
from other sources); (j) consideration paid in respect of a Permitted Acquisitions in accordance with the definition thereof; (k) so long as no Default or Event of Default shall have occurred and be continuing at the time thereof or would
result therefrom, Investments of cash in partnerships or joint ventures in an amount not to exceed $2,000,000, in the aggregate, during the term of this 

  
 17 

MidCap / EndoChoice / Term Credit and Security Agreement 








 
Agreement, (l) investments, in an aggregate amount not to exceed $250,000, necessary to acquire all outstanding equity interests of EndoChoice Israel, Ltd. not currently owned by Borrower;
and (m) other Investments in an amount not exceeding $1,000,000 in the aggregate. 
 “Permitted License” means
(a) any non-exclusive license of Intellectual Property of Borrower or its Subsidiaries so long as all such Permitted Licenses are granted to third parties in the Ordinary Course of Business, do not result in a legal transfer of title to the
licensed property, and have been granted in exchange for fair consideration, (b) any exclusive license of Intellectual Property of Borrower or its Subsidiaries so long as (i) such Permitted Licenses do not result in a legal transfer of
title to the licensed property, are exclusive solely as to discrete geographical areas outside of the United States, and have been granted in exchange for fair consideration and (ii) are not granted to any joint venture or partnership in which
any Borrower or any Subsidiary thereof is engaged (c) any license of Intellectual Property not used or useful in the business of Borrower or its Subsidiaries. 

“Permitted Liens” means: (a) deposits or pledges of cash to secure obligations under workmen’s compensation, social
security or similar laws, or under unemployment insurance (but excluding Liens arising under ERISA or, with respect to any Pension Plan or Multiemployer Plan, the Code) pertaining to a Borrower’s or its Subsidiary’s employees, if any;
(b) deposits or pledges of cash to secure bids, tenders, contracts (other than contracts for the payment of money or the deferred purchase price of property or services), leases, statutory obligations, surety and appeal bonds and other
obligations of like nature arising in the Ordinary Course of Business; (c) carrier’s, warehousemen’s, mechanic’s, workmen’s, materialmen’s or other like Liens on Collateral, other than any Collateral which is part of
the Borrowing Base, arising in the Ordinary Course of Business with respect to obligations which are not due, or which are being contested pursuant to a Permitted Contest; (d) Liens, other than on Collateral that is part of the Borrowing Base,
for taxes or other governmental charges not at the time delinquent or thereafter payable without penalty or the subject of a Permitted Contest; (e) attachments, appeal bonds, judgments and other similar Liens on Collateral for sums not
exceeding $500,000 in the aggregate arising in connection with court proceedings; provided, however, that the execution or other enforcement of such Liens is effectively stayed and the claims secured thereby are the subject of a
Permitted Contest; (f) with respect to real estate, easements, rights of way, restrictions, minor defects or irregularities of title, none of which, individually or in the aggregate, materially interfere with the benefits of the security
intended to be provided by the Security Documents, materially affect the value or marketability of the Collateral, impair the use or operation of the Collateral for the use currently being made thereof or impair Borrowers’ ability to pay the
Obligations in a timely manner or impair the use of the Collateral or the ordinary conduct of the business of any Borrower or any Subsidiary and which, in the case of any real estate that is part of the Collateral, are set forth as exceptions to or
subordinate matters in the title insurance policy accepted by Agent insuring the lien of the Security Documents; (g) Liens and encumbrances in favor of Agent under the Financing Documents; (h) Liens, other than on Collateral that is part
of the Borrowing Base, existing on the date hereof and set forth on Schedule 5.2; (i) any Lien on any equipment securing Debt permitted under subpart (c) of the definition of Permitted Debt, provided, however,
that such Lien attaches concurrently with or within twenty (20) days after the acquisition thereof; (j) Liens in the form of cash collateral securing Contingent Obligations permitted pursuant to clause (h) of the definition of
“Permitted Contingent Obligations”; and (j) Liens and encumbrances in favor of the holders of the Affiliated Financing Documents. 

  
 18 

MidCap / EndoChoice / Term Credit and Security Agreement 








 “Permitted Modifications” means (a) such amendments or other modifications
to a Borrower’s or Subsidiary’s Organizational Documents as are required under this Agreement or by applicable Law, and (b) such amendments or modifications to a Borrower’s or Subsidiary’s Organizational Documents (other
than those involving a change in the name of a Borrower or Subsidiary or involving a reorganization of a Borrower or Subsidiary under the laws of a different jurisdiction) that would not materially and adversely affect the rights and interests of
the Agent or Lenders. 
 “Person” means any natural person, corporation, limited liability company, professional
association, limited partnership, general partnership, joint stock company, joint venture, association, company, trust, bank, trust company, land trust, business trust or other organization, whether or not a legal entity, and any Governmental
Authority. 
 “PNC Account” means each of Borrower’s accounts at PNC Bank, National Association set forth on Schedule
5.14 on the Closing Date. 
 “Products” means any products manufactured, sold, developed, tested or marketed by any
Borrower or any of its Subsidiaries, including without limitation, those products set forth on Schedule 8.1(a) (as updated from time to time in accordance with Section 4.15); provided, that, for the avoidance of doubt, any new Product
not disclosed on Schedule 8.1(a) shall still constitute a “Product” as herein defined. 
 “Pro Rata Share”
means (a) with respect to a Lender’s obligation to make advances in respect of a Term Loan and such Lender’s right to receive payments of principal and interest with respect to the Term Loans, the Term Loan Commitment Percentage of
such Lender, and (b) for all other purposes (including, without limitation, the indemnification obligations arising under Section 11.6) with respect to any Lender, the percentage obtained by dividing (i) the Term Loan
Commitment Amount of such Lender (or, in the event the Term Loan Commitment shall have been terminated, such Lender’s then outstanding principal advances of such Lender under the Term Loan), by (ii) the sum of the Term Loan
Commitment (or, in the event the Term Loan Commitment shall have been terminated, the then outstanding principal advances of such Lenders under the Term Loan) of all Lenders. 

“Recall” means a Person’s Removal or Correction of a marketed product that the FDA considers to be in violation of the
laws it administers and against which the FDA would initiate legal action, e.g., seizure. 
 “Registered Intellectual
Property” means any patent, registered trademark or servicemark, registered copyright, registered mask work, or any pending application for any of the foregoing. 

“Regulatory Reporting Event” has the meaning set forth in Section 4.17. 

  
 19 

MidCap / EndoChoice / Term Credit and Security Agreement 








 “Regulatory Required Permit” means any and all licenses, approvals and
permits issued by the FDA, DEA, CMS or any other applicable Governmental Authority, necessary for the testing, manufacture, marketing or sale of any Product or service performed by any applicable Borrower(s) and its Subsidiaries as such activities
are being conducted by such Borrower and its Subsidiaries with respect to such Product or service at such time and any drug listings and drug establishment registrations under 21 U.S.C. Section 510, registrations issued by DEA under 21 U.S.C.
Section 823 (if applicable to any Product), and those issued by State governments for the conduct of Borrower’s or any Subsidiary’s business. 

“Removal” means the physical removal of a product from its point of use to some other location for repair,
modification, adjustment, relabeling, destruction, or inspection. 
 “Required Lenders” means at any time
Lenders holding (a) fifty percent (50%) or more of the sum of the Term Loan Commitment (taken as a whole), or (b) if the Term Loan Commitment has been terminated, fifty percent (50%) or more of the then aggregate outstanding
principal balance of the Loans; provided that at any time that there are two or more Lenders, “Required Lenders” shall include not less than two such Lenders.  

“Responsible Officer” means any of the Chief Executive Officer, Chief Financial Officer or any other officer of the
applicable Borrower designated to the Agent by the Chief Executive Officer or Chief Financial Officer as a Responsible Officer that is reasonably acceptable to Agent. 

“Restricted Foreign Subsidiary” means each of EndoChoice Innovation Center Ltd., an Israeli company, EndoChoice GmbH, a
German company, and EndoChoice Israel, Ltd. an Israeli company. 
 “Revolving Loan Availability” means “Revolving Loan
Availability” under and as defined in the Affiliated Credit Agreement. 
 “SEC” means the United States
Securities and Exchange Commission. 
 “Securities Account” means a “securities account” (as
defined in Article 9 of the UCC), an investment account, or other account in which investment property or securities are held or invested for credit to or for the benefit of any Borrower. 

“Securities Account Control Agreement” means an agreement, in form and substance satisfactory to Agent, among Agent,
any applicable Borrower and each securities intermediary in which such Borrower maintains a Securities Account pursuant to which Agent shall obtain “control” (as defined in Article 9 of the UCC) over such Securities Account.

 “Security Document” means this Agreement and any other agreement, document or instrument executed
concurrently herewith or at any time hereafter pursuant to which one or more Credit Parties or any other Person either (a) Guarantees payment or performance of all or any portion of the Obligations, and/or (b) provides, as security for all
or any portion of the Obligations, a Lien on any of its assets in favor of Agent for its own benefit and the benefit of the Lenders, as any or all of the same may be amended, supplemented, restated or otherwise modified from time to time.


  
 20 

MidCap / EndoChoice / Term Credit and Security Agreement 








 “Solvent” means, with respect to any Person, that such Person
(a) owns and will own assets the fair saleable value of which are (i) greater than the total amount of its liabilities (including Contingent Obligations), and (ii) greater than the amount that will be required to pay the probable
liabilities of its then existing debts as they become absolute and matured considering all financing alternatives and potential asset sales reasonably available to it; (b) has capital that is not unreasonably small in relation to its business
as presently conducted or after giving effect to any contemplated transaction; and (c) does not intend to incur and does not believe that it will incur debts beyond its ability to pay such debts as they become due. 

“Subordinated Debt” means any Debt of Borrowers incurred pursuant to the terms of the Subordinated Debt Documents and with
the prior written consent of Agent, all of which documents must be in form and substance acceptable to Agent in its sole discretion. As of the Closing Date, there is no Subordinated Debt. 

“Subordinated Debt Documents” means any documents evidencing and/or securing Debt governed by a Subordination Agreement, all
of which documents must be in form and substance acceptable to Agent in its sole discretion. As of the Closing Date, there are no Subordinated Debt Documents. 

“Subordination Agreement” means any agreement between Agent and another creditor of Borrowers, as the same may be
amended, supplemented, restated or otherwise modified from time to time in accordance with the terms thereof, pursuant to which the Debt owing from any Borrower(s) and/or the Liens securing such Debt granted by any Borrower(s) to such creditor are
subordinated in any way to the Obligations and the Liens created under the Security Documents, the terms and provisions of such Subordination Agreements to have been agreed to by and be acceptable to Agent in the exercise of its sole discretion.

 “Subsidiary” means, with respect to any Person, (a) any corporation of which an aggregate of more than
fifty percent (50%) of the outstanding capital stock having ordinary voting power to elect a majority of the board of directors of such corporation (irrespective of whether, at the time, capital stock of any other class or classes of such
corporation shall have or might have voting power by reason of the happening of any contingency) is at the time, directly or indirectly, owned legally or beneficially by such Person or one or more Subsidiaries of such Person, or with respect to
which any such Person has the right to vote or designate the vote of more than fifty percent (50%) of such capital stock whether by proxy, agreement, operation of law or otherwise, and (b) any partnership or limited liability company in
which such Person and/or one or more Subsidiaries of such Person shall have an interest (whether in the form of voting or participation in profits or capital contribution) of more than fifty percent (50%) or of which any such Person is a
general partner or may exercise the powers of a general partner. Unless the context otherwise requires, each reference to a Subsidiary shall be a reference to a Subsidiary of a Borrower. 

  
 21 

MidCap / EndoChoice / Term Credit and Security Agreement 








 “Swap Contract” means any “swap agreement”, as defined in
Section 101 of the Bankruptcy Code, or similar agreement.  
 “Taxes” has the meaning set forth in
Section 2.8. 
 “Termination Date” means the earlier to occur of (a) the Commitment Expiry Date,
(b) any date on which Agent accelerates the maturity of the Loans pursuant to Section 10.2, or (c) the termination date stated in any notice of termination of this Agreement provided by Borrowers in accordance with
Section 2.12. 
 “Term Loan” has the meaning set forth in Section 2.1(a). 

“Term Loan Commitment” means, as of any date of determination, the aggregate Term Loan Commitment Amounts of all
Lenders as of such date. 
 “Term Loan Commitment Amount” means, (a) as to any Lender that is a Lender
on the Closing Date, the dollar amount set forth opposite such Lender’s name on the Commitment Annex under the column “Term Loan Commitment Amount”, as such amount may be adjusted from time to time by any amounts assigned (with
respect to such Lender’s portion of Term Loans outstanding and its commitment to make advances in respect of the Term Loan) pursuant to the terms of any and all effective assignment agreements to which such Lender is a party, and (b) as to
any Lender that becomes a Lender after the Closing Date, the amount of the “Term Loan Commitment Amount(s)” of other Lender(s) assigned to such new Lender pursuant to the terms of the effective assignment agreement(s) pursuant to which
such new Lender shall become a Lender, as such amount may be adjusted from time to time by any amounts assigned (with respect to such Lender’s portion of Term Loans outstanding and its commitment to make advances in respect of the Term Loan)
pursuant to the terms of any and all effective assignment agreements to which such Lender is a party. 
 “Term Loan
Commitment Percentage” means, as to any Lender, (a) on the Closing Date, the percentage set forth opposite such Lender’s name on the Commitment Annex under the column “Term Loan Commitment Percentage” (if such
Lender’s name is not so set forth thereon, then, on the Closing Date, such percentage for such Lender shall be deemed to be zero), and (b) on any date following the Closing Date, the percentage equal to the Term Loan Commitment Amount of
such Lender on such date divided by the Term Loan Commitment on such date. 
 “Third Party
Payor” means Medicare, Medicaid, TRICARE, and other state or federal health care program, Blue Cross and/or Blue Shield, private insurers, managed care plans and any other Person or entity which presently or in the future maintains Third
Party Payor Programs. 
 “Third Party Payor Programs” means all payment and reimbursement programs, sponsored
by a Third Party Payor, in which a Borrower participates. 
 “TRICARE” means the program administered
pursuant to 10 U.S.C. Section 1071 et. seq), Sections 1320a-7 and 1320a-7a of Title 42 of the United States Code and the regulations promulgated pursuant to such statutes. 

  
 22 

MidCap / EndoChoice / Term Credit and Security Agreement 








 “UCC” means the Uniform Commercial Code of the State of Maryland or of
any other state the laws of which are required to be applied in connection with the perfection of security interests in any Collateral. 

“United States” means the United States of America. 

Section 1.2 Accounting Terms and Determinations. Unless otherwise specified herein, all accounting terms used herein shall
be interpreted, all accounting determinations hereunder (including, without limitation, determinations made pursuant to the exhibits hereto) shall be made, and all financial statements required to be delivered hereunder shall be prepared on a
consolidated basis in accordance with GAAP applied on a basis consistent with the most recent audited consolidated financial statements of each Borrower and its Consolidated Subsidiaries delivered to Agent and each of the Lenders on or prior to the
Closing Date. If at any time any change in GAAP would affect the computation of any financial ratio or financial requirement set forth in any Financing Document, and either Borrowers or the Required Lenders shall so request, the Agent, the Lenders
and Borrowers shall negotiate in good faith to amend such ratio or requirement to preserve the original intent thereof in light of such change in GAAP (subject to the approval of the Required Lenders); provided, however, that until so
amended, (a) such ratio or requirement shall continue to be computed in accordance with GAAP prior to such change therein and (b) Borrowers shall provide to the Agent and the Lenders financial statements and other documents required under
this Agreement which include a reconciliation between calculations of such ratio or requirement made before and after giving effect to such change in GAAP. Notwithstanding any other provision contained herein, all terms of an accounting or financial
nature used herein shall be construed, and all computations of amounts and ratios referred to herein shall be made, without giving effect to any election under Statement of Financial Accounting Standards 159 (or any other Financial Accounting
Standard having a similar result or effect) to value any Debt or other liabilities of any Credit Party or any Subsidiary of any Credit Party at “fair value”, as defined therein. 

Section 1.3 Other Definitional and Interpretive Provisions. References in this Agreement to “Articles”,
“Sections”, “Annexes”, “Exhibits”, or “Schedules” shall be to Articles, Sections, Annexes, Exhibits or Schedules of or to this Agreement unless otherwise specifically provided. Any term defined herein may
be used in the singular or plural. “Include”, “includes” and “including” shall be deemed to be followed by “without limitation”. Except as otherwise specified or limited herein, references to any Person
include the successors and assigns of such Person. References “from” or “through” any date mean, unless otherwise specified, “from and including” or “through and including”, respectively. Unless otherwise
specified herein, the settlement of all payments and fundings hereunder between or among the parties hereto shall be made in lawful money of the United States and in immediately available funds. References to any statute or act shall include all
related current regulations and all amendments and any successor statutes, acts and regulations. All amounts used for purposes of financial calculations required to be made herein shall be without duplication. References to any statute or act,
without additional reference, shall be deemed to refer to federal statutes and acts of the United States. References to any agreement, instrument or document shall include all schedules, exhibits, annexes and other attachments thereto. As used in
this Agreement, the meaning of the term “material” or the phrase “in all material respects” is intended to refer to an act, omission, 

  
 23 

MidCap / EndoChoice / Term Credit and Security Agreement 








 
violation or condition which reflects or could reasonably be expected to result in a Material Adverse Effect. References to capitalized terms that are not defined herein, but are defined in the
UCC, shall have the meanings given them in the UCC. All references herein to times of day shall be references to daylight or standard time, as applicable. 

Section 1.4 Time is of the Essence. Time is of the essence in Borrower’s and each other Credit Party’s
performance under this Agreement and all other Financing Documents. 
 ARTICLE 2 - LOANS 

Section 2.1 Loans. 

(a) Term Loans. 

(i) Term Loan Amounts. On the terms and subject to the conditions set forth herein and in the other Financing Documents,
the Lenders severally hereby agree to make to Borrowers a term loan in an aggregate original principal amount equal to the Term Loan Commitment (“Term Loan”). Each Lender’s obligation to fund the Term Loan shall be limited to
such Lender’s Term Loan Commitment Percentage, and no Lender shall have any obligation to fund any portion of any Term Loan required to be funded by any other Lender, but not so funded. No Borrower shall have any right to reborrow any portion
of the Term Loan that is repaid or prepaid from time to time. The Term Loan shall be funded in one advance on the Closing Date. 

(ii) Scheduled Repayments; Mandatory Prepayments; Optional Prepayments. 

(A) There shall become due and payable, and Borrowers shall repay the Term Loan through, scheduled payments as set forth on
Schedule 2.1 attached hereto. Notwithstanding the payment schedule set forth above, the outstanding principal amount of the Term Loan shall become immediately due and payable in full on the Termination Date. 

(B) There shall become due and payable and Borrowers shall prepay the Term Loan in the following amounts and at the following
times: 
 (i) Unless Agent shall otherwise consent in writing, on the date on which any Credit Party (or Agent as loss payee
or assignee) receives any casualty proceeds in excess of $250,000 with respect to assets upon which Agent maintained a Lien, an amount equal to one hundred percent (100%) of such proceeds (net of out-of-pocket expenses and repayment of secured
debt permitted under clause (c) of the definition of Permitted Debt and encumbering the property that suffered such casualty), or such lesser portion of such proceeds as Agent shall elect to apply to the Obligations; 

  
 24 

MidCap / EndoChoice / Term Credit and Security Agreement 








 (ii) an amount equal to any interest that is deemed to be in excess of the
Maximum Lawful Rate (as defined below) and is required to be applied to the reduction of the principal balance of the Loans by any Lender as provided for in Section 2.7; 

(iii) unless Agent shall otherwise consent in writing, upon receipt by any Credit Party of the proceeds of any Asset
Disposition that is not a Permitted Asset Disposition (other than pursuant to clause (b) of the definition thereof) or that pertains to any Collateral upon which a Borrowing Base is calculated, an amount equal to one hundred percent
(100%) of the net cash proceeds of such asset disposition (net of out-of-pocket expenses and repayment of secured debt permitted under clause (c) of the definition of Permitted Debt and encumbering such asset), or such lesser portion as
Agent shall elect to apply to the Obligations; and 
 (iv) unless Agent shall otherwise consent in writing, upon receipt by
any Credit Party of any extraordinary receipts or the proceeds from the incurrence of Debt or issuance and sale of any Debt, an amount equal to one hundred percent (100%) of such extraordinary receipts, or such lesser portion as Agent shall
elect to apply to the Obligations. 
 Notwithstanding the foregoing and so long as no Event of Default or Default then
exists: (1) any such casualty proceeds in excess of $250,000 (other than with respect to Inventory and any real property, unless Agent shall otherwise elect) may be used by Borrowers within one hundred eighty (180) days from the receipt of
such proceeds to replace or repair any assets in respect of which such proceeds were paid so long as such proceeds are deposited into an account with Agent promptly upon receipt by such Borrower; and (2) proceeds of personal property asset
dispositions that are not made in the Ordinary Course of Business (other than Collateral upon which the Borrowing Base is calculated or Intellectual Property, unless Agent shall otherwise elect) may be used by Borrowers within one hundred eighty
(180) days from the receipt of such proceeds to purchase new or replacement assets of comparable value, provided, however, that such proceeds are deposited into an account with Agent promptly upon receipt by such Borrower. All sums held
by Agent pending reinvestment as described in subsections (1) and (2) above shall be deemed additional collateral for the Obligations and may be commingled with the general funds of Agent. 

(C) Borrowers may from time to time, with at least thirty (30) days prior written notice, prepay the Term Loan in whole
but not in part (other than mandatory partial prepayments required under this Agreement); provided, however, that each such prepayment shall be accompanied by any prepayment fees and exit fees required hereunder. 

  
 25 

MidCap / EndoChoice / Term Credit and Security Agreement 








 (iii) All Prepayments. Except as this Agreement may specifically provide
otherwise, all prepayments of the Term Loan shall be applied by Agent to the Obligations in inverse order of maturity. The monthly payments required under Schedule 2.1 shall continue in the same amount (for so long as the Term Loan
and/or (if applicable) any advance thereunder shall remain outstanding) notwithstanding any partial prepayment, whether mandatory or optional, of the Term Loan. 

(iv) Interest Rate. The Term Loan shall accrue interest at a per annum rate of interest equal to nine and one half
percent (9.50%) (the “Applicable Interest Rate”). 
 (b) Reserved. 

(c) Reserved. 

Section 2.2 Interest, Interest Calculations and Certain Fees. 

(a) Interest. From and following the Closing Date, except as expressly set forth in this Agreement, Loans and the other Obligations
shall bear interest at the sum of the Applicable Interest Rate. Interest on the Loans shall be paid in arrears on the first (1st) day of each month and on the maturity of such Loans, whether by acceleration or otherwise. Interest on all other
Obligations shall be payable upon demand. For purposes of calculating interest, all funds transferred to the Payment Account for application to the Term Loan shall be subject to a three (3) Business Day clearance period and all interest
accruing on such funds during such clearance period shall accrue for the benefit of Agent, and not for the benefit of the Lenders. 
 (b)
Reserved. 
 (c) Reserved. 

(d) Reserved. 
 (e)
Reserved. 
 (f) Reserved. 

(g) Reserved. 
 (h)
Exit Fee. Borrowers shall pay to Agent, for the benefit of all Lenders committed to make Term Loan advances, as compensation for the costs of making funds available to Borrowers under this Agreement an exit fee (the “Exit
Fee”) calculated in accordance with this subsection and upon the date or dates required under this subsection. The Exit Fee shall be equal to 2.95% times the amount of all Term Loans advanced to Borrower under this Agreement. Upon
any repayment of any portion of the Term Loan (whether voluntary, involuntary or mandatory) other than scheduled amortization payments (if any) and the final payment of principal in respect of the Term Loan, a portion of the Exit Fee shall be due in
the following amount: that percentage which is obtained by dividing the amount prepaid by 

  
 26 

MidCap / EndoChoice / Term Credit and Security Agreement 








 
the then outstanding principal balance of the Term Loan. Any remaining unpaid amount of the Exit Fee shall be due and payable on the Termination Date. All fees payable pursuant to this paragraph
shall be deemed fully accrued and earned as of the Closing Date. 
 (i) Prepayment Fee. If any advance under the Term Loan is prepaid
at any time, in whole or in part, for any reason (whether by voluntary prepayment by Borrowers, by reason of the occurrence of an Event of Default or the acceleration of the Term Loan, or otherwise), or if the Term Loan shall become accelerated and
due and payable in full, or if the Lenders’ funding obligations in respect of any unfunded portion of the Term Loan shall terminate prior to the Commitment Expiry Date, Borrowers shall pay to Agent, for the benefit of all Lenders committed to
make Term Loan advances, as compensation for the costs of such Lenders making funds available to Borrowers under this Agreement, a prepayment fee (the “Prepayment Fee”) calculated in accordance with this subsection. The
Prepayment Fee shall be equal to an amount determined by multiplying the amount being prepaid by the following applicable percentage amount: (x) 2.0% for the first year following the Closing Date, (y) 1.0% for the second
year following the Closing Date and (z) 0% thereafter. The Prepayment Fee shall not apply to or be assessed upon any prepayment made by Borrowers if such payments were required by Agent to be made pursuant to Section 2.1(a)(ii)(B)
subpart (i) (relating to casualty proceeds), or subpart (ii) (relating to payments exceeding the Maximum Lawful Rate). All fees payable pursuant to this paragraph shall be deemed fully earned and non-refundable as of the Closing Date. 

(j) Audit Fees. Borrowers shall pay to Agent, for its own account and not for the benefit of any other Lenders, all reasonable fees and
expenses in connection with audits and inspections of Borrowers’ books and records, audits, valuations or appraisals of the Collateral, audits of Borrowers’ compliance with applicable Laws and such other matters as Agent shall deem
appropriate, which shall be due and payable on the first Business Day of the month following the date of issuance by Agent of a written request for payment thereof to Borrowers. Notwithstanding the foregoing, so long as no Event of Default has
occurred and is continuing, Borrowers shall not be required to reimburse Agent for more than one (1) audit per fiscal year; provided, however, if Borrowers have previously reimbursed the agent under the Affiliated Credit Agreement for
two (2) audits in the applicable fiscal year, Borrowers shall not be required to reimburse Agent for any such audits conducted hereunder unless an Event of Default has occurred and is continuing). 

(k) Reserved. 
 (l)
Late Charges. If payments of principal (other than a final installment of principal upon the Termination Date), interest due on the Obligations, or any other amounts due hereunder or under the other Financing Documents are not timely made and
remain overdue for a period of five (5) days, Borrowers, without notice or demand by Agent, promptly shall pay to Agent, for its own account and not for the benefit of any other Lenders, as additional compensation to Agent in administering the
Obligations, an amount equal to five percent (5.0%) of each delinquent payment. 

  
 27 

MidCap / EndoChoice / Term Credit and Security Agreement 








 (m) Computation of Interest and Related Fees. All interest and fees under each Financing
Document shall be calculated on the basis of a 360-day year for the actual number of days elapsed. The date of funding of a Loan shall be included in the calculation of interest. The date of payment of a Loan shall be excluded from the calculation
of interest. If a Loan is repaid on the same day that it is made, one (1) day’s interest shall be charged. 
 (n) Automated
Clearing House Payments. If Agent so elects, monthly payments of principal, interest, fees, expenses or any other amounts due and owing from Borrower to Agent hereunder shall be paid to Agent by Automated Clearing House debit of immediately
available funds from the financial institution account designated by Borrower Representative in the Automated Clearing House debit authorization executed by Borrowers or Borrower Representative in connection with this Agreement, and shall be
effective upon receipt. Borrowers shall execute any and all forms and documentation necessary from time to time to effectuate such automatic debiting. In no event shall any such payments be refunded to Borrowers. 

Section 2.3 Notes. The portion of the Loans made by each Lender shall be evidenced, if so requested by such Lender,
by one or more promissory notes executed by Borrowers on a joint and several basis (each, a “Note”) in an original principal amount equal to such Lender’s Term Loan Commitment Amount.  

Section 2.4 [Reserved]. 

Section 2.5 [Reserved]. 

Section 2.6 General Provisions Regarding Payment; Loan Account. 

(a) All payments to be made by each Borrower under any Financing Document, including payments of principal and interest made hereunder and
pursuant to any other Financing Document, and all fees, expenses, indemnities and reimbursements, shall be made without set-off, recoupment or counterclaim. If any payment hereunder becomes due and payable on a day other than a Business Day, such
payment shall be extended to the next succeeding Business Day and, with respect to payments of principal, interest thereon shall be payable at the then applicable rate during such extension (it being understood and agreed that, solely for purposes
of calculating financial covenants and computations contained herein and determining compliance therewith, if payment is made, in full, on any such extended due date, such payment shall be deemed to have been paid on the original due date without
giving effect to any extension thereto). Any payments received in the Payment Account before 12:00 Noon (Eastern time) on any date shall be deemed received by Agent on such date, and any payments received in the Payment Account at or after 12:00
Noon (Eastern time) on any date shall be deemed received by Agent on the next succeeding Business Day. 
 (b) Agent shall maintain a loan
account (the “Loan Account”) on its books to record Loans and other extensions of credit made by the Lenders hereunder or under any other Financing Document, and all payments thereon made by each Borrower. All entries in the Loan
Account shall be made in accordance with Agent’s customary accounting practices as in effect 

  
 28 

MidCap / EndoChoice / Term Credit and Security Agreement 








 
from time to time. The balance in the Loan Account, as recorded in Agent’s books and records at any time shall be conclusive and binding evidence of the amounts due and owing to Agent by
each Borrower absent manifest error; provided, however, that any failure to so record or any error in so recording shall not limit or otherwise affect any Borrower’s duty to pay all amounts owing hereunder or under any other
Financing Document. Agent shall endeavor to provide Borrowers with a monthly statement regarding the Loan Account (but neither Agent nor any Lender shall have any liability if Agent shall fail to provide any such statement). Unless any Borrower
notifies Agent of any objection to any such statement (specifically describing the basis for such objection) within ninety (90) days after the date of receipt thereof, it shall be deemed final, binding and conclusive upon Borrowers in all
respects as to all matters reflected therein. 
 Section 2.7 Maximum Interest. In no event shall the interest charged
with respect to the Loans or any other Obligations of any Borrower under any Financing Document exceed the maximum amount permitted under the laws of the State of Maryland or of any other applicable jurisdiction. Notwithstanding anything to the
contrary herein or elsewhere, if at any time the rate of interest payable hereunder or under any Note or other Financing Document (the “Stated Rate”) would exceed the highest rate of interest permitted under any applicable law to be
charged (the “Maximum Lawful Rate”), then for so long as the Maximum Lawful Rate would be so exceeded, the rate of interest payable shall be equal to the Maximum Lawful Rate; provided, however, that if at any time
thereafter the Stated Rate is less than the Maximum Lawful Rate, each Borrower shall, to the extent permitted by law, continue to pay interest at the Maximum Lawful Rate until such time as the total interest received is equal to the total interest
which would have been received had the Stated Rate been (but for the operation of this provision) the interest rate payable. Thereafter, the interest rate payable shall be the Stated Rate unless and until the Stated Rate again would exceed the
Maximum Lawful Rate, in which event this provision shall again apply. In no event shall the total interest received by any Lender exceed the amount which it could lawfully have received had the interest been calculated for the full term hereof at
the Maximum Lawful Rate. If, notwithstanding the prior sentence, any Lender has received interest hereunder in excess of the Maximum Lawful Rate, such excess amount shall be applied to the reduction of the principal balance of the Loans or to other
amounts (other than interest) payable hereunder, and if no such principal or other amounts are then outstanding, such excess or part thereof remaining shall be paid to Borrowers. In computing interest payable with reference to the Maximum Lawful
Rate applicable to any Lender, such interest shall be calculated at a daily rate equal to the Maximum Lawful Rate divided by the number of days in the year in which such calculation is made. 

Section 2.8 Taxes; Capital Adequacy. 

(a) All payments of principal and interest on the Loans and all other amounts payable hereunder shall be made free and clear of and without
deduction for any present or future income, excise, stamp, documentary, payroll, employment, property or franchise taxes and other taxes, fees, duties, levies, assessments, withholdings or other charges of any nature whatsoever (including interest
and penalties thereon) imposed by any taxing authority, excluding taxes imposed on or measured by Agent’s or any Lender’s net income by the jurisdictions under which Agent or such Lender is organized or conducts business (other than solely
as the result of entering into any of the Financing Documents or taking any action thereunder) (all non-excluded 

  
 29 

MidCap / EndoChoice / Term Credit and Security Agreement 








 
items being called “Taxes”). If any withholding or deduction from any payment to be made by any Borrower hereunder is required in respect of any Taxes pursuant to any applicable
Law, then Borrowers will: (i) pay directly to the relevant authority the full amount required to be so withheld or deducted; (ii) promptly forward to Agent an official receipt or other documentation satisfactory to Agent evidencing such
payment to such authority; and (iii) pay to Agent for the account of Agent and Lenders such additional amount or amounts as is necessary to ensure that the net amount actually received by Agent and each Lender will equal the full amount Agent
and such Lender would have received had no such withholding or deduction been required. If any Taxes are directly asserted against Agent or any Lender with respect to any payment received by Agent or such Lender hereunder, Agent or such Lender may
pay such Taxes and Borrowers will promptly pay such additional amounts (including any penalty, interest or expense) as is necessary in order that the net amount received by such Person after the payment of such Taxes (including any Taxes on such
additional amount) shall equal the amount such Person would have received had such Taxes not been asserted so long as such amounts have accrued on or after the day which is two hundred seventy (270) days prior to the date on which Agent or such
Lender first made written demand therefor. 
 (b) If any Borrower fails to pay any Taxes when due to the appropriate taxing authority or
fails to remit to Agent, for the account of Agent and the respective Lenders, the required receipts or other required documentary evidence, Borrowers shall indemnify Agent and Lenders for any incremental Taxes, interest or penalties that may become
payable by Agent or any Lender as a result of any such failure. 
 (c) Each Lender that (i) is organized under the laws of a
jurisdiction other than the United States, and (ii)(A) is a party hereto on the Closing Date or (B) purports to become an assignee of an interest as a Lender under this Agreement after the Closing Date (unless such Lender was already a
Lender hereunder immediately prior to such assignment) (each such Lender a “Foreign Lender”) shall execute and deliver to each of Borrowers and Agent one or more (as Borrowers or Agent may reasonably request) United States Internal
Revenue Service Forms W-8ECI, W-8BEN, W-8IMY (as applicable) and other applicable forms, certificates or documents prescribed by the United States Internal Revenue Service or reasonably requested by Agent certifying as to such Lender’s
entitlement to a complete exemption from withholding or deduction of Taxes. Borrowers shall not be required to pay additional amounts to any Lender pursuant to this Section 2.8 with respect to United States withholding and income Taxes to the
extent that the obligation to pay such additional amounts would not have arisen but for the failure of such Lender to comply with this paragraph other than as a result of a change in law. 

(d) If any Lender shall determine in its commercially reasonable judgment that the adoption or taking effect of, or any change in, any
applicable Law regarding capital adequacy, in each instance, after the Closing Date, or any change after the Closing Date in the interpretation, administration or application thereof by any Governmental Authority, central bank or comparable agency
charged with the interpretation, administration or application thereof, or the compliance by any Lender or any Person controlling such Lender with any request, guideline or directive regarding capital adequacy (whether or not having the force of
law) of any such Governmental Authority, central bank or comparable agency adopted or otherwise taking effect 

  
 30 

MidCap / EndoChoice / Term Credit and Security Agreement 








 
after the Closing Date, has or would have the effect of reducing the rate of return on such Lender’s or such controlling Person’s capital as a consequence of such Lender’s
obligations hereunder to a level below that which such Lender or such controlling Person could have achieved but for such adoption, taking effect, change, interpretation, administration, application or compliance (taking into consideration such
Lender’s or such controlling Person’s policies with respect to capital adequacy) then from time to time, upon written demand by such Lender (which demand shall be accompanied by a statement setting forth the basis for such demand and a
calculation of the amount thereof in reasonable detail, a copy of which shall be furnished to Agent), Borrowers shall promptly pay to such Lender such additional amount as will compensate such Lender or such controlling Person for such reduction, so
long as such amounts have accrued on or after the day which is two hundred seventy (270) days prior to the date on which such Lender first made demand therefor; provided, however, that notwithstanding anything in this Agreement to the contrary,
(i) the Dodd-Frank Wall Street Reform and Consumer Protection Act and all requests, rules, guidelines or directives thereunder or issued in connection therewith and (ii) all requests, rules, guidelines or directives promulgated by the Bank
for International Settlements, the Basel Committee on Banking Supervision (or any successor or similar authority) or the United States or foreign regulatory authorities, in each case pursuant to Basel III, shall in each case be deemed to be a
“change in applicable Law”, regardless of the date enacted, adopted or issued. 
 (e) If any Lender requires compensation under
Section 2.8(d), or requires any Borrower to pay any additional amount to any Lender or any Governmental Authority for the account of any Lender pursuant to Section 2.8(a), then, upon the written request of Borrower Representative, such
Lender shall use reasonable efforts to designate a different lending office for funding or booking its Loans hereunder or to assign its rights and obligations hereunder (subject to the terms of this Agreement) to another of its offices, branches or
affiliates, if, in the judgment of such Lender, such designation or assignment (i) would eliminate or materially reduce amounts payable pursuant to any such subsection, as the case may be, in the future, and (ii) would not subject such
Lender to any unreimbursed cost or expense and would not otherwise be disadvantageous to such Lender (as determined in its sole discretion). Borrowers hereby agree to pay all reasonable costs and expenses incurred by any Lender in connection with
any such designation or assignment. 
 Section 2.9 Appointment of Borrower Representative. Each Borrower hereby
designates Borrower Representative as its representative and agent on its behalf for the purposes of issuing Notices of Borrowing, and giving instructions with respect to the disbursement of the proceeds of the Loans, giving and receiving all other
notices and consents hereunder or under any of the other Financing Documents and taking all other actions (including in respect of compliance with covenants) on behalf of any Borrower or Borrowers under the Financing Documents. Borrower
Representative hereby accepts such appointment. Notwithstanding anything to the contrary contained in this Agreement, no Borrower other than Borrower Representative shall be entitled to take any of the foregoing actions. The proceeds of each Loan
made hereunder shall be advanced to or at the direction of Borrower Representative and if not used by Borrower Representative in its business (for the purposes provided in this Agreement) shall be deemed to be immediately advanced by Borrower
Representative to the appropriate other Borrower hereunder as an intercompany loan (collectively, “Intercompany Loans”). All 

  
 31 

MidCap / EndoChoice / Term Credit and Security Agreement 








 
collections of each Borrower in respect of Accounts and other proceeds of Collateral of such Borrower received by Agent and applied to the Obligations shall also be deemed to be repayments of the
Intercompany Loans owing by such Borrower to Borrower Representative. Borrowers shall maintain accurate books and records with respect to all Intercompany Loans and all repayments thereof. Agent and each Lender may regard any notice or other
communication pursuant to any Financing Document from Borrower Representative as a notice or communication from all Borrowers, and may give any notice or communication required or permitted to be given to any Borrower or all Borrowers hereunder to
Borrower Representative on behalf of such Borrower or all Borrowers. Each Borrower agrees that each notice, election, representation and warranty, covenant, agreement and undertaking made on its behalf by Borrower Representative shall be deemed for
all purposes to have been made by such Borrower and shall be binding upon and enforceable against such Borrower to the same extent as if the same had been made directly by such Borrower. 

Section 2.10 Joint and Several Liability; Rights of Contribution; Subordination and Subrogation. 

(a) Borrowers are defined collectively to include all Persons named as one of the Borrowers herein; provided, however, that any
references herein to “any Borrower”, “each Borrower” or similar references, shall be construed as a reference to each individual Person named as one of the Borrowers herein. Each Person so named shall be jointly and severally
liable for all of the obligations of Borrowers under this Agreement. Each Borrower, individually, expressly understands, agrees and acknowledges, that the credit facilities would not be made available on the terms herein in the absence of the
collective credit of all of the Persons named as the Borrowers herein, the joint and several liability of all such Persons, and the cross-collateralization of the collateral of all such Persons. Accordingly, each Borrower individually acknowledges
that the benefit to each of the Persons named as one of the Borrowers as a whole constitutes reasonably equivalent value, regardless of the amount of the credit facilities actually borrowed by, advanced to, or the amount of collateral provided by,
any individual Borrower. In addition, each entity named as one of the Borrowers herein hereby acknowledges and agrees that all of the representations, warranties, covenants, obligations, conditions, agreements and other terms contained in this
Agreement shall be applicable to and shall be binding upon and measured and enforceable individually against each Person named as one of the Borrowers herein as well as all such Persons when taken together. By way of illustration, but without
limiting the generality of the foregoing, the terms of Section 10.1 of this Agreement are to be applied to each individual Person named as one of the Borrowers herein (as well as to all such Persons taken as a whole), such that the occurrence
of any of the events described in Section 10.1 of this Agreement as to any Person named as one of the Borrowers herein shall constitute an Event of Default even if such event has not occurred as to any other Persons named as the Borrowers or as
to all such Persons taken as a whole. 
 (b) Notwithstanding any provisions of this Agreement to the contrary, it is intended that the joint
and several nature of the liability of each Borrower for the Obligations and the Liens granted by Borrowers to secure the Obligations, not constitute a Fraudulent Conveyance (as defined below). Consequently, Agent, Lenders and each Borrower agree
that if the liability of a Borrower for the Obligations, or any Liens granted by such Borrower securing 

  
 32 

MidCap / EndoChoice / Term Credit and Security Agreement 








 
the Obligations would, but for the application of this sentence, constitute a Fraudulent Conveyance, the liability of such Borrower and the Liens securing such liability shall be valid and
enforceable only to the maximum extent that would not cause such liability or such Lien to constitute a Fraudulent Conveyance, and the liability of such Borrower and this Agreement shall automatically be deemed to have been amended accordingly. For
purposes hereof, the term “Fraudulent Conveyance” means a fraudulent conveyance under Section 548 of Chapter 11 of Title II of the Bankruptcy Code or a fraudulent conveyance or fraudulent transfer under the applicable
provisions of any fraudulent conveyance or fraudulent transfer law or similar law of any state, nation or other governmental unit, as in effect from time to time. 

(c) Agent is hereby authorized, without notice or demand (except as otherwise specifically required under this Agreement) and without
affecting the liability of any Borrower hereunder, at any time and from time to time, to (i) renew, extend or otherwise increase the time for payment of the Obligations; (ii) with the written agreement of any Borrower, change the terms
relating to the Obligations or otherwise modify, amend or change the terms of any Note or other agreement, document or instrument now or hereafter executed by any Borrower and delivered to Agent for any Lender; (iii) accept partial payments of
the Obligations; (iv) take and hold any Collateral for the payment of the Obligations or for the payment of any guaranties of the Obligations and exchange, enforce, waive and release any such Collateral; (v) apply any such Collateral and
direct the order or manner of sale thereof as Agent, in its sole discretion, may determine; and (vi) settle, release, compromise, collect or otherwise liquidate the Obligations and any Collateral therefor in any manner, all guarantor and surety
defenses being hereby waived by each Borrower. Without limitations of the foregoing, with respect to the Obligations, each Borrower hereby makes and adopts each of the agreements and waivers set forth in each Guarantee, the same being incorporated
hereby by reference. Except as specifically provided in this Agreement or any of the other Financing Documents, Agent shall have the exclusive right to determine the time and manner of application of any payments or credits, whether received from
any Borrower or any other source, and such determination shall be binding on all Borrowers. All such payments and credits may be applied, reversed and reapplied, in whole or in part, to any of the Obligations that Agent shall determine, in its sole
discretion, without affecting the validity or enforceability of the Obligations of the other Borrower. 
 (d) Each Borrower hereby agrees
that, except as hereinafter provided, its obligations hereunder shall be unconditional, irrespective of (i) the absence of any attempt to collect the Obligations from any obligor or other action to enforce the same; (ii) the waiver or
consent by Agent with respect to any provision of any instrument evidencing the Obligations, or any part thereof, or any other agreement heretofore, now or hereafter executed by a Borrower and delivered to Agent; (iii) failure by Agent to take
any steps to perfect and maintain its security interest in, or to preserve its rights to, any security or collateral for the Obligations; (iv) the institution of any proceeding under the Bankruptcy Code, or any similar proceeding, by or against
a Borrower or Agent’s election in any such proceeding of the application of Section 1111(b)(2) of the Bankruptcy Code; (v) any borrowing or grant of a security interest by a Borrower as debtor-in-possession, under Section 364 of
the Bankruptcy Code; (vi) the disallowance, under Section 502 of the Bankruptcy Code, of all or any portion of Agent’s claim(s) for repayment of any of the Obligations; or (vii) any other circumstance other than payment in full
of the Obligations which might otherwise constitute a legal or equitable discharge or defense of a guarantor or surety. 

  
 33 

MidCap / EndoChoice / Term Credit and Security Agreement 








 (e) The Borrowers hereby agree, as between themselves, that to the extent that Agent, on behalf
of Lenders, shall have received from any Borrower any Recovery Amount (as defined below), then the paying Borrower shall have a right of contribution against each other Borrower in an amount equal to such other Borrower’s contributive share of
such Recovery Amount; provided, however, that in the event any Borrower suffers a Deficiency Amount (as defined below), then the Borrower suffering the Deficiency Amount shall be entitled to seek and receive contribution from and against the other
Borrowers in an amount equal to the Deficiency Amount; and provided, further, that in no event shall the aggregate amounts so reimbursed by reason of the contribution of any Borrower equal or exceed an amount that would, if paid, constitute or
result in Fraudulent Conveyance. Until all Obligations have been paid and satisfied in full, no payment made by or for the account of a Borrower including, without limitation, (i) a payment made by such Borrower on behalf of the liabilities of
any other Borrower, or (ii) a payment made by any other Guarantor under any Guarantee, shall entitle such Borrower, by subrogation or otherwise, to any payment from such other Borrower or from or out of such other Borrower’s property. The
right of each Borrower to receive any contribution under this Section 2.10(e) or by subrogation or otherwise from any other Borrower shall be subordinate in right of payment to the Obligations and such Borrower shall not exercise any right or
remedy against such other Borrower or any property of such other Borrower by reason of any performance of such Borrower of its joint and several obligations hereunder, until the Obligations have been indefeasibly paid and satisfied in full, and no
Borrower shall exercise any right or remedy with respect to this Section 2.10(e) until the Obligations have been indefeasibly paid and satisfied in full. As used in this Section 2.10(e), the term “Recovery Amount” means
the amount of proceeds received by or credited to Agent from the exercise of any remedy of the Lenders under this Agreement or the other Financing Documents, including, without limitation, the sale of any Collateral. As used in this
Section 2.10(e), the term “Deficiency Amount” means any amount that is less than the entire amount a Borrower is entitled to receive by way of contribution or subrogation from, but that has not been paid by, the other Borrowers
in respect of any Recovery Amount attributable to the Borrower entitled to contribution, until the Deficiency Amount has been reduced to $0 through contributions and reimbursements made under the terms of this Section 2.10(e) or otherwise. 

Section 2.11 Deposit Accounts. Except for the Amegy Accounts and the PNC Accounts prior to the time such accounts are
required to be closed in accordance with Section 7.4, Borrowers shall maintain all of their depository, operating and securities accounts with Silicon Valley Bank, so long as it remains a Lender under this Agreement. Notwithstanding the
foregoing, Borrower shall ensure that the aggregate amount on deposit in the Amegy Accounts and the PNC Accounts, collectively, does not exceed $1,000,000 at any time. 

Section 2.12 Termination; Restriction on Termination. 

(a) Termination by Lenders. In addition to the rights set forth in Section 10.2, Agent may, and at the direction of Required
Lenders shall, terminate this Agreement without notice upon or after the occurrence and during the continuance of an Event of Default. 

  
 34 

MidCap / EndoChoice / Term Credit and Security Agreement 








 (b) Termination by Borrowers. Upon at least thirty (30) days’ prior written
notice and pursuant to payoff documentation in form and substance satisfactory to Agent and Lenders, Borrowers may, at its option, terminate this Agreement; provided, however, that no such termination shall be effective until Borrowers
have complied with Section 2.2. Any notice of termination given by Borrowers shall be irrevocable unless all Lenders otherwise agree in writing and no Lender shall have any obligation to make any Loans on or after the termination date
stated in such notice. Borrowers may elect to terminate this Agreement in its entirety only. No section of this Agreement or type of Loan available hereunder may be terminated singly. 

(c) Effectiveness of Termination. All of the Obligations shall be immediately due and payable upon the Termination Date. All
undertakings, agreements, covenants, warranties and representations of Borrowers contained in the Financing Documents shall survive any such termination and Agent shall retain its Liens in the Collateral and Agent and each Lender shall retain all of
its rights and remedies under the Financing Documents notwithstanding such termination until all Obligations and Affiliated Obligations have been discharged or paid, in full, in immediately available funds, including, without limitation, all
Obligations under Section 2.2(g) and Section 2.2(h) and the terms of any fee letter resulting from such termination. Notwithstanding the foregoing or the payment in full of the Obligations, Agent shall not be required to terminate its
Liens in the Collateral unless, with respect to any loss or damage Agent may incur as a result of dishonored checks or other items of payment received by Agent from Borrower or any Account Debtor and applied to the Obligations, Agent shall, at its
option, (i) have received a written agreement satisfactory to Agent, executed by Borrowers and by any Person whose loans or other advances to Borrowers are used in whole or in part to satisfy the Obligations, indemnifying Agent and each Lender
from any such loss or damage or (ii) have retained cash Collateral or other Collateral for such period of time as Agent, in its discretion, may deem necessary to protect Agent and each Lender from any such loss or damage. 

ARTICLE 3 - REPRESENTATIONS AND WARRANTIES 

To induce Agent and Lenders to enter into this Agreement and to make the Loans and other credit accommodations contemplated hereby, each
Borrower hereby represents and warrants to Agent and each Lender that: 
 Section 3.1 Existence and Power. Each Credit
Party is an entity as specified on Schedule 3.1, is duly organized, validly existing and in good standing under the laws of the jurisdiction specified on Schedule 3.1 and no other jurisdiction, has the same legal name as it appears in such
Credit Party’s Organizational Documents and an organizational identification number (if any), in each case as specified on Schedule 3.1, and has all powers and all Permits necessary or desirable in the operation of its business as
presently conducted or as proposed to be conducted, except where the failure to have such Permits could not reasonably be expected to have a Material Adverse Effect. Each Credit Party is qualified to do business as a foreign entity in each
jurisdiction in which it is required to be so qualified, which jurisdictions as of the Closing Date are specified on Schedule 3.1, except where the failure to be so qualified could not reasonably be expected to have a Material Adverse Effect.
Except as set forth on Schedule 3.1, no Credit Party (a) has had, over the five (5) year period preceding the Closing Date, any name other than its current name, or (b) was incorporated or organized under the laws of any
jurisdiction other than its current jurisdiction of incorporation or organization. 

  
 35 

MidCap / EndoChoice / Term Credit and Security Agreement 








 Section 3.2 Organization and Governmental Authorization; No Contravention. The
execution, delivery and performance by each Credit Party of the Operative Documents to which it is a party (a) are within its powers, (b) have been duly authorized by all necessary action pursuant to its Organizational Documents,
(c) require no further action by or in respect of, or filing with, any Governmental Authority, except for the filings necessary to perfect the Liens created by the Operative Documents, and (d) do not violate, conflict with or cause a
breach or a default under (i) any Law applicable to any Credit Party or any of the Organizational Documents of any Credit Party, or (ii) any agreement or instrument binding upon it, except for such violations, conflicts, breaches or
defaults as could not, with respect to this clause (ii), reasonably be expected to have a Material Adverse Effect. 

Section 3.3 Binding Effect. Each of the Operative Documents to which any Credit Party is a party constitutes a valid and
binding agreement or instrument of such Credit Party, enforceable against such Credit Party in accordance with its respective terms, except as the enforceability thereof may be limited by bankruptcy, insolvency or other similar laws relating to the
enforcement of creditors’ rights generally and by general equitable principles. 
 Section 3.4 Capitalization. The
authorized equity securities of each of the Credit Parties (other than Holdings) as of the Closing Date are as set forth on Schedule 3.4. All issued and outstanding equity securities of each of the Credit Parties (other than Holdings) are duly
authorized and validly issued, fully paid, nonassessable, free and clear of all Liens other than those in favor of Agent for the benefit of Agent and Lenders and Permitted Liens disclosed Schedule 5.2 on the Closing Date, and such equity securities
were issued in compliance with all applicable Laws. The identity of the holders of the equity securities of each of the Credit Parties (other than Holdings) and the percentage of their fully-diluted ownership of the equity securities of each of the
Credit Parties (other than Holdings) as of the Closing Date is set forth on Schedule 3.4. No shares of the capital stock or other equity securities of any Credit Party (other than Holdings), other than those described above, are issued and
outstanding as of the Closing Date. Except as set forth on Schedule 3.4, as of the Closing Date there are no preemptive or other outstanding rights, options, warrants, conversion rights or similar agreements or understandings for the purchase
or acquisition from any Credit Party (other than Holdings) of any equity securities of any such entity. 
 Section 3.5
Financial Information. All information delivered to Agent and pertaining to the financial condition of any Credit Party fairly presents in all material respects the financial position of such Credit Party as of such date in conformity with
GAAP (and as to unaudited financial statements, subject to normal year-end adjustments and the absence of footnote disclosures). Since December 31, 2014, there has been no material adverse change in the business, operations, properties or
condition (financial or otherwise) of any Credit Party. 
 Section 3.6 Litigation. Except as set forth on
Schedule 3.6 as of the Closing Date, and except as hereafter disclosed to Agent in writing, there is no Litigation pending against, or to such Borrower’s knowledge threatened against, any Credit Party and which involves any 

  
 36 

MidCap / EndoChoice / Term Credit and Security Agreement 








 
reasonably likelihood of any judgment or liability of more than Five Hundred Thousand Dollars ($500,000) or that could result in a Material Adverse Effect. There is no Litigation pending which
could reasonably be expected to have a Material Adverse Effect or which in any manner draws into question the validity of any of the Operative Documents. 

Section 3.7 Ownership of Property. Each Borrower and each of its Subsidiaries is the lawful owner of, has good and
marketable title to and is in lawful possession of, or has valid leasehold interests in, all material properties and other material assets (real or personal, tangible, intangible or mixed) purported or reported to be owned or leased (as the case may
be) by such Person. 
 Section 3.8 No Default. No Event of Default, or to such Borrower’s knowledge, Default, has
occurred and is continuing. No Credit Party is in breach or default under or with respect to any contract, agreement, lease or other instrument to which it is a party or by which its property is bound or affected, which breach or default could
reasonably be expected to have a Material Adverse Effect. 
 Section 3.9 Labor Matters. As of the Closing Date, except as
could not reasonably be expected to have a Material Adverse Effect, there are no strikes or other labor disputes pending or, to any Borrower’s knowledge, threatened against any Credit Party. The consummation of the transactions contemplated by
the Financing Documents will not give rise to a right of termination or right of renegotiation on the part of any union under any collective bargaining agreement to which it is a party or by which it is bound. 

Section 3.10 Regulated Entities. No Credit Party is an “investment company” or a company “controlled”
by an “investment company” or a “subsidiary” of an “investment company,” all within the meaning of the Investment Company Act of 1940. 

Section 3.11 Margin Regulations. None of the proceeds from the Loans have been or will be used, directly or indirectly, for
the purpose of purchasing or carrying any “margin stock” (as defined in Regulation U of the Federal Reserve Board), for the purpose of reducing or retiring any indebtedness which was originally incurred to purchase or carry any
“margin stock” or for any other purpose which might cause any of the Loans to be considered a “purpose credit” within the meaning of Regulation T, U or X of the Federal Reserve Board. 

Section 3.12 Compliance With Laws; Anti-Terrorism Laws. 

(a) Each Credit Party is in compliance with the requirements of all applicable Laws, except for such Laws the noncompliance with which could
not reasonably be expected to have a Material Adverse Effect. 
 (b) None of the Credit Parties and, to the knowledge of the Credit Parties,
none of their Affiliates (i) is in violation of any Anti-Terrorism Law, (ii) engages in or conspires to engage in any transaction that evades or avoids, or has the purpose of evading or avoiding, or attempts to violate, any of the
prohibitions set forth in any Anti-Terrorism Law, (iii) is a Blocked Person, or is controlled by a Blocked Person, (iv) is acting or will act for or on behalf of a 

  
 37 

MidCap / EndoChoice / Term Credit and Security Agreement 








 
Blocked Person, (v) is associated with, or will become associated with, a Blocked Person or (vi) is providing, or will provide, material, financial or technical support or other
services to or in support of acts of terrorism of a Blocked Person. No Credit Party nor, to the knowledge of any Credit Party, any of its Affiliates or agents acting or benefiting in any capacity in connection with the transactions contemplated by
this Agreement, (A) conducts any business or engages in making or receiving any contribution of funds, goods or services to or for the benefit of any Blocked Person, or (B) deals in, or otherwise engages in any transaction relating to, any
property or interest in property blocked pursuant to Executive Order No. 13224, any similar executive order or other Anti-Terrorism Law. 

Section 3.13 Taxes. All federal, state, foreign and material local tax returns, reports and statements required to be filed
by or on behalf of each Credit Party have been filed with the appropriate Governmental Authorities in all jurisdictions in which such returns, reports and statements are required to be filed and, except to the extent subject to a Permitted Contest,
all Taxes (including real property Taxes) and other charges shown to be due and payable in respect thereof have been timely paid prior to the date on which any fine, penalty, interest, late charge or loss may be added thereto for nonpayment thereof.
Except to the extent subject to a Permitted Contest, all material state and local sales and use Taxes required to be paid by each Credit Party have been paid. All federal and state Tax returns have been filed by each Credit Party for all periods for
which returns were due with respect to employee income tax withholding, social security and unemployment taxes, and, except to the extent subject to a Permitted Contest, the amounts shown thereon to be due and payable have been paid in full or
adequate provisions therefor have been made. 
 Section 3.14 Compliance with ERISA. 

(a) Each ERISA Plan (and the related trusts and funding agreements) complies in form and in operation with, has been administered in compliance
with, and the terms of each ERISA Plan satisfy, the applicable requirements of ERISA and the Code in all material respects. Each ERISA Plan which is intended to be qualified under Section 401(a) of the Code is so qualified, and the United
States Internal Revenue Service has issued a favorable determination letter with respect to each such ERISA Plan which may be relied on currently. No Credit Party has incurred liability for any material excise tax under any of Sections 4971
through 5000 of the Code. 
 (b) Except as could not reasonably be expected, individually or in the aggregate, to have a Material Adverse
Effect, each Borrower and each Subsidiary is in compliance with the applicable provisions of ERISA and the provision of the Code relating to ERISA Plans and the regulations and published interpretations therein. During the thirty-six (36) month
period prior to the Closing Date or the making of any Loan (i) no steps have been taken to terminate any Pension Plan, and (ii) no contribution failure has occurred with respect to any Pension Plan sufficient to give rise to a Lien under
Section 303(k) of ERISA or Section 430(k) of the Code and no event has occurred that would give rise to a Lien under Section 4068 of ERISA. No condition exists or event or transaction has occurred with respect to any Pension Plan
which could result in the incurrence by any Credit Party of any material liability, fine or penalty. No Credit Party has incurred liability to the PBGC (other than for current premiums) with respect to


  
 38 

MidCap / EndoChoice / Term Credit and Security Agreement 








 
any employee Pension Plan. All contributions (if any) have been made on a timely basis to any Multiemployer Plan that are required to be made by any Credit Party or any other member of the
Controlled Group under the terms of the plan or of any collective bargaining agreement or by applicable Law; no Credit Party nor any member of the Controlled Group has withdrawn or partially withdrawn from any Multiemployer Plan, incurred any
withdrawal liability with respect to any such plan or received notice of any claim or demand for withdrawal liability or partial withdrawal liability from any such plan, and no condition has occurred which, if continued, could result in a withdrawal
or partial withdrawal from any such plan, and no Credit Party nor any member of the Controlled Group has received any notice that any Multiemployer Plan is in reorganization, that increased contributions may be required to avoid a reduction in plan
benefits or the imposition of any excise tax, that any such plan is or has been funded at a rate less than that required under Section 412 of the Code, that any such plan is or may be terminated, or that any such plan is or may become
insolvent. 
 Section 3.15 Consummation of Operative Documents; Brokers. Except for fees payable to Agent and/or Lenders,
no broker, finder or other intermediary has brought about the obtaining, making or closing of the transactions contemplated by the Operative Documents, and no Credit Party has or will have any obligation to any Person in respect of any finder’s
or brokerage fees, commissions or other expenses in connection herewith or therewith. 
 Section 3.16 Reserved. 

Section 3.17 Material Contracts. Except for the Operative Documents and the agreements set forth on Schedule 3.17, as
of the Closing Date there are no Material Contracts. The consummation of the transactions contemplated by the Financing Documents will not give rise to a right of termination in favor of any party to any Material Contract (other than any Credit
Party), except for such Material Contracts the noncompliance with which would not reasonably be expected to have a Material Adverse Effect. 

Section 3.18 Compliance with Environmental Requirements; No Hazardous Materials. Except in each case as set forth on
Schedule 3.18: 
 (a) no written notice, notification, demand, request for information, citation, summons, complaint or order has been
issued, no complaint has been filed, no penalty has been assessed and no investigation or review is pending, or to such Borrower’s knowledge, threatened by any Governmental Authority or other Person with respect to any (i) alleged material
violation by any Credit Party of any Environmental Law, (ii) alleged failure by any Credit Party to have any material Permits required in connection with the conduct of its business or to comply with the terms and conditions thereof,
(iii) any generation, treatment, storage, recycling, transportation or disposal of any Hazardous Materials, or (iv) release of Hazardous Materials; and 

(b) no property now owned or leased by any Credit Party and, to the knowledge of each Borrower, no such property previously owned or leased by
any Credit Party, to which any Credit Party has, directly or indirectly, transported or arranged for the transportation of any Hazardous Materials, is listed or, to such Borrower’s knowledge, proposed for listing, on the National Priorities
List promulgated pursuant to CERCLA, or CERCLIS (as 

  
 39 

MidCap / EndoChoice / Term Credit and Security Agreement 








 
defined in CERCLA) or any similar state list or is the subject of federal, state or local enforcement actions or, to the knowledge of such Borrower, other investigations which may lead to claims
against any Credit Party for clean-up costs, remedial work, damage to natural resources or personal injury claims, including, without limitation, claims under CERCLA. 

Section 3.19 Intellectual Property and License Agreements. A list of all Registered Intellectual Property of each Credit
Party and all in-bound license or sublicense agreements, exclusive out-bound license or sublicense agreements, or other rights of any Credit Party to use Intellectual Property (but excluding in-bound licenses of over-the-counter software that is
commercially available to the public), as of the Closing Date and, as updated pursuant to Section 4.15, is set forth on Schedule 3.19. Schedule 3.19 shall be prepared by Borrower in the form provided by Agent and contain all information
required in such form. Except for Permitted Licenses, each Credit Party is the sole owner of its Intellectual Property free and clear of any Liens (other than Permitted Liens). Each Patent is valid and enforceable and no part of the Material
Intangible Assets has been judged invalid or unenforceable, in whole or in part, and to the best of Borrower’s knowledge, no claim has been made that any part of the Intellectual Property violates the rights of any third party, which, either
individually or in the aggregate, could reasonably be expected to have a Material Adverse Effect. 
 Section 3.20
Solvency. After giving effect to the Loan advance and the liabilities and obligations of each Borrower under the Operative Documents, each Borrower is and, the Credit Parties (taken as a whole) are, Solvent. 

Section 3.21 Full Disclosure. None of the written information (financial or otherwise), other than projections and any
information of a general economic or industry specific nature, furnished by or on behalf of any Credit Party to Agent or any Lender in connection with the consummation of the transactions contemplated by the Operative Documents, contains any untrue
statement of a material fact or omits to state a material fact necessary to make the statements contained herein or therein not materially misleading in light of the circumstances under which such statements were made. All financial projections
delivered to Agent and the Lenders by Borrowers (or their agents) have been prepared on the basis of the assumptions stated therein. Such projections represent each Borrower’s good faith estimate of such Borrower’s future financial
performance and such assumptions are believed by such Borrower to be fair and reasonable in light of current business conditions; provided, however, that it being understood that projections are as to future events and are not to be viewed as
facts, projections are subject to significant uncertainties and contingencies, many of which are beyond Borrowers’ control, that no assurance can be given that such projections will be attained and that actual results during the period or
periods covered by any such projections may differ significantly from the projected results and such differences may be material. 

Section 3.22 Reserved. 

Section 3.23 Subsidiaries. Borrowers do not own any stock, partnership interests, limited liability company interests or
other equity securities or Subsidiaries except for Permitted Investments. 

  
 40 

MidCap / EndoChoice / Term Credit and Security Agreement 








 Section 3.24 Reserved. 

Section 3.25 Accuracy of Schedules. All information set forth in the Schedules to this Agreement (including Schedule 3.19
and Schedule 8.1(a)) is true, accurate and complete as of the Closing Date, the date of delivery of the last Compliance Certificate and any other subsequent date in which Borrower is requested to update such Schedules. All information set forth in
the Perfection Certificate is true, accurate and complete as of the Closing Date and any other subsequent date in which Borrower is requested to update such certificate. 

ARTICLE 4 - AFFIRMATIVE COVENANTS 

Each Borrower agrees that, so long as any Credit Exposure exists: 

Section 4.1 Financial Statements and Other Reports. Each Borrower will deliver to Agent: (a) as soon as available, but
no later than forty-five (45) days after the last day of each fiscal quarter, a company prepared consolidated balance sheet, cash flow and income statement covering Borrowers’ and its Consolidated Subsidiaries’ consolidated operations
during the period, prepared under GAAP, consistently applied, certified by a Responsible Officer and in a form acceptable to Agent; (b) as soon as available, but no later than one hundred and twenty (120) days after the last day of
Borrower’s fiscal year, audited consolidated financial statements prepared under GAAP, consistently applied, together with an unqualified opinion on the financial statements from KPMG International or another independent certified public
accounting firm; (c) within five (5) Business Days of delivery or filing thereof, copies of all statements, reports and notices made available to Borrower’s security holders or to any holders of Subordinated Debt and copies of all
reports and other filings made by Borrower with any stock exchange on which any securities of any Borrower are traded and/or the SEC; (d) a prompt written report of any legal actions pending or threatened against any Borrower or any of its
Subsidiaries that could reasonably be expected to result in damages or costs to any Borrower or any of its Subsidiaries of Five Hundred Thousand Dollars ($500,000) or more; (f) prompt written notice of an event that materially and adversely
affects the value of any Intellectual Property material to the business of the Credit Parties; (g) within sixty (60) days after the start of each fiscal year, projections for the forthcoming fiscal year, on a quarterly basis; and
(h) promptly (and in any event within ten (10) days of any request therefor) such readily available budgets, sales projections, operating plans and other financial information and information, reports or statements regarding the Borrowers,
their business and the Collateral as Agent may from time to time reasonably request; provided, however, that reporting related to Regulatory Required Permits and/or Regulatory Reporting Events shall be governed by Section 4.17. Each Borrower
will, within thirty (30) days after the last day of each month, deliver to Agent with the, a duly completed Compliance Certificate signed by a Responsible Officer. 

Section 4.2 Payment and Performance of Obligations. Each Borrower (a) will pay and discharge, and cause each
Subsidiary to pay and discharge, on a timely basis as and when due (including prior to the expiration of any applicable grace periods), all of their respective obligations and liabilities, except for such obligations and/or liabilities (i) that
may be the subject of a Permitted Contest, and (ii) the nonpayment or nondischarge of which could not reasonably be expected to have a Material Adverse Effect or result in a Lien against any Collateral, except 

  
 41 

MidCap / EndoChoice / Term Credit and Security Agreement 








 
for Permitted Liens, (b) without limiting anything contained in the foregoing clause (a) and unless subject to a Permitted Contest, pay all amounts due and owing in respect of material
Taxes (including without limitation, payroll and withholdings tax liabilities) on a timely basis as and when due, and in any case prior to the date on which any fine, penalty, interest, late charge or loss may be added thereto for nonpayment
thereof, and (c) will maintain, and cause each Subsidiary to maintain, in accordance with GAAP, appropriate reserves for the accrual of all of their respective obligations and liabilities, and (d) will not breach or permit any Subsidiary
to breach, or permit to exist any default under, the terms of any lease, commitment, contract, instrument or obligation to which it is a party, or by which its properties or assets are bound, except for such breaches or defaults which could not
reasonably be expected to have a Material Adverse Effect. 
 Section 4.3 Maintenance of Existence. Subject to
Section 5.6(a), each Borrower will preserve, renew and keep in full force and effect and in good standing, and will cause each Subsidiary to preserve, renew and keep in full force and effect and in good standing, (a) their respective
existence and (b) their respective rights, privileges and franchises necessary or desirable in the normal conduct of business, except, in case of this clause (b) where a failure to do so could not reasonably be expected to result in a
Material Adverse Effect. 
 Section 4.4 Maintenance of Property; Insurance. 

(a) Each Borrower will keep, and will cause each Subsidiary to keep, all material tangible property useful and necessary in its business in
good working order and condition, ordinary wear and tear and casualty events excepted; and make all necessary repairs and/or restore the affected property in a good and workmanlike manner, regardless of whether Agent agrees to disburse insurance
proceeds or other sums to pay costs of the work of repair or reconstruction, except where the failure to do so could not reasonably be expected to have a Material Adverse Effect. 

(b) Each Borrower will maintain (i) casualty insurance on all real and tangible personal property (including all Collateral),
(ii) general and professional liability insurance (including products/completed operations liability coverage), and (iii) such other insurance coverage, in each case against loss or damage of the kinds customarily insured against by
Persons engaged in the same or similar business, of such types and in such amounts as are customarily carried under similar circumstances by such other Persons. 

(c) On or prior to the Closing Date, and at all times thereafter, each Borrower will cause Agent to be named as an additional insured,
assignee and lender loss payee (which shall include, as applicable, identification as mortgagee), as applicable, on each insurance policy required to be maintained pursuant to this Section 4.4 pursuant to endorsements in form and substance
acceptable to Agent. Borrowers shall deliver to Agent and the Lenders (i) on the Closing Date, a certificate from Borrowers’ insurance broker dated such date showing the amount of coverage as of such date, and that such policies will
include effective waivers (whether under the terms of any such policy or otherwise) by the insurer of all claims for insurance premiums against all loss payees and additional insureds and all rights of subrogation against all loss payees and
additional insureds, and that if all or any part of such policy is 

  
 42 

MidCap / EndoChoice / Term Credit and Security Agreement 








 
canceled, terminated or expires, the insurer will forthwith give notice thereof to each additional insured, assignee and loss payee and that no cancellation, reduction in amount or material
change in coverage thereof shall be effective until at least thirty (30) days after receipt by each additional insured, assignee and loss payee of written notice thereof. 

Section 4.5 Compliance with Laws and Material Contracts. 

(a) Each Borrower will comply, and cause each Subsidiary to comply, with the requirements of all applicable Laws and Material Contracts, except
to the extent that failure to so comply could not reasonably be expected to (i) have a Material Adverse Effect, or (ii) result in any Lien upon either (x) a material portion of the assets of any such Person in favor of any
Governmental Authority, or (y) any Collateral which is part of the Borrowing Base. 
 (b) Without limiting the preceding
Section 4.5(a), except as could not reasonably be expected to have a Material Adverse Effect: (i) each Borrower will comply, and cause each Subsidiary to comply, in all material respects, with all applicable Environmental Laws and
Healthcare Laws; (ii) obtain and comply in all material respects with, and maintain, all Permits and Regulatory Required Permits necessary for its operations and properties; and (iii) conduct any investigation, study, sampling and testing,
and undertake any cleanup, removal, remedial or other action necessary to remove and clean up Hazardous Materials from any of its properties, in accordance with the requirements of all Environmental Laws; provided, however, that neither Borrower nor
any of their Subsidiaries shall be required to undertake any such cleanup, removal, remedial or other action to the extent that its obligation to do so is being contested in good faith and by proper proceedings and appropriate reserves are being
maintained with respect to such circumstances in accordance with GAAP. 
 Section 4.6 Inspection of Property, Books and
Records. Each Borrower will keep, and will cause each Subsidiary to keep, proper books of record substantially in accordance with GAAP in which full, true and correct entries shall be made of all material dealings and transactions in relation to
its business and activities; and will permit, and will cause each Subsidiary to permit, at the sole cost of the applicable Borrower or any applicable Subsidiary, representatives of Agent and of any Lender to visit and inspect any of their respective
properties, to examine and make abstracts or copies from any of their respective books and records, to conduct a collateral audit and analysis of their respective operations and the Collateral, to verify the amount and age of the Accounts, the
identity and credit of the respective Account Debtors, to review the billing practices of Borrowers and to discuss their respective affairs, finances and accounts with their respective officers, employees and independent public accountants, at such
reasonable times during normal business hours and as often as may reasonably be desired (but not to exceed once per quarter so long as there is no Event of Default), upon reasonable advance notice to the applicable Borrower or any applicable
Subsidiary; provided that, so long as no Event of Default is continuing, the applicable Borrower shall, notwithstanding any other provision of this Agreement, only be required to reimburse Agent for reasonable costs and expenses incurred in
connection with two (2) such inspection per calendar year; and provided, further, that, when an Event of Default exists, Agent or any Lender (or any of their representatives) may do any of the foregoing, all at the expense of the applicable
Borrower, at any time (without limitation regarding frequency). Notwithstanding anything to the contrary in 

  
 43 

MidCap / EndoChoice / Term Credit and Security Agreement 








 
this Section 4.6, no Borrower nor any of its respective Subsidiaries will be required to disclose or permit the inspection or discussion of, any document, information or other matter in
respect of which disclosure to Agent or any Lender (or their respective representative) (a) is prohibited by Law or (b) would require the forfeiture by such Borrower or Subsidiary of attorney client or similar privilege with respect to
such document; provided, however, that such Borrower or Subsidiary shall take all actions reasonably requested by Agent to allow access to such document without otherwise forfeiting such privilege. Further, so long as no Event of Default
exists, no Borrower nor any of its respective Subsidiaries will be required to disclose or permit the inspection or discussion of, any document, information or other matter that constitutes non-financial trade secrets or non-financial proprietary
information. 
 Section 4.7 Use of Proceeds. Borrowers shall use the proceeds of Loans solely for (a) transaction
fees incurred in connection with the Financing Documents and the payment in full on the Closing Date of certain existing Debt, and (b) for working capital needs and general business purposes (including Permitted Acquisitions and other
Investments not prohibited hereunder) of Borrowers and their Subsidiaries. No portion of the proceeds of the Loans will be used for family, personal, agricultural or household use. 

Section 4.8 Estoppel Certificates. After written request by Agent, Borrowers, within fifteen (15) days and at their
expense, will furnish Agent with a statement, duly acknowledged and certified, setting forth (a) the amount of the original principal amount of the Notes, and the unpaid principal amount of the Notes, (b) the rate of interest of the Notes,
(c) the date payments of interest and/or principal were last paid, (d) any offsets or defenses to the payment of the Obligations, and if any are alleged, the nature thereof, (e) that the Notes and this Agreement have not been modified
or if modified, giving particulars of such modification, and (f) that there has occurred and is then continuing no Default or if such Default exists, the nature thereof, the period of time it has existed, and the action being taken to remedy
such Default. After written request by Agent, Borrowers, within fifteen (15) days and at their expense, will furnish Agent with a certificate, signed by a Responsible Officer of Borrowers, updating all of the representations and warranties
contained in this Agreement and the other Financing Documents and certifying that all of the representations and warranties contained in this Agreement and the other Financing Documents, as updated pursuant to such certificate, are true, accurate
and complete as of the date of such certificate. 
 Section 4.9 Notices of Material Contracts, Litigation and Defaults.

 (a) Borrower shall provide (i) three (3) Business Days written notice to Agent of Borrower (1) prior to executing and
delivering any amendment, consent, waiver or other modification to any Material Contract which is material and adverse to such Material Contract or which could reasonably be expected to have a Material Adverse Effect or (2) after receiving or
delivering any notice of termination or default or similar notice in connection with any Material Contract and (ii) together with delivery of the next Compliance Certificate (included as an update to any schedule delivered therewith) the
execution of any new Material Contract and/or any new material amendment, consent, waiver or other modification to any Material Contract not previously disclosed. 

  
 44 

MidCap / EndoChoice / Term Credit and Security Agreement 








 (b) Borrowers will give prompt written notice to Agent (i) of any litigation or governmental
proceedings pending or threatened (in writing) against Borrowers or other Credit Party which would reasonably be expected to have a Material Adverse Effect with respect to Borrowers or any other Credit Party or which in any manner calls into
question the validity or enforceability of any Financing Document, (ii) upon any Borrower becoming aware of the existence of any Default or Event of Default, (iii) of any strikes or other labor disputes pending or, to any Borrower’s
knowledge, threatened against any Credit Party, (iv) if there is any infringement or written claim of infringement by any other Person with respect to any Intellectual Property rights of any Credit Party that could reasonably be expected to
have a Material Adverse Effect, (v) if there is any written claim by any other Person that any Credit Party in the conduct of its business is infringing on the Intellectual Property rights of others and an adverse resolution of such claim could
reasonably be expected to have a Material Adverse Effect, and (vi) of all returns, recoveries, disputes and claims that involve more than $500,000. 

(c) Borrower shall, and shall cause each Credit Party, to provide such further information (including copies of such documentation) as Agent
or any Lender shall reasonably request with respect to any of the events or notices described in clauses (a) and (b) above. From the date hereof and continuing through the termination of this Agreement, Borrower shall, and shall cause each
Credit Party to, make available to Agent and each Lender, without expense to Agent or any Lender, each Credit Party’s officers, employees and agents and books, to the extent that Agent or any Lender may deem them reasonably necessary to
prosecute or defend any third-party suit or proceeding instituted by or against Agent or any Lender with respect to any Collateral or relating to a Credit Party. 

Section 4.10 Reserved. 

Section 4.11 Further Assurances. 

(a) Each Borrower will, and will cause each Subsidiary to, at its own cost and expense, promptly and duly take, execute, acknowledge and
deliver all such further acts, documents and assurances as may from time to time be necessary or as Agent or the Required Lenders through Agent may from time to time reasonably request in order to carry out the intent and purposes of the Financing
Documents and the transactions contemplated thereby, including all such actions to (i) establish, create, preserve, protect and perfect a first priority Lien (subject only to the Intercreditor Agreement and to Permitted Liens) in favor of Agent
for itself and for the benefit of the Lenders on the Collateral (including Collateral acquired after the date hereof), (ii) unless Agent shall agree otherwise in writing, cause all Subsidiaries of Borrowers (other than the Restricted Foreign
Subsidiaries) to be jointly and severally obligated with the other Borrowers under all covenants and obligations under this Agreement, including the obligation to repay the Obligations and (iii) to correct any material defect or error that may
be discovered in any Operative Document or in the execution, acknowledgment, filing or recordation thereof. 
 (b) Upon receipt of an
affidavit of an authorized representative of Agent or a Lender as to the loss, theft, destruction or mutilation of any Note or any other Financing Document which is not of public record, and, in the case of any such mutilation, upon surrender and
cancellation of such Note or other applicable Financing Document, Borrowers will issue, in 

  
 45 

MidCap / EndoChoice / Term Credit and Security Agreement 








 
lieu thereof, a replacement Note or other applicable Financing Document, dated the date of such lost, stolen, destroyed or mutilated Note or other Financing Document in the same principal amount
thereof and otherwise of like tenor. 
 (c) Upon the request of Agent, Borrowers shall obtain a landlord’s agreement or mortgagee
agreement, as applicable, from the lessor of each leased property or mortgagee of owned property with respect to any business location where any portion of the Collateral included in or proposed to be included in the Borrowing Base, or the records
relating to such Collateral and/or software and equipment relating to such records or Collateral, is stored or located, which agreement or letter shall be reasonably satisfactory in form and substance to Agent. Borrowers shall timely and fully pay
and perform its obligations under all material leases and other agreements with respect to each leased location where any Collateral, or any records related thereto, is or may be located. 

(d) Borrower shall provide Agent with at least thirty (30) days (or such shorter period as Agent may accept in its sole discretion) prior
written notice of its intention to create (or to the extent permitted under this Agreement, acquire) a new Subsidiary. Upon the formation (or to the extent permitted under this Agreement, acquisition) of a new Subsidiary, Borrowers shall
(i) pledge, have pledged or cause or have caused to be pledged to the Agent pursuant to a pledge agreement in form and substance satisfactory to the Agent, all of the outstanding shares of equity interests or other equity interests of such new
Subsidiary owned directly or indirectly by any Borrower, along with undated stock or equivalent powers for such certificates, executed in blank; (ii) unless Agent shall agree otherwise in writing, cause the new Subsidiary to take such other
actions (including entering into or joining any Security Documents) as are necessary or advisable in the reasonable opinion of the Agent in order to grant the Agent, acting on behalf of the Lenders, a first priority Lien (subject to the
Intercreditor Agreement) on all real and personal property of such Subsidiary in existence as of such date and in all after acquired property, which first priority Liens are required to be granted pursuant to this Agreement; (iii) unless Agent
shall agree otherwise in writing, cause such new Subsidiary to either (at the election of Agent) become a Borrower hereunder with joint and several liability for all obligations of Borrowers hereunder and under the other Financing Documents pursuant
to a joinder agreement or other similar agreement in form and substance satisfactory to Agent or to become a Guarantor of the obligations of Borrowers hereunder and under the other Financing Documents pursuant to a guaranty and suretyship agreement
in form and substance satisfactory to Agent; and (iv) cause the new Subsidiary to deliver certified copies of such Subsidiary’s certificate or articles of incorporation, together with good standing certificates, by-laws (or other operating
agreement or governing documents), resolutions of the Board of Directors or other governing body, approving and authorize the execution and delivery of the Security Documents, incumbency certificates and to execute and/or deliver such other
documents and legal opinions or to take such other actions as may be requested by the Agent, in each case, in form and substance satisfactory to the Agent (clauses (i)-(iv), collectively, the “Joinder Requirements”). 

(e) Borrower further agrees to comply, and cause its Subsidiaries and each Credit Party to comply with the following requirements with respect
to the Restricted Foreign Subsidiaries: (i) the total amount of cash and cash equivalents held by the Restricted Foreign Subsidiaries in Accounts other than a Collateral Accounts, in aggregate for all such Accounts,


  
 46 

MidCap / EndoChoice / Term Credit and Security Agreement 








 
shall not, at any time, exceed $3,000,000; and (ii) the value of the assets of all the Restricted Foreign Subsidiaries, in the aggregate for all such Restricted Foreign Subsidiaries, shall
not, at any time, exceed $5,000,000. 
 Section 4.12 Reserved. 

Section 4.13 Power of Attorney. Each of the authorized representatives of Agent is hereby irrevocably made, constituted and
appointed the true and lawful attorney for Borrowers (without requiring any of them to act as such) with full power of substitution to do the following: (a) endorse the name of Borrowers upon any and all checks, drafts, money orders, and other
instruments for the payment of money that are payable to Borrowers and constitute collections on Borrowers’ Accounts; (b) so long as Agent has provided not less than three (3) Business Days’ prior written notice to Borrower to
perform the same and Borrower has failed to take such action, execute in the name of Borrowers any schedules, assignments, instruments, documents, and statements that Borrowers are obligated to give Agent under this Agreement; (c) after the
occurrence and during the continuance of an Event of Default, take any action Borrowers are required to take under this Agreement; (d) so long as Agent has provided not less than three (3) Business Days’ prior written notice to
Borrower to perform the same and Borrower has failed to take such action, do such other and further acts and deeds in the name of Borrowers that Agent may deem necessary or desirable to enforce any Account or other Collateral or perfect Agent’s
security interest or Lien in any Collateral; and (e) after the occurrence and during the continuance of an Event of Default, do such other and further acts and deeds in the name of Borrowers that Agent may deem necessary or desirable to enforce
its rights with regard to any Account or other Collateral. This power of attorney shall be irrevocable and coupled with an interest. 

Section 4.14 Reserved. 

Section 4.15 Schedule Updates. Borrower shall, in the event of any information in the Schedules becoming outdated,
inaccurate, incomplete or misleading in any material respect, deliver to Agent, together with the next Compliance Certificate required to be delivered under this Agreement after such event a proposed update to such Schedule correcting all outdated,
inaccurate, incomplete or misleading information; provided, however, (i) with respect to any proposed updates to the Schedules involving Permitted Liens, Permitted Indebtedness or Permitted Investments, Agent will replace the respective
Schedule attached hereto with such proposed update only if such updated information is consistent with the definitions of and limitations herein pertaining to Permitted Liens, Permitted Indebtedness or Permitted Investments and (ii) with
respect to any proposed updates to such Schedule involving other matters, Agent will replace the applicable portion of such Schedule attached hereto with such proposed update upon Agent’s approval thereof. 

Section 4.16 Intellectual Property and Licensing. Borrower shall own, or be licensed to use or otherwise have the right to
use, all Material Intangible Assets. Borrower shall cause all Registered Intellectual Property to be duly and properly registered, filed or issued in the appropriate office and jurisdictions for such registrations, filings or issuances, except where
the failure to do so would not reasonably be expected to result in a Material Adverse Effect. 

  
 47 

MidCap / EndoChoice / Term Credit and Security Agreement 








 
Borrower shall at all times conduct its business without infringement of any Intellectual Property rights of others, except where the failure to do so would not reasonably be expected to result
in a Material Adverse Effect. Borrower shall (i) protect, defend and maintain the validity and enforceability of its Material Intangible Assets (ii) promptly advise Agent in writing of material infringements of its Material Intangible
Assets, or of a claim of infringement by Borrower on the Intellectual Property rights of others which could reasonably be expected to result in a Material Adverse Effect; and (iii) not allow any of Borrower’s Material Intangible Assets to
be abandoned, invalidated, forfeited or dedicated to the public or to become unenforceable. Borrower shall not become a party to, nor become bound by, any material license or other agreement (other than the Financing Documents and the Affiliated
Financing Documents) with respect to which Borrower is the licensee that prohibits or otherwise restricts Borrower from granting a security interest in Borrower’s interest in such license or agreement or other property. 

Section 4.17 Regulatory Reporting and Covenants. 

(a) Borrower shall notify Agent and each Lender promptly (and in any event within four (4) Business Days) of receiving, becoming aware of
or determining that (each, a “Regulatory Reporting Event” and collectively, the “Regulatory Reporting Events”): (i) any Governmental Authority, specifically including the FDA is conducting or has conducted
(A) if applicable, any of Borrower’s or its Subsidiaries’ manufacturing facilities and processes for any Product or service, which investigation has disclosed any material deficiencies or violations of Laws and/or the Regulatory
Required Permits related to such thereto or (B) an investigation or review of any Regulatory Required Permit (other than routine reviews in the Ordinary Course of Business associated with the renewal of a Regulatory Required Permit and which
could not reasonably be expected to result in a Material Adverse Effect), (ii) development, testing, and/or manufacturing of any Product or provision of any service that is material to the business of Borrower or its Subsidiaries should cease,
(iii) if a Product that is material to the Business of the Borrower or its Subsidiaries has been approved for marketing and sale, any marketing or sales of such Product should cease or such Product should be withdrawn from the marketplace,
(iv) any Regulatory Required Permit that is material to the business of the Borrower or its Subsidiaries has been revoked or withdrawn, (v) adverse clinical test results with respect to any Product which have or could reasonably be
expected to result in a Material Adverse Effect, (vi) any Product recalls or voluntary Product withdrawals from any market (other than discrete batches or lots that are not material in quantity or amount and are not made in conjunction with a
larger recall), which have or could reasonably be expected to result in a Material Adverse Effect or (vii) any significant failures in the manufacturing of any Product such that the amount of such Product successfully manufactured in accordance
with all specifications thereof and the required payments to be made to Borrower therefor in any month shall decrease significantly with respect to the quantities of such Product and payments produced in the prior month, in each case, which could
reasonably be expected to result in a Material Adverse Effect. Borrower shall provide to Agent or any Lender such further information (including copies of such documentation) as Agent or any Lender shall reasonably request with respect to any such
Regulatory Reporting Event. 
 (b) Borrower shall, and shall cause each Credit Party to, obtain all Regulatory Required Permits necessary
for compliance with Laws with respect to testing, manufacturing, developing, selling or marketing of Products, except where the failure to so would not reasonably 

  
 48 

MidCap / EndoChoice / Term Credit and Security Agreement 








 
be expected to result in a Material Adverse Effect and shall, and shall cause each Credit Party to, maintain and comply fully and completely in all respects with all such Regulatory Required
Permits, the noncompliance with which could have a Material Adverse Effect. In the event Borrower or any Credit Party obtains any new Regulatory Required Permit or any information on the Schedule 8.1(a) becomes outdated, inaccurate,
incomplete or misleading, Borrower shall, together with the next Compliance Certificate required to be delivered under this Agreement after such event, provide Agent with an updated Schedule 8.1(a) including such updated information. 

ARTICLE 5 - NEGATIVE COVENANTS 

Each Borrower agrees that, so long as any Credit Exposure exists: 

Section 5.1 Debt; Contingent Obligations. No Borrower will, or will permit any Subsidiary to, directly or indirectly,
create, incur, assume, guarantee or otherwise become or remain directly or indirectly liable with respect to, any Debt, except for Permitted Debt. No Borrower will, or will permit any Subsidiary to, directly or indirectly, create, assume, incur or
suffer to exist any Contingent Obligations, except for Permitted Contingent Obligations. 
 Section 5.2 Liens. No
Borrower will, or will permit any Subsidiary to, directly or indirectly, create, assume or suffer to exist any Lien on any asset now owned or hereafter acquired by it, except for Permitted Liens. 

Section 5.3 Distributions. No Borrower will, or will permit any Subsidiary to, directly or indirectly, declare, order, pay,
make or set apart any sum for any Distribution, except for Permitted Distributions. 
 Section 5.4 Restrictive
Agreements. No Borrower will, or will permit any Subsidiary to, directly or indirectly (a) enter into or assume any agreement (other than the Financing Documents and any agreements for purchase money debt permitted under clause (c) of
the definition of Permitted Debt) prohibiting the creation or assumption of any Lien upon its properties or assets, whether now owned or hereafter acquired, or (b) create or otherwise cause or suffer to exist or become effective any consensual
encumbrance or restriction of any kind (except as provided by the Financing Documents and the Affiliated Financing Documents) on the ability of any Subsidiary to: (i) pay or make Distributions to any Borrower or any Subsidiary; (ii) pay
any Debt owed to any Borrower or any Subsidiary; (iii) make loans or advances to any Borrower or any Subsidiary; or (iv) transfer any of its property or assets to any Borrower or any Subsidiary. 

Section 5.5 Payments and Modifications of Subordinated Debt. No Borrower will, or will permit any Subsidiary to, directly
or indirectly (a) declare, pay, make or set aside any amount for payment in respect of Subordinated Debt, except for payments made in full compliance with and expressly permitted under the Subordination Agreement, (b) amend or otherwise
modify the terms of any Subordinated Debt, except for amendments or modifications made in full compliance with the Subordination Agreement, (c) declare, pay, make or set aside any amount for payment in respect of any Debt hereinafter incurred
that, by its terms, or by 

  
 49 

MidCap / EndoChoice / Term Credit and Security Agreement 








 
separate agreement, is subordinated to the Obligations, except for payments made in full compliance with and expressly permitted under the subordination provisions applicable thereto, or
(d) amend or otherwise modify the terms of any such Debt if the effect of such amendment or modification is to (i) increase the interest rate or fees on, or change the manner or timing of payment of, such Debt, (ii) accelerate or
shorten the dates upon which payments of principal or interest are due on, or the principal amount of, such Debt, (iii) change in a manner adverse to any Credit Party or Agent any event of default or add or make more restrictive any covenant
with respect to such Debt, (iv) change the prepayment provisions of such Debt or any of the defined terms related thereto, (v) change the subordination provisions thereof (or the subordination terms of any guaranty thereof), or
(vi) change or amend any other term if such change or amendment would materially increase the obligations of the obligor or confer additional material rights on the holder of such Debt in a manner adverse to Borrowers, any Subsidiaries, Agents
or Lenders. Borrowers shall, prior to entering into any such amendment or modification, deliver to Agent reasonably in advance of the execution thereof, any final or execution form copy thereof. 

Section 5.6 Consolidations, Mergers and Sales of Assets; Change in Control. No Borrower will, or will permit any Subsidiary
to, directly or indirectly: 
 (a) (a) consolidate or merge or amalgamate with or into any other Person (other than
(i) consolidations or mergers among Borrowers, the merger or consolidation of EndoChoice Israel, Ltd. with or into a Credit Party, or (ii) the dissolution of EndoChoice Israel, Ltd. in accordance with applicable Law; provided
that (x) Borrower determines in good faith that such dissolution is in the best interests of Borrower and is not materially disadvantageous to the Lenders and (y) any assets transferred or business discontinued in connection
with such dissolution, shall be transferred to, or otherwise owned or conducted by, a Credit Party after giving effect to such dissolution); or 

(b) (b) consummate any Asset Dispositions other than Permitted Asset Dispositions. No Borrower will suffer or permit to occur any Change
in Control with respect to itself, any Subsidiary or any Guarantor. 
 Section 5.7 Purchase of Assets, Investments. No
Borrower will, or will permit any Subsidiary to, directly or indirectly: 
 (a) acquire or enter into any agreement to acquire any assets
other than (i) Permitted Acquisitions or (ii) in the Ordinary Course of Business or as permitted under clause (h) of the definition of Permitted Investments; or 

(b) acquire or own or enter into any agreement to acquire or own any Investment in any Person other than Permitted Investments. 

Section 5.8 Transactions with Affiliates. Except as otherwise disclosed on Schedule 5.8, and except for transactions
which contain terms that are no less favorable to the applicable Borrower or any Subsidiary, as the case may be, than those which might be obtained from a third party not an Affiliate of any Credit Party, no Borrower will, or will permit any
Subsidiary to, directly or indirectly, enter into or permit to exist any transaction (including the purchase, sale, lease or exchange of any property or the rendering of any service) with any Affiliate of any Borrower. 

  
 50 

MidCap / EndoChoice / Term Credit and Security Agreement 








 Section 5.9 Modification of Organizational Documents. No Borrower will, or
will permit any Subsidiary to, directly or indirectly, amend or otherwise modify any Organizational Documents of such Person, except for Permitted Modifications. 

Section 5.10 Modification of Certain Agreements. No Borrower will, or will permit any Subsidiary to, directly or
indirectly, (i) amend or otherwise modify any Material Contract, which amendment or modification in any case: (a) is contrary to the terms of this Agreement or any other Financing Document; (b) could reasonably be expected to be
adverse in any material respect to the rights, interests or privileges of the Agent or the Lenders or their ability to enforce the same; (c) results in the imposition or expansion in any material respect of any obligation of or restriction or
burden on any Borrower or any Subsidiary; or (d) reduces any rights or benefits of any Borrower or any Subsidiaries (it being understood and agreed that any such determination shall be in the discretion of the Agent) in a manner which, in the
case of clauses (c) or (d)could reasonably be expected to result in a Material Adverse Effect, or (ii) without the prior written consent of Agent, amend or otherwise modify any Affiliated Financing Document. Each Borrower shall, prior to
entering into any amendment or other modification of any of the foregoing documents described in the preceding sentence, deliver to Agent reasonably in advance of the execution thereof, any final or execution form copy of amendments or other
modifications to such documents, and such Borrower agrees not to take, nor permit any of its Subsidiaries to take, any such action with respect to any such documents without obtaining such approval from Agent. 

Section 5.11 Conduct of Business. No Borrower will, or will permit any Subsidiary to, directly or indirectly, engage in any
line of business other than those businesses engaged in on the Closing Date and described on Schedule 5.11 and businesses reasonably related thereto. No Borrower will, or will permit any Subsidiary to, other than in the Ordinary Course of
Business, change its normal billing payment and reimbursement policies and procedures with respect to its Accounts (including, without limitation, the amount and timing of finance charges, fees and write-offs). 

Section 5.12 Lease Payments. No Borrower will, or will permit any Subsidiary to, directly or indirectly, incur or assume
(whether pursuant to a Guarantee or otherwise) any liability for rental payments except in the Ordinary Course of Business. 

Section 5.13 Limitation on Sale and Leaseback Transactions. No Borrower will, or will permit any Subsidiary to, directly or
indirectly, enter into any arrangement with any Person whereby, in a substantially contemporaneous transaction, any Borrower or any Subsidiaries sells or transfers all or substantially all of its right, title and interest in an asset and, in
connection therewith, acquires or leases back the right to use such asset. 
 Section 5.14 Deposit Accounts and Securities
Accounts; Payroll and Benefits Accounts. No Borrower will, or will permit any Subsidiary to, directly or indirectly, establish any new Deposit Account or Securities Account without prior written notice to Agent, and unless 

  
 51 

MidCap / EndoChoice / Term Credit and Security Agreement 








 
Agent, such Borrower or such Subsidiary and the bank, financial institution or securities intermediary at which the account is to be opened enter into a Deposit Account Control Agreement or
Securities Account Control Agreement prior to or concurrently with the establishment of such Deposit Account or Securities Account. Borrowers represent and warrant that Schedule 5.14 lists all of the Deposit Accounts and Securities Accounts of
each Borrower. The provisions of this Section requiring Deposit Account Control Agreements shall not apply to Deposit Accounts exclusively used for payroll, payroll taxes and other employee wage and benefit payments to or for the benefit of
Borrowers’ employees and identified to Agent by Borrowers as such; provided, however, that at all times that any Obligations or Affiliated Obligations remain outstanding, Borrower shall maintain one or more separate Deposit Accounts to
hold any and all amounts to be used for payroll, payroll taxes and other employee wage and benefit payments, and shall not commingle any monies allocated for such purposes with funds in any other Deposit Account. 

Section 5.15 Compliance with Anti-Terrorism Laws. Agent hereby notifies Borrowers that pursuant to the requirements of
Anti-Terrorism Laws, and Agent’s policies and practices, Agent is required to obtain, verify and record certain information and documentation that identifies Borrowers and its principals, which information includes the name and address of each
Borrower and its principals and such other information that will allow Agent to identify such party in accordance with Anti-Terrorism Laws. No Borrower will, or will permit any Subsidiary to, directly or indirectly, knowingly enter into any Material
Contracts with any Blocked Person or any Person listed on the OFAC Lists. Each Borrower shall immediately notify Agent if such Borrower has knowledge that any Borrower, any additional Credit Party or any of their respective Affiliates or agents
acting or benefiting in any capacity in connection with the transactions contemplated by this Agreement is or becomes a Blocked Person or (a) is convicted on, (b) pleads nolo contendere to, (c) is indicted on, or (d) is arraigned
and held over on charges involving money laundering or predicate crimes to money laundering. No Borrower will, or will permit any Subsidiary to, directly or indirectly, (i) conduct any business or engage in any transaction or dealing with any
Blocked Person, including, without limitation, the making or receiving of any contribution of funds, goods or services to or for the benefit of any Blocked Person, (ii) deal in, or otherwise engage in any transaction relating to, any property
or interests in property blocked pursuant to Executive Order No. 13224, any similar executive order or other Anti-Terrorism Law, or (iii) engage in or conspire to engage in any transaction that evades or avoids, or has the purpose of
evading or avoiding, or attempts to violate, any of the prohibitions set forth in Executive Order No. 13224 or other Anti-Terrorism Law. 

ARTICLE 6 — FINANCIAL COVENANTS 

Section 6.1 Additional Defined Terms. The following additional definitions are hereby appended to Section 1.1 of this
Agreement: 
 “Defined Period” means, for purposes of calculating the Minimum Net Revenue for any given calendar quarter,
the six (6) month period immediately preceding any such calendar quarter. 

  
 52 

MidCap / EndoChoice / Term Credit and Security Agreement 








 “Net Revenue” means, for any period, (a) Borrower’s gross revenues
during such period, less (b)(i) trade, quantity and cash discounts allowed by Borrower, (ii) discounts, refunds, rebates, charge backs, retroactive price adjustments and any other allowances which effectively reduce net selling price,
(iii) product returns and allowances, (iv) allowances for shipping or other distribution expenses, (iv) set-offs and counterclaims, and (v) any other similar and customary deductions used by Borrower in determining net revenues,
all, in respect of (a) and (b), as determined in accordance with GAAP and in the Ordinary Course of Business. 

Section 6.2 Minimum Liquidity. Borrowers will not permit the Minimum Liquidity at any time during the term of this
Agreement to be less than $5,000,000. 
 Section 6.3 Minimum Net Revenue. Borrower shall not permit its consolidated Net
Revenue for any Defined Period, as tested quarterly, to be less than the minimum amounts set forth on the Minimum Net Revenue Schedule, opposite such quarter set forth on Schedule 6.3 hereto. 

Section 6.4 Evidence of Compliance. Borrower shall furnish to Agent, together with the monthly financial reporting required
of Borrower in this Agreement, a Compliance Certificate as evidence of Borrower’s compliance with the covenants in this Article 6. The Compliance Certificate shall include, without limitation, a statement and report, on a form approved by
Agent, detailing Borrower’s calculations. Further, if reasonably requested by Agent, Borrower’s shall provide promptly following such request (but in any event within ten (10) Business Days thereof) back-up documentation (including,
without limitation, invoices, receipts and other evidence of costs incurred during such quarter as Agent shall reasonably require) evidencing the propriety of the calculations. 

ARTICLE 7 - CONDITIONS 

Section 7.1 Conditions to Closing. The obligation of each Lender to make the initial Loans on the Closing Date shall be
subject to the receipt by Agent of each agreement, document and instrument set forth on the closing checklist prepared by Agent or its counsel, each in form and substance satisfactory to Agent, and such other closing deliverables reasonably
requested by Agent and Lenders, and to the satisfaction of the following conditions precedent, each to the satisfaction of Agent and Lenders and their respective counsel in their sole discretion: 

(a) the payment of all fees, expenses and other amounts due and payable under each Financing Document; 

(b) since December 31, 2014, the absence of any material adverse change in any aspect of the business, operations, properties, or
condition (financial or otherwise) of any Credit Party, or any event or condition which could reasonably be expected to result in such a material adverse change; and 

(c) Borrower shall have completed an initial public offering yielding an amount not less than $85,000,000 in unrestricted net cash proceeds to
Borrower. 

  
 53 

MidCap / EndoChoice / Term Credit and Security Agreement 








 Each Lender, by delivering its signature page to this Agreement, shall be deemed to have
acknowledged receipt of, and consented to and approved, each Financing Document, each additional Operative Document and each other document, agreement and/or instrument required to be approved by Agent, Required Lenders or Lenders, as applicable, on
the Closing Date. 
 Section 7.2 Conditions to Each Loan. The obligation of the Lenders to make a Loan or an advance in
respect of any Loan is subject to the satisfaction of the following additional conditions: 
 (a) in the case of a Term Loan advance, receipt
by Agent of a Notice of Borrowing; 
 (b) the fact that, immediately before and after such advance or issuance, no Default or Event of
Default shall have occurred and be continuing; 
 (c) for Loans made on the Closing Date, the fact that the representations and warranties
of each Credit Party contained in the Financing Documents shall be true, correct and complete on and as of the Closing Date, except to the extent that any such representation or warranty relates to a specific date in which case such representation
or warranty shall be true and correct as of such earlier date; 
 (d) for Loans made after the Closing Date, the fact that the
representations and warranties of each Credit Party contained in the Financing Documents shall be true, correct and complete in all material respects on and as of the date of such borrowing or issuance, except to the extent that any such
representation or warranty relates to a specific date in which case such representation or warranty shall be true and correct in all material respects as of such earlier date; provided, however, in each case, such materiality qualifier shall
not be applicable to any representations and warranties that already are qualified or modified by materiality in the text thereof; 

(e) the fact that no adverse change in the condition (financial or otherwise), properties, business, or operations of Borrowers or any other
Credit Party shall have occurred and be continuing with respect to Borrowers or any Credit Party since the date of this Agreement; and 

(f) the continued compliance by Borrowers with all of the terms, covenants and conditions of Article 8 and, unless Agent shall elect
otherwise from time to time, the absence of any fact, event or circumstance for which Borrower is required to give Agent notice under Article 8. 

Each giving of a Notice of Borrowing hereunder and each acceptance by any Borrower of the proceeds of any Loan made hereunder shall be deemed
to be (y) a representation and warranty by each Borrower on the date of such notice or acceptance as to the facts specified in this Section, and (z) a restatement by each Borrower that each and every one of the representations made by it
in any of the Financing Documents is true and correct in all material respects (without duplication of any materiality qualifier in the text of such representation or warranty) as of such date (except to the extent that such representations and
warranties expressly relate solely to an earlier date). 

  
 54 

MidCap / EndoChoice / Term Credit and Security Agreement 








 Section 7.3 Searches. Before the Closing Date, and thereafter (as and when
determined by Agent in its discretion), Agent shall have the right to perform, all at Borrowers’ expense, the searches described in clauses (a), (b), and (c) below against Borrowers and any other Credit Party, the results of which are to
be consistent with Borrowers’ representations and warranties under this Agreement and the satisfactory results of which shall be a condition precedent to all advances of Loan proceeds: (a) UCC searches with the Secretary of State of the
jurisdiction in which the applicable Person is organized; (b) judgment, pending litigation, federal tax lien, personal property tax lien, and corporate and partnership tax lien searches, in each jurisdiction searched under clause (a)
above; and (c) searches of applicable corporate, limited liability company, partnership and related records to confirm the continued existence, organization and good standing of the applicable Person and the exact legal name under which such
Person is organized. 
 Section 7.4 Post Closing Requirements. Borrowers shall complete each of the post closing
obligations and/or provide to Agent each of the documents, instruments, agreements and information listed on Schedule 7.4 attached hereto on or before the date set forth for each such item thereon, each of which shall be completed or provided
in form and substance satisfactory to Agent, and may be extended by Agent in writing in its sole discretion. 

ARTICLE 8 - REGULATORY AND LIFE SCIENCES MATTERS 

Section 8.1 Representations and Warranties. To induce Agent and Lenders to enter into this Agreement and to make credit
accommodations contemplated hereby, Borrowers hereby represent and warrant that all of the information regarding the Borrowers set forth in Schedule 8.1(a) is true, complete and correct, and that, except as disclosed in Schedule 8.1(b), the
following statements are true, complete and correct as of the date hereof, and Borrowers hereby covenant and agree to notify Agent each month in connection with the Compliance Certificate required to be delivered pursuant to Section 4.1 and
upon each submittal of a Notice of Borrowing of the occurrence of any facts, events or circumstances known to a Borrower, whether threatened, existing or pending, that would make any of the following representations and warranties untrue, incomplete
or incorrect (together with such supporting data and information as shall be necessary to fully explain to Agent the scope and nature of the fact, event or circumstance), and shall provide to Agent within five (5) Business Days of Agent’s
request, such additional information as Agent shall request regarding such disclosure: 
 (a) Disclosure. All of Borrower’s
Products and Regulatory Required Permits, the loss of which could reasonably expected to result in a Material Adverse Effect, are listed on Schedule 8.1(a) (as updated from time to time pursuant to Section 4.15). 

(b) Permits. Borrowers have (i) each Permit and other rights from, and have made all declarations and filings with, all applicable
Governmental Authorities, all self-regulatory authorities and all courts and other tribunals necessary to engage in the ownership, management and operation of the business or the assets of any Borrower, except where the


  
 55 

MidCap / EndoChoice / Term Credit and Security Agreement 








 
failure to do so could not reasonably expected to result in a Material Adverse Effect (“Material Permits and Rights”) and (ii) no knowledge that any Governmental Authority
is considering limiting, suspending or revoking any such Material Permit or Right. Borrower has delivered to Agent a copy of all Permits requested by Agent as of the date hereof or to the extent requested by Agent pursuant to Section 4.17. All
such Material Permits and Rights are valid and in full force and effect and Borrowers are in compliance with the terms and conditions of all such Permits. 

(c) Regulatory Required Permits. With respect to any Product or service, (i) Borrower and its Subsidiaries have received, and such
Product or service is the subject of, all Regulatory Required Permits needed in connection with the testing, manufacture, marketing or sale of such Product or conduct of such service as currently being conducted by or on behalf of Borrower, except
where the failure to have such Regulatory Required Permits would not have a Material Adverse Effect, and have provided Agent and each Lender with all notices and other information required by Section 4.17, and (ii) such Product is being
tested, manufactured, marketed or sold or service is being provided, as the case may be, in compliance in all material respects with all applicable Laws and Material Permits and Rights. 

(d) Healthcare and Regulatory Events. 

(i) None of the Borrowers are in violation of any Healthcare Laws, except where any such violation would not have a Material
Adverse Effect. 
 (ii) As of the Closing Date, there have been no Regulatory Reporting Events which could reasonably be
expected to result in a Material Adverse Effect or is subject to a Corporate Integrity Agreement. 
 (iii) No Borrower is
participating in any Third Party Payor Program other than Medicare and Medicaid. 
 (iv) To the knowledge of any of
Borrower’s Responsible Officers, none of the Borrower’s officers, directors, employees, shareholders, their agents or affiliates has made an untrue statement of material fact or fraudulent statement to the FDA or failed to disclose a
material fact required to be disclosed to the FDA, committed an act, made a statement, or failed to make a statement that could reasonably be expected to provide a basis for the FDA to invoke its policy respecting “Fraud, Untrue Statements of
Material Facts, Bribery, and Illegal Gratuities,” set forth in 56 Fed. Regulation 46191 (September 10, 1991). 
 (v)
Borrower has not received any written notice that any Governmental Authority, including without limitation the FDA, the CMS, the DEA, the Office of the Inspector General of HHS or the United States Department of Justice has commenced or threatened
to initiate any action against a Credit Party, any action to enjoin a Credit Party, their officers, directors, employees, shareholders or their agents and Affiliates, from conducting their businesses at any facility owned or used by them or for any
civil penalty, injunction, seizure or criminal action, in each case, which could reasonably be expected to result in a Material Adverse Effect. 

  
 56 

MidCap / EndoChoice / Term Credit and Security Agreement 








 (vi) Borrower has not received from the FDA, the CMS or the DEA, a Warning
Letter, Form FDA-483, “Untitled Letter,” other correspondence or notice setting forth allegedly objectionable observations or alleged violations of laws and regulations enforced by the FDA or the DEA, or any comparable correspondence from
any state or local authority responsible for regulating drug products and establishments, or any comparable correspondence from any foreign counterpart of the FDA or DEA, or any comparable correspondence from any foreign counterpart of any state or
local authority with regard to any Product or the manufacture, processing, packing, or holding thereof, in each case, which could reasonably be expected to result in a Material Adverse Effect. 

(vii) Borrower has not engaged in any Recalls, Market Withdrawals, or other forms of product retrieval from the marketplace of
any Products which could reasonably be expected to result in a Material Adverse Effect. 
 (viii) Each Product (a) is
not adulterated or misbranded within the meaning of the FDCA; (b) is not an article prohibited from introduction into interstate commerce under the provisions of Sections 404, 505 or 512 of the FDCA; (c) each Product has been and/or shall
be manufactured, imported, possessed, owned, warehoused, marketed, promoted, sold, labeled, furnished, distributed and marketed and each service has been conducted in accordance with all applicable Permits and Laws; and (d) each Product has
been and/or shall be manufactured in accordance with Good Manufacturing Practices, in each case, except where the failure to do so would not have a Material Adverse Effect. 

(e) Proceedings. No Borrower is subject to any proceeding, suit or, to Borrowers’ knowledge, investigation by any federal, state
or local government or quasi-governmental body, agency, board or authority or any other administrative or investigative body (including the Office of the Inspector General of the United States Department of Health and Human Services) which would
have a Material Adverse Effect on any Borrower; 
 (f) Ancillary Laws. Borrowers have received no notice, and are not aware, of any
violation of applicable antitrust laws, employment or landlord-tenant laws of any federal, state or local government or quasi-governmental body, agency, board or other authority with respect to the Borrowers that could reasonably be expected to
result in a Material Adverse Effect. 
 ARTICLE 9 - SECURITY AGREEMENT 

Section 9.1 Generally. As security for the payment and performance of the Obligations, and for the payment and performance
of all obligations under the Affiliated Financing Documents (if any) and without limiting any other grant of a Lien and security interest in any Security Document, Borrowers hereby assign and grant to Agent, for the benefit of itself and Lenders,
and subject to the Intercreditor Agreement, a continuing first priority Lien on and security interest in, upon, and to the personal property set forth on Schedule 9.1 attached hereto and made a part hereof. 

  
 57 

MidCap / EndoChoice / Term Credit and Security Agreement 








 Section 9.2 Representations and Warranties and Covenants Relating to Collateral. 

(a) Schedule 9.2 sets forth (i) each chief executive office and principal place of business of each Borrower and each of their
respective Subsidiaries, and (ii) all of the addresses (including all warehouses) at which Collateral that is part of the Borrowing Base or with an aggregate value in excess of $10,000 is located and/or books and records of Borrowers regarding
any Collateral or any of Borrower’s assets, liabilities, business operations or financial condition are kept, which such Schedule 9.2 indicates in each case which Borrower(s) have Collateral and/or books located at such address,
and, in the case of any such address not owned by one or more of the Borrowers(s), indicates the nature of such location (e.g., leased business location operated by Borrower(s), third party warehouse, consignment location, processor location, etc.)
and the name and address of the third party owning and/or operating such location. 
 (b) Without limiting the generality of
Section 3.2, except as indicated on Schedule 3.19 with respect to any rights of any Borrower as a licensee under any license of Intellectual Property owned by another Person, and except for the filing of financing statements under
the UCC, no authorization, approval or other action by, and no notice to or filing with, any Governmental Authority or consent of any other Person is required for (i) the grant by each Borrower to Agent of the security interests and Liens in
the Collateral provided for under this Agreement and the other Security Documents (if any), or (ii) the exercise by Agent of its rights and remedies with respect to the Collateral provided for under this Agreement and the other Security
Documents or under any applicable Law, including the UCC and neither any such grant of Liens in favor of Agent or exercise of rights by Agent shall violate or cause a default under any agreement between any Borrower and any other Person relating to
any such Collateral, including any license to which a Borrower is a party, whether as licensor or licensee, with respect to any Intellectual Property, whether owned by such Borrower or any other Person. 

(c) As of the Closing Date, no Borrower has any ownership interest in any Chattel Paper (as defined in Article 9 of the UCC), letter of
credit rights, commercial tort claims, Instruments, documents or investment property (other than equity interests in any Subsidiaries of such Borrower disclosed on Schedule 3.4) and Borrowers shall give notice to Agent promptly (but in
any event not later than the delivery by Borrowers of the next Compliance Certificate required pursuant to Section 4.1 above) upon the acquisition by any Borrower of any such Chattel Paper, letter of credit rights, commercial tort claims,
Instruments, documents, investment property. No Person other than Agent or (if applicable) any Lender has “control” (as defined in Article 9 of the UCC) over any Deposit Account, investment property (including Securities Accounts and
commodities account), letter of credit rights or electronic chattel paper in which any Borrower has any interest (except for such control arising by operation of law in favor of any bank or securities intermediary or commodities intermediary with
whom any Deposit Account, Securities Account or commodities account of Borrowers is maintained) or except as otherwise permitted in this Agreement. 

(d) Borrowers shall not, and shall not permit any Credit Party to, take any of the following actions or make any of the following changes
unless Borrowers have given at least thirty (30) days prior written notice to Agent of Borrowers’ intention to take any such action (which such written notice shall include an updated version of any Schedule impacted by such change)
and have executed any and all documents, instruments and agreements and taken any other actions which Agent may request after receiving such written notice in order to protect and 

  
 58 

MidCap / EndoChoice / Term Credit and Security Agreement 








 
preserve the Liens, rights and remedies of Agent with respect to the Collateral: (i) change the legal name or organizational identification number of any Borrower as it appears in official
filings in the jurisdiction of its organization, (ii) change the jurisdiction of incorporation or formation of any Borrower or Credit Party or allow any Borrower or Credit Party to designate any jurisdiction as an additional jurisdiction of
incorporation for such Borrower or Credit Party, or change the type of entity that it is, or (iii) change its chief executive office, principal place of business, or the location of its books and records or move any Collateral that is part of
the Borrowing Base or that has an aggregate value in excess of $10,000 to or place any such Collateral on any location that is not then listed on the Schedules and/or establish any business location at any location that is not then listed on the
Schedules. 
 (e) Borrowers shall not adjust, settle or compromise the amount or payment of any Account, or release wholly or partly any
Account Debtor, or allow any credit or discount thereon (other than adjustments, settlements, compromises, credits and discounts in that are made (i) in the Ordinary Course of Business and (ii) except with respect to adjustments,
settlements, compromises, credits and discounts in an aggregate amount not in excess of $25,000 in any calendar month are made while no Event of Default exists), without the prior written consent of Agent. Without limiting the generality of this
Agreement or any other provisions of any of the Financing Documents relating to the rights of Agent after the occurrence and during the continuance of an Event of Default, Agent shall have the right at any time after the occurrence and during the
continuance of an Event of Default to: (i) exercise the rights of Borrowers with respect to the obligation of any Account Debtor to make payment or otherwise render performance to Borrowers and with respect to any property that secures the
obligations of any Account Debtor or any other Person obligated on the Collateral, and (ii) adjust, settle or compromise the amount or payment of such Accounts. 

(f) Without limiting the generality of Sections 9.2(c) and 9.2(e): 

(i) Borrowers shall deliver to Agent all tangible Chattel Paper and all Instruments and documents owned by any Borrower and
constituting part of the Collateral duly endorsed and accompanied by duly executed instruments of transfer or assignment, all in form and substance satisfactory to Agent. Borrowers shall provide Agent with “control” (as defined in
Article 9 of the UCC) of all electronic Chattel Paper owned by any Borrower and constituting part of the Collateral by having Agent identified as the assignee on the records pertaining to the single authoritative copy thereof and otherwise
complying with the applicable elements of control set forth in the UCC. Borrowers also shall deliver to Agent all security agreements securing any such Chattel Paper and securing any such Instruments. Borrowers will mark conspicuously all such
Chattel Paper and all such Instruments and documents with a legend, in form and substance satisfactory to Agent, indicating that such Chattel Paper and such instruments and documents are subject to the security interests and Liens in favor of Agent
created pursuant to this Agreement and the Security Documents. Borrowers shall comply with all the provisions of Section 5.14 with respect to the Deposit Accounts and Securities Accounts of Borrowers. 

  
 59 

MidCap / EndoChoice / Term Credit and Security Agreement 








 (ii) Borrowers shall deliver to Agent all letters of credit on which any Borrower
is the beneficiary and which give rise to letter of credit rights owned by such Borrower which constitute part of the Collateral in each case duly endorsed and accompanied by duly executed instruments of transfer or assignment, all in form and
substance satisfactory to Agent. Borrowers shall take any and all actions as may be necessary or desirable, or that Agent may request, from time to time, to cause Agent to obtain exclusive “control” (as defined in Article 9 of the
UCC) of any such letter of credit rights in a manner acceptable to Agent. 
 (iii) Borrowers shall promptly advise Agent upon
any Borrower becoming aware that it has any interests in any commercial tort claim that constitutes part of the Collateral, which such notice shall include descriptions of the events and circumstances giving rise to such commercial tort claim and
the dates such events and circumstances occurred, the potential defendants with respect such commercial tort claim and any court proceedings that have been instituted with respect to such commercial tort claims, and Borrowers shall, with respect to
any such commercial tort claim, execute and deliver to Agent such documents as Agent shall request to perfect, preserve or protect the Liens, rights and remedies of Agent with respect to any such commercial tort claim. 

(iv) Except for Accounts and Inventory in an aggregate amount of $500,000, no Accounts or Inventory or other Collateral and no
books and records and/or software and equipment of the Borrowers regarding any of the Collateral or any of the Borrower’s assets, liabilities, business operations or financial condition shall at any time be located at any leased location or in
the possession or control of any warehouse, consignee, bailee or any of Borrowers’ agents or processors, without prior written notice to Agent and the receipt by Agent, of warehouse receipts, consignment agreements, landlord waivers, or bailee
waivers (as applicable) satisfactory to Agent prior to the commencement of such lease or of such possession or control (as applicable). Borrower has notified Agent that Collateral and books and records are currently located at the locations set
forth on Schedule 9.2. Borrowers shall, upon the request of Agent, notify any such landlord, warehouse, consignee, bailee, agent or processor of the security interests and Liens in favor of Agent created pursuant to this Agreement and
the Security Documents, instruct such Person to hold all such Collateral for Agent’s account subject to Agent’s instructions and shall obtain an acknowledgement from such Person that such Person holds the Collateral for Agent’s
benefit. 
 (v) Upon request of Agent, Borrowers shall promptly deliver to Agent any and all certificates of title,
applications for title or similar evidence of ownership of all tangible Personal Property with a value greater than $100,000 and shall cause Agent to be named as lienholder on any such certificate of title or other evidence of ownership. Borrowers
shall not permit any such tangible Personal Property to become fixtures to real estate unless such real estate is subject to a Lien in favor of Agent. 

(vi) Each Borrower hereby authorizes Agent to file without the signature of such Borrower one or more UCC financing statements
relating to liens on personal property relating to all or any part of the Collateral, which financing statements 

  
 60 

MidCap / EndoChoice / Term Credit and Security Agreement 








 
may list Agent as the “secured party” and such Borrower as the “debtor” and which describe and indicate the collateral covered thereby as all or any part of the Collateral
under the Financing Documents, in such jurisdictions as Agent from time to time determines are appropriate, and to file without the signature of such Borrower any continuations of or corrective amendments to any such financing statements, in any
such case in order for Agent to perfect, preserve or protect the Liens, rights and remedies of Agent with respect to the Collateral. Each Borrower also ratifies its authorization for Agent to have filed in any jurisdiction any initial financing
statements or amendments thereto if filed prior to the date hereof. 
 (vii) As of the Closing Date (except for Accounts
payable by Medicare or Medicaid), no Borrower holds, and after the Closing Date Borrowers shall promptly notify Agent in writing upon creation or acquisition by any Borrower of, any Collateral which constitutes a claim against any Governmental
Authority, including, without limitation, the federal government of the United States or any instrumentality or agency thereof, the assignment of which claim is restricted by any applicable Law, including, without limitation, the federal Assignment
of Claims Act and any other comparable Law. Upon the request of Agent, Borrowers shall take such steps as may be necessary or desirable, or that Agent may request, to comply with any such applicable Law. 

(viii) Borrowers shall furnish to Agent from time to time any statements and schedules further identifying or describing the
Collateral and/or Borrower’s Intellectual Property and any other information, reports or evidence concerning the Collateral and/or Borrower’s Intellectual Property as Agent may reasonably request from time to time. 

ARTICLE 10 - EVENTS OF DEFAULT 

Section 10.1 Events of Default. For purposes of the Financing Documents, the occurrence of any of the following conditions
and/or events, whether voluntary or involuntary, by operation of law or otherwise, shall constitute an “Event of Default”: 

(a) (i) any Borrower shall fail to pay when due any principal or interest, when due, or any premium or fee under any Financing Document or any
other amount payable under any Financing Document within three (3) Business Days of when due, or (ii) there shall occur any default in the performance of or compliance with any of the following sections of this Agreement:
Section 2.11, Section 4.1, Section 4.2(b), Section 4.4(c), Section 4.6, 4.15, 4.16, 4.17, Article 5 or Article 6; 

(b) any Credit Party defaults in the performance of or compliance with any term contained in this Agreement or in any other Financing Document
(other than occurrences described in other provisions of this Section 10.1 for which a different grace or cure period is specified or for which no grace or cure period is specified and thereby constitute immediate Events of Default) and such
default is not remedied by the Credit Party or waived by Agent within thirty (30) days after the earlier of (i) receipt by Borrower Representative of notice from Agent or Required Lenders of such default, or (ii) actual knowledge of
any Borrower or any other Credit Party of such default; 

  
 61 

MidCap / EndoChoice / Term Credit and Security Agreement 








 (c) any representation, warranty, certification or statement made by any Credit Party or any
other Person in any Financing Document or in any certificate, financial statement or other document delivered pursuant to any Financing Document is incorrect in any material respect (or in any material respect if such representation, warranty,
certification or statement is not by its terms already qualified as to materiality) when made (or deemed made); 
 (d) (i) failure of
any Credit Party to pay when due or within any applicable grace period any principal, interest or other amount on Debt (other than the Loans), or the occurrence of any breach, default, condition or event with respect to any Debt (other than the
Loans), if the effect of such failure or occurrence is to cause or to permit the holder or holders of any such Debt, or to cause, Debt or other liabilities having an individual principal amount in excess of $500,000 or having an aggregate principal
amount in excess of $1,000,000 to become or be declared due prior to its stated maturity, or (ii) the occurrence of any breach or default under any terms or provisions of any Subordinated Debt Document or under any agreement subordinating the
Subordinated Debt to all or any portion of the Obligations or the occurrence of any event requiring the prepayment of any Subordinated Debt; 

(e) any Credit Party or any Subsidiary of a Borrower shall commence a voluntary case or other proceeding seeking liquidation, reorganization
or other relief with respect to itself or its debts under any bankruptcy, insolvency or other similar law now or hereafter in effect or seeking the appointment of a trustee, receiver, liquidator, custodian or other similar official of it or any
substantial part of its property, or shall consent to any such relief or to the appointment of or taking possession by any such official in an involuntary case or other proceeding commenced against it, or shall make a general assignment for the
benefit of creditors, or shall fail generally to pay its debts as they become due, or shall take any corporate action to authorize any of the foregoing; 

(f) an involuntary case or other proceeding shall be commenced against any Credit Party or any Subsidiary of a Borrower seeking liquidation,
reorganization or other relief with respect to it or its debts under any bankruptcy, insolvency or other similar law now or hereafter in effect or seeking the appointment of a trustee, receiver, liquidator, custodian or other similar official of it
or any substantial part of its property, and such involuntary case or other proceeding shall remain undismissed and unstayed for a period of sixty (60) days; or an order for relief shall be entered against any Credit Party or any Subsidiary of
a Borrower under applicable federal bankruptcy, insolvency or other similar law in respect of (i) bankruptcy, liquidation, winding-up, dissolution or suspension of general operations, (ii) composition, rescheduling, reorganization,
arrangement or readjustment of, or other relief from, or stay of proceedings to enforce, some or all of the debts or obligations, or (iii) possession, foreclosure, seizure or retention, sale or other disposition of, or other proceedings to
enforce security over, all or any substantial part of the assets of such Credit Party or Subsidiary; 
 (g) (i) institution of any
steps by any Person to terminate a Pension Plan if as a result of such termination any Credit Party or any member of the Controlled Group could be 

  
 62 

MidCap / EndoChoice / Term Credit and Security Agreement 








 
required to make a contribution to such Pension Plan, or could incur a liability or obligation to such Pension Plan, in excess of $500,000, (ii) a contribution failure occurs with respect to
any Pension Plan sufficient to give rise to a Lien under Section 303(k) of ERISA or Section 430(k) of the Code or an event occurs that could reasonably be expected to give rise to a Lien under Section 4068 of ERISA, or
(iii) there shall occur any withdrawal or partial withdrawal from a Multiemployer Plan and the withdrawal liability (without unaccrued interest) to Multiemployer Plans as a result of such withdrawal (including any outstanding withdrawal
liability that any Credit Party or any member of the Controlled Group have incurred on the date of such withdrawal) exceeds $500,000; 
 (h)
one or more judgments or orders for the payment of money (not paid or fully covered by insurance maintained in accordance with the requirements of this Agreement and as to which the relevant insurance company has acknowledged coverage) aggregating
in excess of $500,000 shall be rendered against any or all Credit Parties and either (i) enforcement proceedings shall have been commenced by any creditor upon any such judgments or orders, or (ii) there shall be any period of thirty
(30) consecutive days during which a stay of enforcement of any such judgments or orders, by reason of a pending appeal, bond or otherwise, shall not be in effect; 

(i) any Lien created by any of the Security Documents shall at any time fail to constitute a valid and perfected Lien on all of the Collateral
purported to be encumbered thereby, subject to no prior or equal Lien except Permitted Liens, or any Credit Party shall so assert; 
 (j)
the institution by any Governmental Authority of criminal proceedings against any Credit Party that could reasonably be expected to have a materially adverse impact on the business of such Credit Party; 

(k) a default or event of default occurs under any Guarantee of any portion of the Obligations; 

(l) any Borrower makes any payment on account of any Debt that has been subordinated to any of the Obligations, other than payments
specifically permitted by the terms of such subordination; 
 (m) if any Borrower is or becomes an entity whose equity is registered with
the SEC, and/or is publicly traded on and/or registered with a public securities exchange, such Borrower’s equity fails to remain registered with the SEC in good standing, and/or such equity fails to remain publicly traded on and registered
with a public securities exchange; 
 (n) the occurrence of any fact, event or circumstance that could reasonably be expected to result in a
Material Adverse Effect; 
 (o) (i) the voluntary withdrawal or institution of any action or proceeding by the FDA or similar Governmental
Authority to order the withdrawal of any Product or Product category from the market or to enjoin Borrower, its Subsidiaries or any representative of Borrower or its Subsidiaries from manufacturing, marketing, selling or distributing any Product


  
 63 

MidCap / EndoChoice / Term Credit and Security Agreement 








 
or Product category, which, in each case, has or could reasonably be expected to result in a Material Adverse Effect, (ii) the institution of any action or proceeding by any DEA, FDA, or any
other Governmental Authority to revoke, suspend, reject, withdraw, limit, or restrict any Regulatory Required Permit held by Borrower, its Subsidiaries or any representative of Borrower or its Subsidiaries, which, in each case, has or could
reasonably be expected to result in a Material Adverse Effect, (iii) the commencement of any enforcement action against Borrower, its Subsidiaries or any representative of Borrower or its Subsidiaries (with respect to the business of Borrower
or its Subsidiaries) by DEA, FDA, or any other Governmental Authority which has or could reasonably be expected to result in a Material Adverse Effect, or (iv) the occurrence of adverse test results in connection with a Product which could
result in a Material Adverse Effect; 
 (p) there shall occur any default or event of default under the Affiliated Financing Documents; or

 (q) any Credit Party defaults under or breaches any Material Contract (after any applicable grace period contained therein), or a
Material Contract shall be terminated by a third party or parties party thereto prior to the expiration thereof, or there is a loss of a material right of a Credit Party under any Material Contract to which it is a party, in each case which could
reasonably be expected to result in a Material Adverse Effect. 
 All cure periods provided for in this Section 10.1 shall run
concurrently with any cure period provided for in any applicable Financing Documents under which the default occurred. 

Section 10.2 Acceleration and Suspension or Termination of Term Loan Commitment. Upon the occurrence and during the
continuance of an Event of Default, Agent may, and shall if requested by Required Lenders, (a) by notice to Borrower Representative suspend or terminate the Term Loan Commitment and the obligations of Agent and the Lenders with respect thereto,
in whole or in part (and, if in part, each Lender’s Term Loan Commitment shall be reduced in accordance with its Pro Rata Share), and/or (b) by notice to Borrower Representative declare all or any portion of the Obligations to be, and the
Obligations shall thereupon become, immediately due and payable, with accrued interest thereon, without presentment, demand, protest or other notice of any kind, all of which are hereby waived by each Borrower and Borrowers will pay the same;
provided, however, that in the case of any of the Events of Default specified in Section 10.1(e) or 10.1(f) above, without any notice to any Borrower or any other act by Agent or the Lenders, the Term Loan Commitment and the obligations
of Agent and the Lenders with respect thereto shall thereupon immediately and automatically terminate and all of the Obligations shall become immediately and automatically due and payable without presentment, demand, protest or other notice of any
kind, all of which are hereby waived by each Borrower and Borrowers will pay the same. 
 Section 10.3 UCC
Remedies. 
 (a) Upon the occurrence of and during the continuance of an Event of Default under this Agreement or the other
Financing Documents, Agent, in addition to all other rights, options, and remedies granted to Agent under this Agreement or at law or in equity, may exercise, either directly or through one or more assignees or designees, all rights and remedies
granted to it under all Financing Documents and under the UCC in effect in the applicable jurisdiction(s) and under any other applicable law; including, without limitation: 

(i) the right to take possession of, send notices regarding, and collect directly the Collateral, with or without judicial
process; 

  
 64 

MidCap / EndoChoice / Term Credit and Security Agreement 








 (ii) the right to (by its own means or with judicial assistance) enter any of
Borrowers’ premises and take possession of the Collateral, or render it unusable, or to render it usable or saleable, or dispose of the Collateral on such premises in compliance with subsection (iii) below and to take possession of
Borrowers’ original books and records, to obtain access to Borrowers’ data processing equipment, computer hardware and software relating to the Collateral and to use all of the foregoing and the information contained therein in any manner
Agent deems appropriate, without any liability for rent, storage, utilities, or other sums, and Borrowers shall not resist or interfere with such action (if Borrowers’ books and records are prepared or maintained by an accounting service,
contractor or other third party agent, Borrowers hereby irrevocably authorize such service, contractor or other agent, upon notice by Agent to such Person that an Event of Default has occurred and is continuing, to deliver to Agent or its designees
such books and records, and to follow Agent’s instructions with respect to further services to be rendered); 
 (iii)
the right to require Borrowers at Borrowers’ expense to assemble all or any part of the Collateral and make it available to Agent at any place designated by Lender; 

(iv) the right to notify postal authorities to change the address for delivery of Borrowers’ mail to an address designated
by Agent and to receive, open and dispose of all mail addressed to any Borrower; and/or 
 (v) the right to enforce
Borrowers’ rights against Account Debtors and other obligors, including, without limitation, (i) the right to collect Accounts directly in Agent’s own name (as agent for Lenders) and to charge the collection costs and expenses,
including attorneys’ fees, to Borrowers, and (ii) the right, in the name of Agent or any designee of Agent or Borrowers, to verify the validity, amount or any other matter relating to any Accounts by mail, telephone, telegraph or
otherwise, including, without limitation, verification of Borrowers’ compliance with applicable Laws. Borrowers shall cooperate fully with Agent in an effort to facilitate and promptly conclude such verification process. Such verification may
include contacts between Agent and applicable federal, state and local regulatory authorities having jurisdiction over the Borrowers’ affairs, all of which contacts Borrowers hereby irrevocably authorize. 

(b) Each Borrower agrees that a notice received by it at least ten (10) days before the time of any intended public sale, or the time
after which any private sale or other disposition of the Collateral is to be made, shall be deemed to be reasonable notice of such sale or other disposition. If permitted by applicable law, any perishable Collateral which threatens to speedily
decline in value or which is sold on a recognized market may be sold immediately by 

  
 65 

MidCap / EndoChoice / Term Credit and Security Agreement 








 
Agent without prior notice to Borrowers. At any sale or disposition of Collateral, Agent may (to the extent permitted by applicable law) purchase all or any part of the Collateral, free from any
right of redemption by Borrowers, which right is hereby waived and released. Each Borrower covenants and agrees not to interfere with or impose any obstacle to Agent’s exercise of its rights and remedies with respect to the Collateral. Agent
shall have no obligation to clean-up or otherwise prepare the Collateral for sale. Agent may comply with any applicable state or federal law requirements in connection with a disposition of the Collateral and compliance will not be considered to
adversely affect the commercial reasonableness of any sale of the Collateral. Agent may sell the Collateral without giving any warranties as to the Collateral. Agent may specifically disclaim any warranties of title or the like. This procedure will
not be considered to adversely affect the commercial reasonableness of any sale of the Collateral. If Agent sells any of the Collateral upon credit, Borrowers will be credited only with payments actually made by the purchaser, received by Agent and
applied to the indebtedness of the purchaser. In the event the purchaser fails to pay for the Collateral, Agent may resell the Collateral and Borrowers shall be credited with the proceeds of the sale. Borrowers shall remain liable for any deficiency
if the proceeds of any sale or disposition of the Collateral are insufficient to pay all Obligations. 
 (c) Without restricting the
generality of the foregoing and for the purposes aforesaid, each Borrower hereby appoints and constitutes Agent its lawful attorney-in-fact with full power of substitution in the Collateral, upon the occurrence and during the continuance of an Event
of Default, to (i) use unadvanced funds remaining under this Agreement or which may be reserved, escrowed or set aside for any purposes hereunder at any time, or to advance funds in excess of the face amount of the Notes, (ii) pay, settle
or compromise all existing bills and claims, which may be Liens or security interests, or to avoid such bills and claims becoming Liens against the Collateral, (iii) execute all applications and certificates in the name of such Borrower and to
prosecute and defend all actions or proceedings in connection with the Collateral, and (iv) do any and every act which such Borrower might do in its own behalf; it being understood and agreed that this power of attorney in this
subsection (c) shall be a power coupled with an interest and cannot be revoked. 
 (d) Agent and each Lender is hereby granted a
non-exclusive, royalty-free license or other right to use, without charge, Borrowers’ labels, mask works, rights of use of any name, any other Intellectual Property and advertising matter, and any similar property as it pertains to the
Collateral, in completing production of, advertising for sale, and selling any Collateral and, in connection with Agent’s exercise of its rights under this Article, Borrowers’ rights under all licenses (whether as licensor or licensee) and
all franchise agreements inure to Agent’s and each Lender’s benefit. 
 Section 10.4 [Reserved]. 

Section 10.5 Default Rate of Interest. At the election of Agent or Required Lenders, after the occurrence of an Event of
Default and for so long as it continues, the Loans and other Obligations shall bear interest at rates that are two percent (2.0%) per annum in excess of the rates otherwise payable under this Agreement; provided, however, that in the
case of any Event of Default specified in Section 10.1(e) or 10.1(f) above, such default rates shall apply immediately and automatically without the need for any election or action of any kind on the part of Agent or any Lender. 

  
 66 

MidCap / EndoChoice / Term Credit and Security Agreement 








 Section 10.6 Setoff Rights. During the continuance of any Event of Default,
each Lender is hereby authorized by each Borrower at any time or from time to time, with reasonably prompt subsequent notice to such Borrower (any prior or contemporaneous notice being hereby expressly waived) to set off and to appropriate and to
apply any and all (a) balances held by such Lender or any of such Lender’s Affiliates at any of its offices for the account of such Borrower or any of its Subsidiaries (regardless of whether such balances are then due to such Borrower or
its Subsidiaries), and (b) other property at any time held or owing by such Lender to or for the credit or for the account of such Borrower or any of its Subsidiaries, against and on account of any of the Obligations; except that no Lender
shall exercise any such right without the prior written consent of Agent. Any Lender exercising a right to set off shall purchase for cash (and the other Lenders shall sell) interests in each of such other Lender’s Pro Rata Share of the
Obligations as would be necessary to cause all Lenders to share the amount so set off with each other Lender in accordance with their respective Pro Rata Share of the Obligations. Each Borrower agrees, to the fullest extent permitted by law, that
any Lender and any of such Lender’s Affiliates may exercise its right to set off with respect to the Obligations as provided in this Section 10.6. 

Section 10.7 Application of Proceeds. 

(a) Notwithstanding anything to the contrary contained in this Agreement, upon the occurrence and during the continuance of an Event of
Default, each Borrower irrevocably waives the right to direct the application of any and all payments at any time or times thereafter received by Agent from or on behalf of such Borrower or any Guarantor of all or any part of the Obligations, and,
as between Borrowers on the one hand and Agent and Lenders on the other, Agent shall have the continuing and exclusive right to apply and to reapply any and all payments received against the Obligations in such manner as Agent may deem advisable
notwithstanding any previous application by Agent. 
 (b) Following the occurrence and continuance of an Event of Default, but absent the
occurrence and continuance of an Acceleration Event, Agent shall apply any and all payments received by Agent in respect of the Obligations, and any and all proceeds of Collateral received by Agent, in such order as Agent may from time to time
elect. 
 (c) Notwithstanding anything to the contrary contained in this Agreement, if an Acceleration Event shall have occurred, and so
long as it continues, Agent shall apply any and all payments received by Agent in respect of the Obligations, and any and all proceeds of Collateral received by Agent, in the following order: first, to all fees, costs, indemnities,
liabilities, obligations and expenses incurred by or owing to Agent with respect to this Agreement, the other Financing Documents or the Collateral; second, to all fees, costs, indemnities, liabilities, obligations and expenses
incurred by or owing to any Lender with respect to this Agreement, the other Financing Documents or the Collateral; third, to accrued and unpaid interest on the Obligations (including any interest which, but for the provisions of the
Bankruptcy Code, would have accrued on such amounts); fourth, to the principal amount of the 

  
 67 

MidCap / EndoChoice / Term Credit and Security Agreement 








 
Obligations outstanding; and fifth to any other indebtedness or obligations of Borrowers owing to Agent or any Lender under the Financing Documents. Any balance remaining shall be
delivered to Borrowers or to whomever may be lawfully entitled to receive such balance or as a court of competent jurisdiction may direct. In carrying out the foregoing, (y) amounts received shall be applied in the numerical order provided
until exhausted prior to the application to the next succeeding category, and (z) each of the Persons entitled to receive a payment in any particular category shall receive an amount equal to its Pro Rata Share of amounts available to be
applied pursuant thereto for such category. 
 Section 10.8 Waivers. 

(a) Except as otherwise provided for in this Agreement and to the fullest extent permitted by applicable law, each Borrower waives:
(i) presentment, demand and protest, and notice of presentment, dishonor, intent to accelerate, acceleration, protest, default, nonpayment, maturity, release, compromise, settlement, extension or renewal of any or all Financing Documents, the
Notes or any other notes, commercial paper, accounts, contracts, documents, Instruments, Chattel Paper and Guarantees at any time held by Lenders on which any Borrower may in any way be liable, and hereby ratifies and confirms whatever Lenders may
do in this regard; (ii) all rights to notice and a hearing prior to Agent’s or any Lender’s taking possession or control of, or to Agent’s or any Lender’s replevy, attachment or levy upon, any Collateral or any bond or
security which might be required by any court prior to allowing Agent or any Lender to exercise any of its remedies; and (iii) the benefit of all valuation, appraisal and exemption Laws. Each Borrower acknowledges that it has been advised by
counsel of its choices and decisions with respect to this Agreement, the other Financing Documents and the transactions evidenced hereby and thereby. 

(b) Each Borrower for itself and all its successors and assigns, (i) agrees that its liability shall not be in any manner affected by any
indulgence, extension of time, renewal, waiver, or modification granted or consented to by Lender; (ii) consents to any indulgences and all extensions of time, renewals, waivers, or modifications that may be granted by Agent or any Lender with
respect to the payment or other provisions of the Financing Documents, and to any substitution, exchange or release of the Collateral, or any part thereof, with or without substitution, and agrees to the addition or release of any Borrower,
endorsers, guarantors, or sureties, or whether primarily or secondarily liable, without notice to any other Borrower and without affecting its liability hereunder; (iii) agrees that its liability shall be unconditional and without regard to the
liability of any other Borrower, Agent or any Lender for any tax on the indebtedness; and (iv) to the fullest extent permitted by law, expressly waives the benefit of any statute or rule of law or equity now provided, or which may hereafter be
provided, which would produce a result contrary to or in conflict with the foregoing. 
 (c) To the extent that Agent or any Lender may have
acquiesced in any noncompliance with any requirements or conditions precedent to the closing of the Loans or to any subsequent disbursement of Loan proceeds, such acquiescence shall not be deemed to constitute a waiver by Agent or any Lender of such
requirements with respect to any future disbursements of Loan proceeds and Agent may at any time after such acquiescence require Borrowers to comply with all such requirements. Any forbearance by Agent or Lender in


  
 68 

MidCap / EndoChoice / Term Credit and Security Agreement 








 
exercising any right or remedy under any of the Financing Documents, or otherwise afforded by applicable law, including any failure to accelerate the maturity date of the Loans, shall not be a
waiver of or preclude the exercise of any right or remedy nor shall it serve as a novation of the Notes or as a reinstatement of the Loans or a waiver of such right of acceleration or the right to insist upon strict compliance of the terms of the
Financing Documents. Agent’s or any Lender’s acceptance of payment of any sum secured by any of the Financing Documents after the due date of such payment shall not be a waiver of Agent’s and such Lender’s right to either require
prompt payment when due of all other sums so secured or to declare a default for failure to make prompt payment. The procurement of insurance or the payment of taxes or other Liens or charges by Agent as the result of an Event of Default shall not
be a waiver of Agent’s right to accelerate the maturity of the Loans, nor shall Agent’s receipt of any condemnation awards, insurance proceeds, or damages under this Agreement operate to cure or waive any Credit Party’s default in
payment of sums secured by any of the Financing Documents. 
 (d) Without limiting the generality of anything contained in this Agreement or
the other Financing Documents, each Borrower agrees that if an Event of Default is continuing (i) Agent and Lenders shall not be subject to any “one action” or “election of remedies” law or rule, and (ii) all Liens and
other rights, remedies or privileges provided to Agent or Lenders shall remain in full force and effect until Agent or Lenders have exhausted all remedies against the Collateral and any other properties owned by Borrowers and the Financing Documents
and other security instruments or agreements securing the Loans have been foreclosed, sold and/or otherwise realized upon in satisfaction of Borrowers’ obligations under the Financing Documents. 

(e) Nothing contained herein or in any other Financing Document shall be construed as requiring Agent or any Lender to resort to any part of
the Collateral for the satisfaction of any of Borrowers’ obligations under the Financing Documents in preference or priority to any other Collateral, and Agent may seek satisfaction out of all of the Collateral or any part thereof, in its
absolute discretion in respect of Borrowers’ obligations under the Financing Documents. In addition, Agent shall have the right from time to time to partially foreclose upon any Collateral in any manner and for any amounts secured by the
Financing Documents then due and payable as determined by Agent in its sole discretion, including, without limitation, the following circumstances: (i) in the event any Borrower defaults beyond any applicable grace period in the payment of one
or more scheduled payments of principal and/or interest, Agent may foreclose upon all or any part of the Collateral to recover such delinquent payments, or (ii) in the event Agent elects to accelerate less than the entire outstanding principal
balance of the Loans, Agent may foreclose all or any part of the Collateral to recover so much of the principal balance of the Loans as Lender may accelerate and such other sums secured by one or more of the Financing Documents as Agent may elect.
Notwithstanding one or more partial foreclosures, any unforeclosed Collateral shall remain subject to the Financing Documents to secure payment of sums secured by the Financing Documents and not previously recovered. 

(f) To the fullest extent permitted by law, each Borrower, for itself and its successors and assigns, waives in the event of foreclosure of
any or all of the Collateral any equitable right otherwise available to any Credit Party which would require the separate sale of 

  
 69 

MidCap / EndoChoice / Term Credit and Security Agreement 








 
any of the Collateral or require Agent or Lenders to exhaust their remedies against any part of the Collateral before proceeding against any other part of the Collateral; and further in the event
of such foreclosure each Borrower does hereby expressly consent to and authorize, at the option of Agent, the foreclosure and sale either separately or together of each part of the Collateral. 

Section 10.9 Injunctive Relief. The parties acknowledge and agree that, in the event of a breach or threatened breach of
any Credit Party’s obligations under any Financing Documents, Agent and Lenders may have no adequate remedy in money damages and, accordingly, shall be entitled to an injunction (including, without limitation, a temporary restraining order,
preliminary injunction, writ of attachment, or order compelling an audit) against such breach or threatened breach, including, without limitation, maintaining any cash management and collection procedure described herein. However, no specification
in this Agreement of a specific legal or equitable remedy shall be construed as a waiver or prohibition against any other legal or equitable remedies in the event of a breach or threatened breach of any provision of this Agreement. Each Credit Party
waives, to the fullest extent permitted by law, the requirement of the posting of any bond in connection with such injunctive relief. By joining in the Financing Documents as a Credit Party, each Credit Party specifically joins in this
Section as if this Section were a part of each Financing Document executed by such Credit Party. 
 Section 10.10
Marshalling; Payments Set Aside. Neither Agent nor any Lender shall be under any obligation to marshal any assets in payment of any or all of the Obligations. To the extent that Borrower makes any payment or Agent enforces its Liens or Agent
or any Lender exercises its right of set-off, and such payment or the proceeds of such enforcement or set-off is subsequently invalidated, declared to be fraudulent or preferential, set aside, or required to be repaid by anyone, then to the extent
of such recovery, the Obligations or part thereof originally intended to be satisfied, and all Liens, rights and remedies therefor, shall be revived and continued in full force and effect as if such payment had not been made or such enforcement or
set-off had not occurred. 
 ARTICLE 11 - AGENT 

Section 11.1 Appointment and Authorization. Each Lender hereby irrevocably appoints and authorizes Agent to enter into each
of the Financing Documents to which it is a party (other than this Agreement) on its behalf and to take such actions as Agent on its behalf and to exercise such powers under the Financing Documents as are delegated to Agent by the terms thereof,
together with all such powers as are reasonably incidental thereto. Subject to the terms of Section 11.16 and to the terms of the other Financing Documents, Agent is authorized and empowered to amend, modify, or waive any provisions of this
Agreement or the other Financing Documents on behalf of Lenders. The provisions of this Article 11 are solely for the benefit of Agent and Lenders and neither any Borrower nor any other Credit Party shall have any rights as a third party
beneficiary of any of the provisions hereof. In performing its functions and duties under this Agreement, Agent shall act solely as agent of Lenders and does not assume and shall not be deemed to have assumed any obligation toward or relationship of
agency or trust with or for any Borrower or any other Credit Party. Agent may perform any of its duties hereunder, or under the Financing Documents, by or through its agents, servicers, trustees, investment managers or employees. 

  
 70 

MidCap / EndoChoice / Term Credit and Security Agreement 








 Section 11.2 Agent and Affiliates. Agent shall have the same rights and powers
under the Financing Documents as any other Lender and may exercise or refrain from exercising the same as though it were not Agent, and Agent and its Affiliates may lend money to, invest in and generally engage in any kind of business with each
Credit Party or Affiliate of any Credit Party as if it were not Agent hereunder. 
 Section 11.3 Action by Agent. The
duties of Agent shall be mechanical and administrative in nature. Agent shall not have by reason of this Agreement a fiduciary relationship in respect of any Lender. Nothing in this Agreement or any of the Financing Documents is intended to or shall
be construed to impose upon Agent any obligations in respect of this Agreement or any of the Financing Documents except as expressly set forth herein or therein. 

Section 11.4 Consultation with Experts. Agent may consult with legal counsel, independent public accountants and other
experts selected by it and shall not be liable for any action taken or omitted to be taken by it in good faith in accordance with the advice of such counsel, accountants or experts. 

Section 11.5 Liability of Agent. Neither Agent nor any of its directors, officers, agents, trustees, investment managers,
servicers or employees shall be liable to any Lender for any action taken or not taken by it in connection with the Financing Documents, except that Agent shall be liable with respect to its specific duties set forth hereunder but only to the extent
of its own gross negligence or willful misconduct in the discharge thereof as determined by a final non-appealable judgment of a court of competent jurisdiction. Neither Agent nor any of its directors, officers, agents, trustees, investment
managers, servicers or employees shall be responsible for or have any duty to ascertain, inquire into or verify (a) any statement, warranty or representation made in connection with any Financing Document or any borrowing hereunder;
(b) the performance or observance of any of the covenants or agreements specified in any Financing Document; (c) the satisfaction of any condition specified in any Financing Document; (d) the validity, effectiveness, sufficiency or
genuineness of any Financing Document, any Lien purported to be created or perfected thereby or any other instrument or writing furnished in connection therewith; (e) the existence or non-existence of any Default or Event of Default; or
(f) the financial condition of any Credit Party. Agent shall not incur any liability by acting in reliance upon any notice, consent, certificate, statement, or other writing (which may be a bank wire, facsimile or electronic transmission or
similar writing) believed by it to be genuine or to be signed by the proper party or parties. Agent shall not be liable for any apportionment or distribution of payments made by it in good faith and if any such apportionment or distribution is
subsequently determined to have been made in error the sole recourse of any Lender to whom payment was due but not made, shall be to recover from other Lenders any payment in excess of the amount to which they are determined to be entitled (and such
other Lenders hereby agree to return to such Lender any such erroneous payments received by them). 
 Section 11.6
Indemnification. Each Lender shall, in accordance with its Pro Rata Share, indemnify Agent (to the extent not reimbursed by Borrowers) upon demand against any cost, expense (including counsel fees and disbursements), claim, demand, action,
loss or liability (except such as result from Agent’s gross negligence or willful misconduct as determined by a 

  
 71 

MidCap / EndoChoice / Term Credit and Security Agreement 








 
final non-appealable judgment of a court of competent jurisdiction) that Agent may suffer or incur in connection with the Financing Documents or any action taken or omitted by Agent hereunder or
thereunder. If any indemnity furnished to Agent for any purpose shall, in the opinion of Agent, be insufficient or become impaired, Agent may call for additional indemnity and cease, or not commence, to do the acts indemnified against even if so
directed by Required Lenders until such additional indemnity is furnished. 
 Section 11.7 Right to Request and Act on
Instructions. Agent may at any time request instructions from Lenders with respect to any actions or approvals which by the terms of this Agreement or of any of the Financing Documents Agent is permitted or desires to take or to grant, and if
such instructions are promptly requested, Agent shall be absolutely entitled to refrain from taking any action or to withhold any approval and shall not be under any liability whatsoever to any Person for refraining from any action or withholding
any approval under any of the Financing Documents until it shall have received such instructions from Required Lenders or all or such other portion of the Lenders as shall be prescribed by this Agreement. Without limiting the foregoing, no Lender
shall have any right of action whatsoever against Agent as a result of Agent acting or refraining from acting under this Agreement or any of the other Financing Documents in accordance with the instructions of Required Lenders (or all or such other
portion of the Lenders as shall be prescribed by this Agreement) and, notwithstanding the instructions of Required Lenders (or such other applicable portion of the Lenders), Agent shall have no obligation to take any action if it believes, in good
faith, that such action would violate applicable Law or exposes Agent to any liability for which it has not received satisfactory indemnification in accordance with the provisions of Section 11.6. 

Section 11.8 Credit Decision. Each Lender acknowledges that it has, independently and without reliance upon Agent or any
other Lender, and based on such documents and information as it has deemed appropriate, made its own credit analysis and decision to enter into this Agreement. Each Lender also acknowledges that it will, independently and without reliance upon Agent
or any other Lender, and based on such documents and information as it shall deem appropriate at the time, continue to make its own credit decisions in taking or not taking any action under the Financing Documents. 

Section 11.9 Collateral Matters. Lenders irrevocably authorize Agent, at its option and in its discretion, to
(a) release any Lien granted to or held by Agent under any Security Document (i) upon termination of the Loan Commitment and payment in full of all Obligations; or (ii) constituting property sold or disposed of as part of or in
connection with any disposition permitted under any Financing Document (it being understood and agreed that Agent may conclusively rely without further inquiry on a certificate of a Responsible Officer as to the sale or other disposition of property
being made in full compliance with the provisions of the Financing Documents); and (b) subordinate any Lien granted to or held by Agent under any Security Document to a Permitted Lien that is allowed to have priority over the Liens granted to
or held by Agent pursuant to the definition of “Permitted Liens”. Upon request by Agent at any time, Lenders will confirm Agent’s authority to release and/or subordinate particular types or items of Collateral pursuant to this
Section 11.9. 

  
 72 

MidCap / EndoChoice / Term Credit and Security Agreement 








 Section 11.10 Agency for Perfection. Agent and each Lender hereby appoint each
other Lender as agent for the purpose of perfecting Agent’s security interest in assets which, in accordance with the Uniform Commercial Code in any applicable jurisdiction, can be perfected by possession or control. Should any Lender (other
than Agent) obtain possession or control of any such assets, such Lender shall notify Agent thereof, and, promptly upon Agent’s request therefor, shall deliver such assets to Agent or in accordance with Agent’s instructions or transfer
control to Agent in accordance with Agent’s instructions. Each Lender agrees that it will not have any right individually to enforce or seek to enforce any Security Document or to realize upon any Collateral for the Loan unless instructed to do
so by Agent (or consented to by Agent), it being understood and agreed that such rights and remedies may be exercised only by Agent. 

Section 11.11 Notice of Default. Agent shall not be deemed to have knowledge or notice of the occurrence of any Default or
Event of Default except with respect to defaults in the payment of principal, interest and fees required to be paid to Agent for the account of Lenders, unless Agent shall have received written notice from a Lender or a Borrower referring to this
Agreement, describing such Default or Event of Default and stating that such notice is a “notice of default”. Agent will notify each Lender of its receipt of any such notice. Agent shall take such action with respect to such Default or
Event of Default as may be requested by Required Lenders (or all or such other portion of the Lenders as shall be prescribed by this Agreement) in accordance with the terms hereof. Unless and until Agent has received any such request, Agent may (but
shall not be obligated to) take such action, or refrain from taking such action, with respect to such Default or Event of Default as it shall deem advisable or in the best interests of Lenders. 

Section 11.12 Assignment by Agent; Resignation of Agent; Successor Agent. 

(a) Agent may at any time assign its rights, powers, privileges and duties hereunder to (i) another Lender or an Affiliate of Agent or any
Lender or any Approved Fund, or (ii) any Person to whom Agent, in its capacity as a Lender, has assigned (or will assign, in conjunction with such assignment of agency rights hereunder) 50% or more of its Loan, in each case without the consent
of the Lenders or Borrowers. Following any such assignment, Agent shall endeavor to give notice to the Lenders and Borrowers. Failure to give such notice shall affect such assignment in any way or cause the assignment to be ineffective. An
assignment by Agent pursuant to this subsection (a) shall not be deemed a resignation by Agent for purposes of subsection (b) below. 

(b) Without limiting the rights of Agent to designate an assignee pursuant to subsection (a) above, Agent may at any time give notice of
its resignation to the Lenders and Borrowers. Upon receipt of any such notice of resignation, Required Lenders shall have the right to appoint a successor Agent. If no such successor shall have been so appointed by Required Lenders and shall have
accepted such appointment within ten (10) Business Days after the retiring Agent gives notice of its resignation, then the retiring Agent may on behalf of the Lenders, appoint a successor Agent; provided, however, that if Agent shall
notify Borrowers and the Lenders that no Person has accepted such appointment, then such resignation shall nonetheless become effective in accordance with such notice from Agent that no Person has accepted such appointment and, from and following
delivery of such notice, (i) the retiring Agent 

  
 73 

MidCap / EndoChoice / Term Credit and Security Agreement 








 
shall be discharged from its duties and obligations hereunder and under the other Financing Documents, and (ii) all payments, communications and determinations provided to be made by, to or
through Agent shall instead be made by or to each Lender directly, until such time as Required Lenders appoint a successor Agent as provided for above in this paragraph. 

(c) Upon (i) an assignment permitted by subsection (a) above, or (ii) the acceptance of a successor’s appointment as Agent
pursuant to subsection (b) above, such successor shall succeed to and become vested with all of the rights, powers, privileges and duties of the retiring (or retired) Agent, and the retiring Agent shall be discharged from all of its duties and
obligations hereunder and under the other Financing Documents (if not already discharged therefrom as provided above in this paragraph). The fees payable by Borrowers to a successor Agent shall be the same as those payable to its predecessor unless
otherwise agreed between Borrowers and such successor. After the retiring Agent’s resignation hereunder and under the other Financing Documents, the provisions of this Article and Section 11.12 shall continue in effect for the benefit
of such retiring Agent and its sub-agents in respect of any actions taken or omitted to be taken by any of them while the retiring Agent was acting or was continuing to act as Agent. 

Section 11.13 Payment and Sharing of Payment. 

(a) Reserved. 
 (b)
Term Loan Payments. Payments of principal, interest and fees in respect of the Term Loans will be settled on the date of receipt if received by Agent on the last Business Day of a month or on the Business Day immediately following the date of
receipt if received on any day other than the last Business Day of a month. 
 (c) Return of Payments. 

(i) If Agent pays an amount to a Lender under this Agreement in the belief or expectation that a related payment has been or
will be received by Agent from a Borrower and such related payment is not received by Agent, then Agent will be entitled to recover such amount from such Lender on demand without setoff, counterclaim or deduction of any kind, together with interest
accruing on a daily basis at the Federal Funds Rate. 
 (ii) If Agent determines at any time that any amount received by
Agent under this Agreement must be returned to any Borrower or paid to any other Person pursuant to any insolvency law or otherwise, then, notwithstanding any other term or condition of this Agreement or any other Financing Document, Agent will not
be required to distribute any portion thereof to any Lender. In addition, each Lender will repay to Agent on demand any portion of such amount that Agent has distributed to such Lender, together with interest at such rate, if any, as Agent is
required to pay to any Borrower or such other Person, without setoff, counterclaim or deduction of any kind. 

  
 74 

MidCap / EndoChoice / Term Credit and Security Agreement 








 (d) Defaulted Lenders. The failure of any Defaulted Lender to make any payment required by
it hereunder shall not relieve any other Lender of its obligations to make payment, but neither any other Lender nor Agent shall be responsible for the failure of any Defaulted Lender to make any payment required hereunder. Notwithstanding anything
set forth herein to the contrary, a Defaulted Lender shall not have any voting or consent rights under or with respect to any Financing Document or constitute a “Lender” (or be included in the calculation of “Required Lenders”
hereunder) for any voting or consent rights under or with respect to any Financing Document. 
 (e) Sharing of Payments. If any
Lender shall obtain any payment or other recovery (whether voluntary, involuntary, by application of setoff or otherwise) on account of any Loan (other than pursuant to the terms of Section 2.8(d)) in excess of its Pro Rata Share of payments
entitled pursuant to the other provisions of this Section 11.13, such Lender shall purchase from the other Lenders such participations in extensions of credit made by such other Lenders (without recourse, representation or warranty) as shall be
necessary to cause such purchasing Lender to share the excess payment or other recovery ratably with each of them; provided, however, that if all or any portion of the excess payment or other recovery is thereafter required to be returned or
otherwise recovered from such purchasing Lender, such portion of such purchase shall be rescinded and each Lender which has sold a participation to the purchasing Lender shall repay to the purchasing Lender the purchase price to the ratable extent
of such return or recovery, without interest. Each Borrower agrees that any Lender so purchasing a participation from another Lender pursuant to this clause (e) may, to the fullest extent permitted by law, exercise all its rights of payment
(including pursuant to Section 10.6) with respect to such participation as fully as if such Lender were the direct creditor of Borrowers in the amount of such participation). If under any applicable bankruptcy, insolvency or other similar law,
any Lender receives a secured claim in lieu of a setoff to which this clause (e) applies, such Lender shall, to the extent practicable, exercise its rights in respect of such secured claim in a manner consistent with the rights of the Lenders
entitled under this clause (e) to share in the benefits of any recovery on such secured claim. 
 Section 11.14 Right to
Perform, Preserve and Protect. If any Credit Party fails to perform any obligation hereunder or under any other Financing Document, Agent itself may, but shall not be obligated to, cause such obligation to be performed at Borrowers’
expense. Agent is further authorized by Borrowers and the Lenders to make expenditures from time to time which Agent, in its reasonable business judgment, deems necessary or desirable to (a) preserve or protect the business conducted by
Borrowers, the Collateral, or any portion thereof, and/or (b) enhance the likelihood of, or maximize the amount of, repayment of the Loan and other Obligations. Each Borrower hereby agrees to reimburse Agent on demand for any and all costs,
liabilities and obligations incurred by Agent pursuant to this Section 11.14. Each Lender hereby agrees to indemnify Agent upon demand for any and all costs, liabilities and obligations incurred by Agent pursuant to this Section 11.14, in
accordance with the provisions of Section 11.6. 
 Section 11.15 Reserved. 

  
 75 

MidCap / EndoChoice / Term Credit and Security Agreement 








 Section 11.16 Amendments and Waivers. 

(a) No provision of this Agreement or any other Financing Document may be materially amended, waived or otherwise modified unless such
amendment, waiver or other modification is in writing and is signed or otherwise approved by Borrowers, the Required Lenders and any other Lender to the extent required under Section 11.16(b). 

(b) In addition to the required signatures under Section 11.16(a), no provision of this Agreement or any other Financing Document may be
amended, waived or otherwise modified unless such amendment, waiver or other modification is in writing and is signed or otherwise approved by the following Persons: 

(i) if any amendment, waiver or other modification would increase a Lender’s funding obligations in respect of any Loan,
by such Lender; and/or 
 (ii) if the rights or duties of Agent are affected thereby, by Agent; 

provided, however, that, in each of (i) and (ii) above, no such amendment, waiver or other modification shall, unless signed or otherwise
approved in writing by all the Lenders directly affected thereby, (A) reduce the principal of, rate of interest on or any fees with respect to any Loan or forgive any principal, interest (other than default interest) or fees (other than late
charges) with respect to any Loan; (B) postpone the date fixed for, or waive, any payment of principal of any Loan, or of interest on any Loan (other than default interest) or any fees provided for hereunder (other than late charges) or
postpone the date of termination of any commitment of any Lender hereunder; (C) change the definition of the term Required Lenders or the percentage of Lenders which shall be required for Lenders to take any action hereunder; (D) release
all or substantially all of the Collateral, authorize any Borrower to sell or otherwise dispose of all or substantially all of the Collateral, release any Guarantor of all or any portion of the Obligations or its Guarantee obligations with respect
thereto, or consent to a transfer of any of the Intellectual Property, except, in each case with respect to this clause (D), as otherwise may be provided in this Agreement or the other Financing Documents (including in connection with any
disposition permitted hereunder); (E) amend, waive or otherwise modify this Section 11.16(b) or the definitions of the terms used in this Section 11.16(b) insofar as the definitions affect the substance of this Section 11.16(b);
(F) consent to the assignment, delegation or other transfer by any Credit Party of any of its rights and obligations under any Financing Document or release any Borrower of its payment obligations under any Financing Document, except, in each
case with respect to this clause (F), pursuant to a merger or consolidation permitted pursuant to this Agreement; or (G) amend any of the provisions of Section 10.7 or amend any of the definitions Pro Rata Share, Term Loan Commitment,
Term Loan Commitment Amount, Term Loan Commitment Percentage or that provide for the Lenders to receive their Pro Rata Shares of any fees, payments, setoffs or proceeds of Collateral hereunder. It is hereby understood and agreed that all Lenders
shall be deemed directly affected by an amendment, waiver or other modification of the type described in the preceding clauses (C), (D), (E), (F) and (G) of the preceding sentence. 

  
 76 

MidCap / EndoChoice / Term Credit and Security Agreement 








 Section 11.17 Assignments and Participations. 

(a) Assignments. 

(i) Any Lender may at any time assign to one or more Eligible Assignees all or any portion of such Lender’s Loan together
with all related obligations of such Lender hereunder. Except as Agent may otherwise agree, the amount of any such assignment (determined as of the date of the applicable Assignment Agreement or, if a “Trade Date” is specified in such
Assignment Agreement, as of such Trade Date) shall be in a minimum aggregate amount equal to $1,000,000 or, if less, the assignor’s entire interests in the outstanding Loan; provided, however, that, in connection with simultaneous
assignments to two or more related Approved Funds, such Approved Funds shall be treated as one assignee for purposes of determining compliance with the minimum assignment size referred to above. Borrowers and Agent shall be entitled to continue to
deal solely and directly with such Lender in connection with the interests so assigned to an Eligible Assignee until Agent shall have received and accepted an effective Assignment Agreement executed, delivered and fully completed by the applicable
parties thereto and a processing fee of $3,500 to be paid by the assigning Lender; provided, however, that only one processing fee shall be payable in connection with simultaneous assignments to two or more related Approved Funds. 

(ii) From and after the date on which the conditions described above have been met, (A) such Eligible Assignee shall be
deemed automatically to have become a party hereto and, to the extent of the interests assigned to such Eligible Assignee pursuant to such Assignment Agreement, shall have the rights and obligations of a Lender hereunder, and (B) the assigning
Lender, to the extent that rights and obligations hereunder have been assigned by it pursuant to such Assignment Agreement, shall be released from its rights and obligations hereunder (other than those that survive termination pursuant to
Section 12.1). Upon the request of the Eligible Assignee (and, as applicable, the assigning Lender) pursuant to an effective Assignment Agreement, each Borrower shall execute and deliver to Agent for delivery to the Eligible Assignee (and, as
applicable, the assigning Lender) Notes in the aggregate principal amount of the Eligible Assignee’s Loan (and, as applicable, Notes in the principal amount of that portion of the principal amount of the Loan retained by the assigning Lender).
Upon receipt by the assigning Lender of such Note, the assigning Lender shall return to Borrower Representative any prior Note held by it. 

(iii) Agent, acting solely for this purpose as an agent of Borrower, shall maintain at the office of its servicer located in
Bethesda, Maryland a copy of each Assignment Agreement delivered to it and a register for the recordation of the names and addresses of each Lender, and the commitments of, and principal amount of the Loan owing to, such Lender pursuant to the terms
hereof (the “Register”). The entries in such Register shall be conclusive, absent manifest effort, and Borrower, Agent and Lenders may treat each Person whose name is recorded therein pursuant to the terms hereof as a Lender hereunder for
all purposes of this Agreement, notwithstanding notice to the contrary. Such Register shall be available for inspection by Borrower and any Lender, at any reasonable time upon reasonable prior notice to Agent. Each Lender that sells a participation
shall, acting solely for this purpose as an agent of Borrower maintain a 

  
 77 

MidCap / EndoChoice / Term Credit and Security Agreement 








 
register on which it enters the name and address of each participant and the principal amounts (and stated interest) of each participant’s interest in the Obligations (each, a
“Participant Register”). The entries in the Participant Registers shall be conclusive, absent manifest error. Each Participant Register shall be available for inspection by Borrower and the Agent at any reasonable time upon reasonable
prior notice to the applicable Lender; provided, that no Lender shall have any obligation to disclose all or any portion of the Participant Register (including the identity of any Participant or any information relating to a Participant’s
interest in any commitments, loans, letters of credit or its other obligations under any Financing Document) to any Person (including Borrower) except to the extent that such disclosure is necessary to establish that such commitment, loan, letter of
credit or other obligation is in registered form under Section 5f.103-1(c) of the United States Treasury Regulations. For the avoidance of doubt, the Agent (in its capacity as Agent) shall have no responsibility for maintaining a participant
register. 
 (iv) Notwithstanding the foregoing provisions of this Section 11.17(a) or any other provision of this
Agreement, any Lender may at any time pledge or assign a security interest in all or any portion of its rights under this Agreement to secure obligations of such Lender, including any pledge or assignment to secure obligations to a Federal Reserve
Bank; provided, however, that no such pledge or assignment shall release such Lender from any of its obligations hereunder or substitute any such pledgee or assignee for such Lender as a party hereto. 

(v) Notwithstanding the foregoing provisions of this Section 11.17(a) or any other provision of this Agreement, Agent has
the right, but not the obligation, to effectuate assignments of Loan via an electronic settlement system acceptable to Agent as designated in writing from time to time to the Lenders by Agent (the “Settlement Service”). At any time
when the Agent elects, in its sole discretion, to implement such Settlement Service, each such assignment shall be effected by the assigning Lender and proposed assignee pursuant to the procedures then in effect under the Settlement Service, which
procedures shall be consistent with the other provisions of this Section 11.17(a). Each assigning Lender and proposed Eligible Assignee shall comply with the requirements of the Settlement Service in connection with effecting any assignment of
Loan pursuant to the Settlement Service. With the prior written approval of Agent, Agent’s approval of such Eligible Assignee shall be deemed to have been automatically granted with respect to any transfer effected through the Settlement
Service. Assignments and assumptions of the Loan shall be effected by the provisions otherwise set forth herein until Agent notifies Lenders of the Settlement Service as set forth herein. 

(b) Participations. Any Lender may at any time, without the consent of, or notice to, any Borrower or Agent, sell to one or more
Persons (other than any Borrower or any Borrower’s Affiliates) participating interests in its Loan, commitments or other interests hereunder (any such Person, a “Participant”). In the event of a sale by a Lender of a
participating interest to a Participant, (i) such Lender’s obligations hereunder shall remain unchanged for all purposes, (ii) Borrowers and Agent shall continue to deal solely and directly with such Lender in connection with such
Lender’s rights and obligations hereunder, and (iii) all 

  
 78 

MidCap / EndoChoice / Term Credit and Security Agreement 








 
amounts payable by each Borrower shall be determined as if such Lender had not sold such participation and shall be paid directly to such Lender. Each Borrower agrees that if amounts outstanding
under this Agreement are due and payable (as a result of acceleration or otherwise), each Participant shall be deemed to have the right of set-off in respect of its participating interest in amounts owing under this Agreement to the same extent as
if the amount of its participating interest were owing directly to it as a Lender under this Agreement; provided, however, that such right of set-off shall be subject to the obligation of each Participant to share with Lenders, and Lenders
agree to share with each Participant, as provided in Section 11.5. 
 (c) Replacement of Lenders. Within thirty
(30) days after: (i) receipt by Agent of notice and demand from any Lender for payment of additional costs as provided in Section 2.8(d), which demand shall not have been revoked, (ii) any Borrower is required to pay any
additional amount to any Lender or any Governmental Authority for the account of any Lender pursuant to Section 2.8(a), (iii) any Lender is a Defaulted Lender, and the circumstances causing such status shall not have been cured or waived;
or (iv) any failure by any Lender to consent to a requested amendment, waiver or modification to any Financing Document in which Required Lenders have already consented to such amendment, waiver or modification but the consent of each Lender,
or each Lender affected thereby, is required with respect thereto (each relevant Lender in the foregoing clauses (i) through (iv) being an “Affected Lender”) each of Borrower Representative and Agent may, at its option,
notify such Affected Lender and, in the case of Borrowers’ election, the Agent, of such Person’s intention to obtain, at Borrowers’ expense, a replacement Lender (“Replacement Lender”) for such Lender, which
Replacement Lender shall be an Eligible Assignee and, in the event the Replacement Lender is to replace an Affected Lender described in the preceding clause (iv), such Replacement Lender consents to the requested amendment, waiver or
modification making the replaced Lender an Affected Lender. In the event Borrowers or Agent, as applicable, obtains a Replacement Lender within ninety (90) days following notice of its intention to do so, the Affected Lender shall sell, at par,
and assign all of its Loan and funding commitments hereunder to such Replacement Lender in accordance with the procedures set forth in Section 11.17(a); provided, however, that (A) Borrowers shall have reimbursed such Lender for its
increased costs and additional payments for which it is entitled to reimbursement under Section 2.8(a) or Section 2.8(d), as applicable, of this Agreement through the date of such sale and assignment, and (B) Borrowers shall pay to
Agent the $3,500 processing fee in respect of such assignment. In the event that a replaced Lender does not execute an Assignment Agreement pursuant to Section 11.17(a) within five (5) Business Days after receipt by such replaced Lender of
notice of replacement pursuant to this Section 11.17(c) and presentation to such replaced Lender of an Assignment Agreement evidencing an assignment pursuant to this Section 11.17(c), such replaced Lender shall be deemed to have consented
to the terms of such Assignment Agreement, and any such Assignment Agreement executed by Agent, the Replacement Lender and, to the extent required pursuant to Section 11.17(a), Borrowers, shall be effective for purposes of this
Section 11.17(c) and Section 11.17(a). Upon any such assignment and payment, such replaced Lender shall no longer constitute a “Lender” for purposes hereof, other than with respect to such rights and obligations that
survive termination as set forth in Section 12.1. 

  
 79 

MidCap / EndoChoice / Term Credit and Security Agreement 








 (d) Credit Party Assignments. No Credit Party may assign, delegate or otherwise transfer any of
its rights or other obligations hereunder or under any other Financing Document without the prior written consent of Agent and each Lender. 

Section 11.18 Reserved. 

Section 11.19 Reserved. 

Section 11.20 Definitions. As used in this Article 11, the following terms have the following meanings: 

“Approved Fund” means any (a) investment company, fund, trust, securitization vehicle or conduit that is (or will be)
engaged in making, purchasing, holding or otherwise investing in commercial loans and similar extensions of credit in the Ordinary Course of Business, or (b) any Person (other than a natural person) which temporarily warehouses loans for any
Lender or any entity described in the preceding clause (a) and that, with respect to each of the preceding clauses (a) and (b), is administered or managed by (i) a Lender, (ii) an Affiliate of a Lender, or (iii) a Person
(other than a natural person) or an Affiliate of a Person (other than a natural person) that administers or manages a Lender. 

“Assignment Agreement” means an assignment agreement in form and substance acceptable to Agent. 

“Defaulted Lender” means, so long as such failure shall remain in existence and uncured, any Lender which shall have
failed to make any Loan or other credit accommodation, disbursement, settlement or reimbursement required pursuant to the terms of any Financing Document. 

“Eligible Assignee” means (a) a Lender, (b) an Affiliate of a Lender, (c) an Approved Fund, and
(d) any other Person (other than a natural person) approved by Agent; provided, however, that notwithstanding the foregoing, (x) “Eligible Assignee” shall not include (i) any Borrower or any of a
Borrower’s Affiliates or (ii) unless a Default or an Event of Default has occurred and is continuing, (A) any hedge fund or private equity fund that is primarily engaged in the business of purchasing distressed debt or (B) any
direct competitor of Credit Parties, in each case, as determined by Agent in its reasonable discretion and (y) no proposed assignee intending to assume any unfunded portion of the Term Loan Commitment shall be an Eligible Assignee unless such
proposed assignee either already holds a portion of Term Loan Commitment, or has been approved as an Eligible Assignee by Agent. 

“Federal Funds Rate” means, for any day, the rate of interest per annum (rounded upwards, if necessary, to the nearest
whole multiple of 1/100 of 1%) equal to the weighted average of the rates on overnight Federal funds transactions with members of the Federal Reserve System arranged by Federal funds brokers on such day, as published by the Federal Reserve Bank of
New York on the Business Day next succeeding such day, provided, however, that (a) if such day is not a Business Day, the Federal Funds Rate for such day shall be such rate on such transactions on the next preceding
Business Day, and (b) if no such rate is so published on such next preceding Business Day, the Federal Funds Rate for such day shall be the average rate quoted to Agent on such day on such transactions as determined by Agent. 

  
 80 

MidCap / EndoChoice / Term Credit and Security Agreement 








 ARTICLE 12 - MISCELLANEOUS 

Section 12.1 Survival. All agreements, representations and warranties made herein and in every other Financing Document
shall survive the execution and delivery of this Agreement and the other Financing Documents and the other Operative Documents. The provisions of Section 2.10 and Articles 11 and 12 shall survive the payment of the Obligations (both with
respect to any Lender and all Lenders collectively) and any termination of this Agreement and any judgment with respect to any Obligations, including any final foreclosure judgment with respect to any Security Document, and no unpaid or unperformed,
current or future, Obligations will merge into any such judgment. 
 Section 12.2 No Waivers. No failure or delay by
Agent or any Lender in exercising any right, power or privilege under any Financing Document shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any
other right, power or privilege. The rights and remedies herein and therein provided shall be cumulative and not exclusive of any rights or remedies provided by law. Any reference in any Financing Document to the “continuing” nature of any
Event of Default shall not be construed as establishing or otherwise indicating that any Borrower or any other Credit Party has the independent right to cure any such Event of Default, but is rather presented merely for convenience should such Event
of Default be waived in accordance with the terms of the applicable Financing Documents. 
 Section 12.3 Notices. 

(a) All notices, requests and other communications to any party hereunder shall be in writing (including prepaid overnight courier, facsimile
transmission or similar writing) and shall be given to such party at its address, facsimile number or e-mail address set forth on the signature pages hereof (or, in the case of any such Lender who becomes a Lender after the date hereof, in an
assignment agreement or in a notice delivered to Borrower Representative and Agent by the assignee Lender forthwith upon such assignment) or at such other address, facsimile number or e-mail address as such party may hereafter specify for the
purpose by notice to Agent and Borrower Representative; provided, however, that notices, requests or other communications shall be permitted by electronic means only in accordance with the provisions of Section 12.3(b) and (c). Each such
notice, request or other communication shall be effective (i) if given by facsimile, when such notice is transmitted to the facsimile number specified by this Section and the sender receives a confirmation of transmission from the sending
facsimile machine, or (ii) if given by mail, prepaid overnight courier or any other means, when received or when receipt is refused at the applicable address specified by this Section 12.3(a). 

(b) Notices and other communications to the parties hereto may be delivered or furnished by electronic communication (including e-mail and
Internet or intranet websites) pursuant to procedures approved from time to time by Agent, provided, however, that the 

  
 81 

MidCap / EndoChoice / Term Credit and Security Agreement 








 
foregoing shall not apply to notices sent directly to any Lender if such Lender has notified the Agent that it is incapable of receiving notices by electronic communication. The Agent or Borrower
Representative may, in their discretion, agree to accept notices and other communications to them hereunder by electronic communications pursuant to procedures approved by it, provided, however, that approval of such procedures may be limited
to particular notices or communications. 
 (c) Unless the Agent otherwise prescribes, (i) notices and other communications sent to an
e-mail address shall be deemed received upon the sender’s receipt of an acknowledgment from the intended recipient (such as by the “return receipt requested” function, as available, return e-mail or other written acknowledgment), and
(ii) notices or communications posted to an Internet or intranet website shall be deemed received upon the deemed receipt by the intended recipient at its e-mail address as described in the foregoing clause (i) of notification that such
notice or communication is available and identifying the website address therefor, provided, however, that if any such notice or other communication is not sent or posted during normal business hours, such notice or communication shall be deemed to
have been sent at the opening of business on the next Business Day. 
 Section 12.4 Severability. In case any provision
of or obligation under this Agreement or any other Financing Document shall be invalid, illegal or unenforceable in any jurisdiction, the validity, legality and enforceability of the remaining provisions or obligations, or of such provision or
obligation in any other jurisdiction, shall not in any way be affected or impaired thereby. 
 Section 12.5 Headings.
Headings and captions used in the Financing Documents (including the Exhibits, Schedules and Annexes hereto and thereto) are included for convenience of reference only and shall not be given any substantive effect. 

Section 12.6 Confidentiality. 

(a) Each Credit Party agrees (i) not to transmit or disclose provisions of any Financing Document to any Person (other than to
Borrowers’ advisors and officers on a need-to-know basis or as otherwise may be required by Law) without Agent’s and Borrowers’ prior written consent, (ii) to inform all Persons of the confidential nature of the Financing
Documents and to direct them not to disclose the same to any other Person and to require each of them to be bound by these provisions. 

(b) Agent and each Lender shall hold all non-public information regarding the Credit Parties and their respective businesses identified as
such by Borrowers and obtained by Agent or any Lender pursuant to the requirements hereof in accordance with such Person’s customary procedures for handling information of such nature, except that disclosure of such information may be made
(i) to their respective agents, employees, Subsidiaries, Affiliates, attorneys, auditors, professional consultants, rating agencies, insurance industry associations and portfolio management services to the extent necessary in connection with
the transactions contemplated hereby or related to Agent’s or such Lender’s customary practices in connection therewith, (ii) to prospective transferees or purchasers of any interest in the Loans, the Agent or a


  
 82 

MidCap / EndoChoice / Term Credit and Security Agreement 








 
Lender, provided, however, that any such Persons are bound by obligations of confidentiality, (iii) as required by Law, subpoena, judicial order
or similar order and in connection with any litigation, (iv) as may be required in connection with the examination, audit or similar investigation of such Person, and (v) to a Person that is a trustee, investment advisor or investment
manager, collateral manager, servicer, noteholder or secured party in a Securitization (as hereinafter defined) in connection with the administration, servicing and reporting on the assets serving as collateral for such Securitization. For the
purposes of this Section, “Securitization” shall mean (A) the pledge of the Loans as collateral security for loans to a Lender, or (B) a public or private offering by a Lender or any of its Affiliates or their respective
successors and assigns, of securities which represent an interest in, or which are collateralized, in whole or in part, by the Loans. Confidential information shall include only such information identified as such at the time provided to Agent and
shall not include information that either: (y) is in the public domain, or becomes part of the public domain after disclosure to such Person through no fault of such Person, or (z) is disclosed to such Person by a Person other than a
Credit Party, provided, however, Agent does not have actual knowledge that such Person is prohibited from disclosing such information. The obligations of Agent and Lenders under this Section 12.6 shall
supersede and replace the obligations of Agent and Lenders under any confidentiality agreement in respect of this financing executed and delivered by Agent or any Lender prior to the date hereof. 

Section 12.7 Waiver of Consequential and Other Damages. To the fullest extent permitted by applicable law, no Borrower
shall assert, and each Borrower hereby waives, any claim against any Indemnitee (as defined below), on any theory of liability, for special, indirect, consequential or punitive damages (as opposed to direct or actual damages) arising out of, in
connection with, or as a result of this Agreement, any other Financing Document or any agreement or instrument contemplated hereby or thereby, the transactions contemplated hereby or thereby, any Loan or the use of the proceeds thereof. No
Indemnitee shall be liable for any damages arising from the use by unintended recipients of any information or other materials distributed by it through telecommunications, electronic or other information transmission systems in connection with this
Agreement or the other Financing Documents or the transactions contemplated hereby or thereby. 
 Section 12.8 GOVERNING LAW;
SUBMISSION TO JURISDICTION. 
 (a) THIS AGREEMENT, EACH NOTE AND EACH OTHER FINANCING DOCUMENT, AND ALL DISPUTES AND OTHER MATTERS
RELATING HERETO OR THERETO OR ARISING THEREFROM (WHETHER SOUNDING IN CONTRACT LAW, TORT LAW OR OTHERWISE), SHALL BE GOVERNED BY, AND SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF MARYLAND, WITHOUT REGARD TO CONFLICTS
OF LAWS PRINCIPLES. 
 (b) EACH BORROWER HEREBY CONSENTS TO THE JURISDICTION OF ANY STATE OR FEDERAL COURT LOCATED WITHIN THE COUNTY OF
MONTGOMERY, STATE OF MARYLAND AND IRREVOCABLY AGREES THAT, SUBJECT TO AGENT’S ELECTION, ALL ACTIONS OR PROCEEDINGS ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE OTHER FINANCING DOCUMENTS 

  
 83 

MidCap / EndoChoice / Term Credit and Security Agreement 








 
SHALL BE LITIGATED IN SUCH COURTS. EACH BORROWER EXPRESSLY SUBMITS AND CONSENTS TO THE JURISDICTION OF THE AFORESAID COURTS AND WAIVES ANY DEFENSE OF FORUM NON CONVENIENS. EACH BORROWER HEREBY
WAIVES PERSONAL SERVICE OF ANY AND ALL PROCESS AND AGREES THAT ALL SUCH SERVICE OF PROCESS MAY BE MADE UPON SUCH BORROWER BY CERTIFIED OR REGISTERED MAIL, RETURN RECEIPT REQUESTED, ADDRESSED TO SUCH BORROWER AT THE ADDRESS SET FORTH IN THIS
AGREEMENT AND SERVICE SO MADE SHALL BE COMPLETE TEN (10) DAYS AFTER THE SAME HAS BEEN POSTED. 
 (c) Each Borrower, Agent and each
Lender agree that each Loan (including those made on the Closing Date) shall be deemed to be made in, and the transactions contemplated hereunder and in any other Financing Document shall be deemed to have been performed in, the State of Maryland.

 Section 12.9 WAIVER OF JURY TRIAL. EACH BORROWER, AGENT AND THE LENDERS HEREBY IRREVOCABLY WAIVES ANY AND ALL RIGHT TO
TRIAL BY JURY IN ANY LEGAL ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THE FINANCING DOCUMENTS OR THE TRANSACTIONS CONTEMPLATED THEREBY AND AGREES THAT ANY SUCH ACTION OR PROCEEDING SHALL BE TRIED BEFORE A COURT AND NOT BEFORE A JURY. EACH
BORROWER, AGENT AND EACH LENDER ACKNOWLEDGES THAT THIS WAIVER IS A MATERIAL INDUCEMENT TO ENTER INTO A BUSINESS RELATIONSHIP, THAT EACH HAS RELIED ON THE WAIVER IN ENTERING INTO THIS AGREEMENT AND THE OTHER FINANCING DOCUMENTS, AND THAT EACH WILL
CONTINUE TO RELY ON THIS WAIVER IN THEIR RELATED FUTURE DEALINGS. EACH BORROWER, AGENT AND EACH LENDER WARRANTS AND REPRESENTS THAT IT HAS HAD THE OPPORTUNITY OF REVIEWING THIS JURY WAIVER WITH LEGAL COUNSEL, AND THAT IT KNOWINGLY AND VOLUNTARILY
WAIVES ITS JURY TRIAL RIGHTS. 
 Section 12.10 Publication; Advertisement. 

(a) Publication. No Credit Party will directly or indirectly publish, disclose or otherwise use in any public disclosure, advertising
material, promotional material, press release or interview, any reference to the name, logo or any trademark of MCF or any of its Affiliates or any reference to this Agreement or the financing evidenced hereby, in any case except (i) as
required by Law (including in connection with any securities law filing), subpoena or judicial or similar order, in which case the applicable Credit Party shall give Agent prior written notice of such publication or other disclosure, or
(ii) with MCF’s prior written consent. 
 (b) Advertisement. Each Lender and each Credit Party hereby authorizes MCF to
publish the name of such Lender and Credit Party, the existence of the financing arrangements referenced under this Agreement, the primary purpose and/or structure of those arrangements, the amount of credit extended under each facility, the title
and role of each party to this Agreement, and the total amount of the financing evidenced hereby in any “tombstone”, comparable advertisement or press release which MCF elects to submit for publication. In addition, each Lender and each
Credit Party agrees that MCF may provide lending industry trade 

  
 84 

MidCap / EndoChoice / Term Credit and Security Agreement 








 
organizations with information necessary and customary for inclusion in league table measurements after the Closing Date. With respect to any of the foregoing, MCF shall provide Borrowers with an
opportunity to review and confer with MCF regarding the contents of any such tombstone, advertisement or information, as applicable, prior to its submission for publication and, following such review period, MCF may, from time to time, publish such
information in any media form desired by MCF, until such time that Borrowers shall have requested MCF cease any such further publication. 

Section 12.11 Counterparts; Integration. This Agreement and the other Financing Documents may be signed in any number of
counterparts, each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument. Signatures by facsimile or by electronic mail delivery of an electronic version of any executed signature
page shall bind the parties hereto. This Agreement and the other Financing Documents constitute the entire agreement and understanding among the parties hereto and supersede any and all prior agreements and understandings, oral or written, relating
to the subject matter hereof. 
 Section 12.12 No Strict Construction. The parties hereto have participated jointly in
the negotiation and drafting of this Agreement. In the event an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the parties hereto and no presumption or burden of proof shall arise
favoring or disfavoring any party by virtue of the authorship of any provisions of this Agreement. 
 Section 12.13 Lender
Approvals. Unless expressly provided herein to the contrary, any approval, consent, waiver or satisfaction of Agent or Lenders with respect to any matter that is the subject of this Agreement, the other Financing Documents may be granted or
withheld by Agent and Lenders in their sole and absolute discretion and credit judgment. 
 Section 12.14 Expenses;
Indemnity 
 (a) Borrowers hereby agree to promptly pay (i) all reasonable and documented out-of-pocket costs and expenses of Agent
(including, without limitation, the reasonable documented fees, costs and expenses of counsel to, and independent appraisers and consultants retained by Agent) in connection with the examination, review, due diligence investigation, documentation,
negotiation, closing and syndication of the transactions contemplated by the Financing Documents, in connection with the performance by Agent of its rights and remedies under the Financing Documents and in connection with the continued
administration of the Financing Documents including (A) any amendments, modifications, consents and waivers to and/or under any and all Financing Documents, and (B) any periodic public record searches conducted by or at the request of
Agent (including, without limitation, title investigations, UCC searches, fixture filing searches, judgment, pending litigation and tax lien searches and searches of applicable corporate, limited liability, partnership and related records concerning
the continued existence, organization and good standing of certain Persons); (ii) without limitation of the preceding clause (i), all costs and expenses of Agent in connection with the creation, perfection and maintenance of Liens pursuant
to the Financing Documents; (iii) without limitation of the preceding clause (i), all costs and expenses of Agent in connection with (A) protecting, storing, insuring, handling, maintaining or selling any Collateral, (B) any


  
 85 

MidCap / EndoChoice / Term Credit and Security Agreement 








 
litigation, dispute, suit or proceeding relating to any Financing Document, and (C) any workout, collection, bankruptcy, insolvency and other enforcement proceedings under any and all of the
Financing Documents; and (iv) all costs and expenses incurred by Lenders in connection with any litigation, dispute, suit or proceeding relating to any Financing Document and in connection with any workout, collection, bankruptcy, insolvency
and other enforcement proceedings under any and all Financing Documents, whether or not Agent or Lenders are a party thereto. If Agent or any Lender uses in-house counsel for any of these purposes, Borrowers further agree that the Obligations
include reasonable charges for such work commensurate with the fees that would otherwise be charged by outside legal counsel selected by Agent or such Lender for the work performed. 

(b) Each Borrower hereby agrees to indemnify, pay and hold harmless Agent and Lenders and the officers, directors, employees, trustees,
agents, investment advisors and investment managers, collateral managers, servicers, and counsel of Agent and Lenders (collectively called the “Indemnitees”) from and against any and all liabilities, obligations, losses, damages,
penalties, actions, judgments, suits, claims, costs, expenses and disbursements of any kind or nature whatsoever (including the reasonable fees and disbursements of counsel for such Indemnitee) in connection with any investigative, response,
remedial, administrative or judicial matter or proceeding, whether or not such Indemnitee shall be designated a party thereto and including any such proceeding initiated by or on behalf of a Credit Party, and the reasonable expenses of investigation
by engineers, environmental consultants and similar technical personnel and any commission, fee or compensation claimed by any broker (other than any broker retained by Agent or Lenders) asserting any right to payment for the transactions
contemplated hereby, which may be imposed on, incurred by or asserted against such Indemnitee as a result of or in connection with the transactions contemplated hereby or by the other Operative Documents (including (i) any actual or alleged
presence of Hazardous Materials on or from any property owned or operated by any Borrower or any of its Subsidiaries, and (ii) proposed and actual extensions of credit under this Agreement) and the use or intended use of the proceeds of the
Loans, except that Borrower shall have no obligation hereunder to an Indemnitee with respect to any liability described in this Section 12.14(b) resulting from (x) the gross negligence or willful misconduct of such Indemnitee or (y) a
claim brought by the Borrower or any other Credit Party against an Indemnitee for a material breach in bad faith of such Indemnitee’s obligations hereunder or under any Operative Document, in each case as determined by a final non-appealable
judgment of a court of competent jurisdiction. To the extent that the undertaking set forth in the immediately preceding sentence may be unenforceable, Borrower shall contribute the maximum portion which it is permitted to pay and satisfy under
applicable Law to the payment and satisfaction of all such indemnified liabilities incurred by the Indemnitees or any of them. 
 (c)
Notwithstanding any contrary provision in this Agreement, the obligations of Borrowers under this Section 12.14 shall survive the payment in full of the Obligations and the termination of this Agreement. NO INDEMNITEE SHALL BE RESPONSIBLE OR
LIABLE TO THE BORROWERS OR TO ANY OTHER PARTY TO ANY FINANCING DOCUMENT, ANY SUCCESSOR, ASSIGNEE OR THIRD PARTY BENEFICIARY OR ANY OTHER PERSON ASSERTING CLAIMS DERIVATIVELY THROUGH SUCH PARTY, FOR INDIRECT, PUNITIVE, EXEMPLARY OR CONSEQUENTIAL
DAMAGES 

  
 86 

MidCap / EndoChoice / Term Credit and Security Agreement 








 
WHICH MAY BE ALLEGED AS A RESULT OF CREDIT HAVING BEEN EXTENDED, SUSPENDED OR TERMINATED UNDER THIS AGREEMENT OR ANY OTHER FINANCING DOCUMENT OR AS A RESULT OF ANY OTHER TRANSACTION CONTEMPLATED
HEREUNDER OR THEREUNDER. 
 Section 12.15 Reserved. 

Section 12.16 Reinstatement. This Agreement shall remain in full force and effect and continue to be effective should any
petition or other proceeding be filed by or against any Credit Party for liquidation or reorganization, should any Credit Party become insolvent or make an assignment for the benefit of any creditor or creditors or should an interim receiver,
receiver, receiver and manager or trustee be appointed for all or any significant part of any Credit Party’s assets, and shall continue to be effective or to be reinstated, as the case may be, if at any time payment and performance of the
Obligations, or any part thereof, is, pursuant to applicable law, rescinded or reduced in amount, or must otherwise be restored or returned by any obligee of the Obligations, whether as a fraudulent preference reviewable transaction or otherwise,
all as though such payment or performance had not been made. In the event that any payment, or any part thereof, is rescinded, reduced, restored or returned, the Obligations shall be reinstated and deemed reduced only by such amount paid and not so
rescinded, reduced, restored or returned. 
 Section 12.17 Successors and Assigns. This Agreement shall be binding upon
and inure to the benefit of Borrowers and Agent and each Lender and their respective successors and permitted assigns. 

Section 12.18 USA PATRIOT Act Notification. Agent (for itself and not on behalf of any Lender) and each Lender hereby
notifies Borrowers that pursuant to the requirements of the USA PATRIOT Act, it is required to obtain, verify and record certain information and documentation that identifies Borrowers, which information includes the name and address of Borrower and
such other information that will allow Agent or such Lender, as applicable, to identify Borrowers in accordance with the USA PATRIOT Act. 

Section 12.19 Cross Default and Cross Collateralization. 

(a) Cross-Default. As stated under Section 10.1 hereof, an Event of Default under any of the Affiliated Financing Documents
shall be an Event of Default under this Agreement. In addition, a Default or Event of Default under any of the Financing Documents shall be a Default under the Affiliated Financing Documents. 

(b) Cross Collateralization. Borrowers acknowledge and agree that the Collateral securing this Loan, also secures the Affiliated
Obligations. 
 (c) Consent. Each Borrower authorizes Agent, without giving notice to any Borrower or obtaining the consent of any
Borrower and without affecting the liability of any Borrower for the Affiliated Obligations directly incurred by the Borrowers, from time to time to: 

(i) compromise, settle, renew, extend the time for payment, change the manner or terms of payment, discharge the performance
of, decline to enforce, or 

  
 87 

MidCap / EndoChoice / Term Credit and Security Agreement 








 
release all or any of the Affiliated Obligations; grant other indulgences to any Borrowers in respect thereof; or modify in any manner any documents relating to the Affiliated Obligations; 

(ii) declare all Affiliated Obligations due and payable upon the occurrence and during the continuance of an Event of Default;

 (iii) take and hold security for the performance of the Affiliated Obligations of any Borrowers and exchange, enforce,
waive and release any such security; 
 (iv) apply and reapply such security and direct the order or manner of sale thereof
as Agent, in its sole discretion, may determine; 
 (v) release, surrender or exchange any deposits or other property
securing the Affiliated Obligations or on which Agent at any time may have a Lien; release, substitute or add any one or more endorsers or guarantors of the Affiliated Obligations of any Borrowers; or compromise, settle, renew, extend the time for
payment, discharge the performance of, decline to enforce, or release all or any obligations of any such endorser or guarantor or other Person who is now or may hereafter be liable on any Affiliated Obligations or release, surrender or exchange any
deposits or other property of any such Person; 
 (vi) apply payments received by Lender from Borrower to any Obligations or
Affiliated Obligations, as permitted in accordance with the terms of this Agreement and in such order as Lender shall determine, in its sole discretion; and 

(vii) assign the Affiliated Financing Documents in whole or in part. 

[SIGNATURES APPEAR ON FOLLOWING PAGE(S)] 

  
 88 

MidCap / EndoChoice / Term Credit and Security Agreement 








 IN WITNESS WHEREOF, intending to be legally bound, and intending that this
Agreement constitute an agreement executed under seal, each of the parties have caused this Agreement to be executed under seal the day and year first above mentioned. 
  

					
	BORROWER:		 ENDOCHOICE HOLDINGS, INC., as Borrower and

Borrower Representative

			
			By:		 /s/ David N. Gill

			Name:		David N. Gill
			Title:		Chief Financial Officer
		
			ENDOCHOICE, INC., as Borrower
			
			By:		 /s/ David N. Gill

			Name:		David N. Gill
			Title:		Chief Financial Officer
		
			ROBERT S. SMITH, M.D., INC. as Borrower
			
			By:		 /s/ David N. Gill

			Name:		David N. Gill
			Title:		Chief Financial Officer
		
			Address:
		
			EndoChoice Holdings, Inc.
			11810 Wills Road
			Alpharetta, GA 30009
			Attn: David Gill, Chief Financial Officer
			Facsimile: 866-567-8218
			E-Mail: david.gill@endochoice.com


  
 MidCap / EndoChoice / Term Credit and
Security Agreement 









							
	AGENT:		MIDCAP FINANCIAL TRUST
			
			By:		 Apollo Capital Management, L.P.,

					 its investment manager

			
			By:		 Apollo Capital Management GP, LLC,

					 its general partner

				
					By:		 /s/ Maurice Amsellem

					Name:		Maurice Amsellem
					Title:		Authorized Signatory
		
			 Address:

		
			 c/o MidCap Financial Services, LLC, as servicer

			 7255 Woodmont Avenue, Suite 200

			 Bethesda, Maryland 20814

			 Attn: Account Manager for EndoChoice transaction

			 Facsimile: 301-941-1450

			 E-mail: notices@midcapfinancial.com

		
			 with a copy to:

		
			 c/o MidCap Financial Services, LLC, as servicer

			 7255 Woodmont Avenue, Suite 200

			 Bethesda, Maryland 20814

			 Attn: General Counsel

			 Facsimile: 301-941-1450

			 E-mail: legalnotices@midcapfinancial.com

		
			 Payment Account Designation:

		
			 SunTrust Bank

			 ABA #: 061000104

			 Account Name: MidCap Funding IV Trust - Collections

			 Account #: 1000113400435

			 Attention: EndoChoice Holdings, Inc.



  
 MidCap / EndoChoice / Term Credit and
Security Agreement 









					
	LENDER:		MIDCAP FUNDING III TRUST
			
			By:		Apollo Capital Management, L.P.,
					its investment manager
			
			By:		Apollo Capital Management GP, LLC,
					its general partner


							
				
					By:		 /s/ Maurice Amsellem

					Name:		Maurice Amsellem
					Title:		Authorized Signatory


					
		
			Address:
		
			c/o MidCap Financial Services, LLC, as servicer
			7255 Woodmont Avenue, Suite 200
			Bethesda, Maryland 20814
			Attn: Account Manager for EndoChoice transaction
			Facsimile: 301-941-1450
			E-mail: notices@midcapfinancial.com
		
			with a copy to:
		
			c/o MidCap Financial Services, LLC, as servicer
			7255 Woodmont Avenue, Suite 200
			Bethesda, Maryland 20814
			Attn: General Counsel
			Facsimile: 301-941-1450
			E-mail: legalnotices@midcapfinancial.com


  
 MidCap / EndoChoice / Term Credit and
Security Agreement 









					
	LENDER:		MIDCAP FUNDING XIII TRUST
			
			By:		Apollo Capital Management, L.P.,
			its investment manager
			
			By:		Apollo Capital Management GP, LLC,
			its general partner
			
			By:		 /s/ Maurice Amsellem

					Name: Maurice Amsellem
					Title: Authorized Signatory
		
			Address:
		
			c/o MidCap Financial Services, LLC, as servicer
			7255 Woodmont Avenue, Suite 200
			Bethesda, Maryland 20814
			Attn: Account Manager for EndoChoice transaction
			Facsimile: 301-941-1450
			E-mail: notices@midcapfinancial.com
		
			with a copy to:
		
			c/o MidCap Financial Services, LLC, as servicer
			7255 Woodmont Avenue, Suite 200
			Bethesda, Maryland 20814
			Attn: General Counsel
			Facsimile: 301-941-1450
			E-mail: legalnotices@midcapfinancial.com


  
 MidCap / EndoChoice / Term Credit and
Security Agreement 









					
	LENDER:		SILICON VALLEY BANK
			
			By:		 /s/ Andrew J. Kink

			Name:		Andrew J. Kink
			Title:		Director
			
			Address:		3353 Peachtree Rd, NE
					North Tower, Suite M-10
					Atlanta, GA 30325


  
 MidCap / EndoChoice / Term Credit and
Security Agreement 









					
	LENDER:		FLEXPOINT MCLS HOLDINGS LLC
			
			By:		 /s/ Daniel Edelman

			Name:		Daniel Edelman
			Title:		Vice President
		
			Address:
		
			Flexpoint MCLS Holdings, LLC
			c/o MidCap Financial Services, LLC, as servicer
			7255 Woodmont Avenue, Suite 200
			Bethesda, Maryland 20814
			Attn: Account Manager for EndoChoice transaction
			Facsimile: 301-941-1450
			E-mail: LViera@midcapfinancial.com
		
			with a copy to:
		
			Flexpoint MCLS Holdings, LLC
			c/o MidCap Financial Services, LLC, as servicer
			7255 Woodmont Avenue, Suite 200
			Bethesda, Maryland 20814
			Attn: Legal
			Facsimile: 301-941-1450
			E-mail: legalnotices@midcapfinancial.com


  
 MidCap / EndoChoice / Term Credit and
Security Agreement 








 ANNEXES, EXHIBITS AND SCHEDULES 

ANNEXES 
  

			
	Annex A		Commitment Annex

 EXHIBITS 
  

			
	Exhibit A		[Reserved]
	Exhibit B		Form of Compliance Certificate
	Exhibit C		[Reserved]
	Exhibit D		Form of Notice of Borrowing


  
 MidCap / EndoChoice / Term Credit and
Security Agreement 








 ANNEX A TO CREDIT AGREEMENT (COMMITMENT ANNEX) 

 

									
	 Lender
	  	Term Loan
Commitment Amount	 	  	Term Loan
Commitment
Percentage	 
	 MidCap Funding III Trust
	  	$	15,000,000	  	  	 	34.88	% 
	 MidCap Funding XIII Trust
	  	$	9,950,000	  	  	 	23.14	% 
	 Flexpoint MCLS Holdings LLC
	  	$	3,000,000	  	  	 	6.98	% 
	 Silicon Valley Bank
	  	$	15,050,000	  	  	 	35.00	% 
		  	  
	  
	 	  	  
	  
	 
	 TOTALS
		$	43,000,000	  		 	100	% 


  
 MidCap / EndoChoice / Term Credit and
Security Agreement 








 EXHIBIT A TO CREDIT AGREEMENT (RESERVED) 

  
 MidCap / EndoChoice / Term Credit and
Security Agreement 








 EXHIBIT B TO CREDIT AGREEMENT (FORM OF COMPLIANCE CERTIFICATE) 

COMPLIANCE CERTIFICATE 

This Compliance Certificate is given by
                    , a Responsible Officer of EndoChoice Holdings, Inc. (the “Borrower Representative”), pursuant to that certain
Credit and Security Agreement dated as of June 30, 2015 among the Borrower Representative, EndoChoice, Inc., Robert S. Smith, M.D., Inc. and any additional Borrower that may hereafter be added thereto (collectively,
“Borrowers”), MidCap Financial Trust, individually as a Lender and as Agent, and the financial institutions or other entities from time to time parties hereto, each as a Lender (as such agreement may have been amended, restated,
supplemented or otherwise modified from time to time, the “Credit Agreement”). Capitalized terms used herein without definition shall have the meanings set forth in the Credit Agreement. 

The undersigned Responsible Officer hereby certifies to Agent and Lenders that: 

(a) the financial statements delivered with this certificate in accordance with Section 4.1 of the Credit Agreement fairly present in all
material respects the results of operations and financial condition of Borrowers and their Consolidated Subsidiaries as of the dates and the accounting period covered by such financial statements; 

(b) I have reviewed the terms of the Credit Agreement and have made, or caused to be made under my supervision, a review in reasonable detail
of the transactions and conditions of Borrowers and their Consolidated Subsidiaries during the accounting period covered by such financial statements and such review has not disclosed the existence during or at the end of such accounting period, and
I have no knowledge of the existence as of the date hereof, of any condition or event that constitutes a Default or an Event of Default, except as set forth in Schedule 1 hereto, which includes a description of the nature and period of
existence of such Default or an Event of Default and what action Borrowers have taken, are undertaking and propose to take with respect thereto; 

(c) Schedule 5.14 to the Credit Agreement contains a complete and accurate statement of all deposit accounts and investment accounts
maintained by Borrowers and Guarantors; 
 (d) except as noted on Schedule 5 attached hereto, no Borrower or Guarantor has
acquired, by purchase, by the approval or granting of any application for registration (whether or not such application was previously disclosed to Agent by Borrowers) or otherwise, any Intellectual Property that is registered with any United States
or foreign Governmental Authority, or has filed with any such United States or foreign Governmental Authority, any new application for the registration of any Intellectual Property (other than with respect to provisional patents), or acquired rights
under a license as a licensee with respect to any such registered Intellectual Property (or any such application for the registration of Intellectual Property) owned by another Person, that has not previously been reported to Agent on
Schedule 3.17 to the Credit Agreement or any Schedule 5 to any previous Compliance Certificate delivered by the Borrower Representative to Agent; 

  
 Exhibit B – Page 1

 MidCap / EndoChoice / Term Credit and Security Agreement 








 (e) except as noted on Schedule 6 attached hereto, no Borrower or Guarantor has
acquired, by purchase or otherwise, any Chattel Paper, letter of credit rights, Instruments, documents or investment property that has not previously been reported to Agent on any Schedule 6 to any previous Compliance Certificate
delivered by Borrower Representative to Agent; 
 (f) except as noted on Schedule 7 attached hereto, no Borrower or Guarantor is
aware of any commercial tort claim that has not previously been reported to Agent on any Schedule 7 to any previous Compliance Certificate delivered by Borrower Representative to Agent; and 

(g) Borrowers are in compliance with the covenants contained in Article 6 of the Credit Agreement, as demonstrated by the calculation of such
covenants below, except as set forth below; in determining such compliance, the following calculations have been made: 
 [insert
calculations, as applicable] 
 Such calculations and the certifications contained therein are true, correct and complete. 

The foregoing certifications and computations are made as of             ,
201     (end of month) and as of             , 201    . 
  


			
	Sincerely,
	
	ENDOCHOICE HOLDINGS, INC.
		
	By:		  

	Name:		
	Title:		



  
 Exhibit B – Page 2

 MidCap / EndoChoice / Term Credit and Security Agreement 








 EXHIBIT C TO CREDIT AGREEMENT (RESERVED) 

  
 MidCap / EndoChoice / Term Credit and
Security Agreement 








 EXHIBIT D TO CREDIT AGREEMENT (FORM OF NOTICE OF BORROWING) 

NOTICE OF BORROWING 

This Notice of Borrowing is given by
                    , a Responsible Officer of EndoChoice Holdings, Inc. (the “Borrower Representative”), pursuant to that certain
Credit and Security Agreement dated as of June 30, 2015 among the Borrower Representative, Endochoice, Inc., Robert S. Smith, M.D., Inc. and any additional Borrower that may hereafter be added thereto (collectively,
“Borrowers”), MidCap Financial Trust, individually as Agent, and the financial institutions or other entities from time to time parties hereto, each as a Lender (as such agreement may have been amended, restated, supplemented or
otherwise modified from time to time, the “Credit Agreement”). Capitalized terms used herein without definition shall have the meanings set forth in the Credit Agreement. 

The undersigned Responsible Officer hereby gives notice to Agent of Borrower Representative’s request to borrow
$            of Term Loans on             , 201    . 

The undersigned officer hereby certifies that, both before and after giving effect to the request above (a) each of the conditions
precedent set forth in Section 7.2 have been satisfied, (b) all of the representations and warranties contained in the Credit Agreement and the other Financing Documents are true, correct and complete in all material respects as of the
date hereof, except to the extent such representation or warranty relates to a specific date, in which case such representation or warranty is true, correct and complete as of such earlier date; provided, however, in each case, such
materiality qualifier shall not be applicable to any representations and warranties that already are qualified or modified by materiality in the text thereof, and (c) no Default or Event of Default has occurred and is continuing on the date
hereof. 
 IN WITNESS WHEREOF, the undersigned officer has executed and delivered this Notice of Borrowing this
     day of         , 201    . 
  

			
	Sincerely,
	
	ENDOCHOICE HOLDINGS, INC.
		
	By:		  

	Name:		
	Title:		



  
 MidCap / EndoChoice / Term Credit and
Security Agreement 








 TABLE OF CONTENTS 

 

							
	 	  	 	  	Page	 
		
	 ARTICLE 1 - DEFINITIONS
	  	 	1	  
			
	 Section 1.1
	  	Certain Defined Terms	  	 	1	  
			
	 Section 1.2
	  	Accounting Terms and Determinations	  	 	23	  
			
	 Section 1.3
	  	Other Definitional and Interpretive Provisions	  	 	23	  
			
	 Section 1.4
	  	Time is of the Essence	  	 	24	  
		
	 ARTICLE 2 - LOANS
	  	 	24	  
			
	 Section 2.1
	  	Loans	  	 	24	  
			
	 Section 2.2
	  	Interest, Interest Calculations and Certain Fees	  	 	26	  
			
	 Section 2.3
	  	Notes	  	 	28	  
			
	 Section 2.4
	  	[Reserved]	  	 	28	  
			
	 Section 2.5
	  	[Reserved]	  	 	28	  
			
	 Section 2.6
	  	General Provisions Regarding Payment; Loan Account	  	 	28	  
			
	 Section 2.7
	  	Maximum Interest	  	 	29	  
			
	 Section 2.8
	  	Taxes; Capital Adequacy	  	 	29	  
			
	 Section 2.9
	  	Appointment of Borrower Representative	  	 	31	  
			
	 Section 2.10
	  	Joint and Several Liability; Rights of Contribution; Subordination and Subrogation	  	 	32	  
			
	 Section 2.11
	  	Accounts	  	 	34	  
			
	 Section 2.12
	  	Termination; Restriction on Termination	  	 	34	  
		
	 ARTICLE 3 - REPRESENTATIONS AND WARRANTIES
	  	 	35	  
			
	 Section 3.1
	  	Existence and Power	  	 	35	  
			
	 Section 3.2
	  	Organization and Governmental Authorization; No Contravention	  	 	36	  
			
	 Section 3.3
	  	Binding Effect	  	 	36	  
			
	 Section 3.4
	  	Capitalization	  	 	36	  
			
	 Section 3.5
	  	Financial Information	  	 	36	  
			
	 Section 3.6
	  	Litigation	  	 	36	  
			
	 Section 3.7
	  	Ownership of Property	  	 	37	  
			
	 Section 3.8
	  	No Default	  	 	37	  


  
 i 

MidCap / EndoChoice / Term Credit and Security Agreement 








 TABLE OF CONTENTS 

(continued) 
  

							
	 	  	 	  	Page	 
			
	 Section 3.9
	  	Labor Matters	  	 	37	  
			
	 Section 3.10
	  	Regulated Entities	  	 	37	  
			
	 Section 3.11
	  	Margin Regulations	  	 	37	  
			
	 Section 3.12
	  	Compliance With Laws; Anti-Terrorism Laws	  	 	37	  
			
	 Section 3.13
	  	Taxes	  	 	38	  
			
	 Section 3.14
	  	Compliance with ERISA	  	 	38	  
			
	 Section 3.15
	  	Consummation of Operative Documents; Brokers	  	 	39	  
			
	 Section 3.16
	  	Reserved	  	 	39	  
			
	 Section 3.17
	  	Material Contracts	  	 	39	  
			
	 Section 3.18
	  	Compliance with Environmental Requirements; No Hazardous Materials	  	 	39	  
			
	 Section 3.19
	  	Intellectual Property and License Agreements	  	 	40	  
			
	 Section 3.20
	  	Solvency	  	 	40	  
			
	 Section 3.21
	  	Full Disclosure	  	 	40	  
			
	 Section 3.22
	  	Reserved	  	 	40	  
			
	 Section 3.23
	  	Subsidiaries	  	 	40	  
			
	 Section 3.24
	  	Reserved	  	 	41	  
			
	 Section 3.25
	  	Accuracy of Schedules	  	 	41	  
		
	 ARTICLE 4 - AFFIRMATIVE COVENANTS
	  	 	41	  
			
	 Section 4.1
	  	Financial Statements and Other Reports	  	 	41	  
			
	 Section 4.2
	  	Payment and Performance of Obligations	  	 	41	  
			
	 Section 4.3
	  	Maintenance of Existence	  	 	42	  
			
	 Section 4.4
	  	Maintenance of Property; Insurance	  	 	42	  
			
	 Section 4.5
	  	Compliance with Laws and Material Contracts	  	 	43	  
			
	 Section 4.6
	  	Inspection of Property, Books and Records	  	 	43	  
			
	 Section 4.7
	  	Use of Proceeds	  	 	44	  
			
	 Section 4.8
	  	Estoppel Certificates	  	 	44	  
			
	 Section 4.9
	  	Notices of Material Contracts, Litigation and Defaults	  	 	44	  
			
	 Section 4.10
	  	Reserved	  	 	45	  


  
 ii 

MidCap / EndoChoice / Term Credit and Security Agreement 








 TABLE OF CONTENTS 

(continued) 
  

							
	 	  	 	  	Page	 
			
	 Section 4.11
	  	Further Assurances	  	 	45	  
			
	 Section 4.12
	  	Reserved	  	 	47	  
			
	 Section 4.13
	  	Power of Attorney	  	 	47	  
			
	 Section 4.14
	  	Reserved	  	 	47	  
			
	 Section 4.15
	  	Schedule Updates	  	 	47	  
			
	 Section 4.16
	  	Intellectual Property and Licensing	  	 	47	  
			
	 Section 4.17
	  	Regulatory Reporting and Covenants	  	 	48	  
		
	 ARTICLE 5 - NEGATIVE COVENANTS
	  	 	49	  
			
	 Section 5.1
	  	Debt; Contingent Obligations	  	 	49	  
			
	 Section 5.2
	  	Liens	  	 	49	  
			
	 Section 5.3
	  	Distributions	  	 	49	  
			
	 Section 5.4
	  	Restrictive Agreements	  	 	49	  
			
	 Section 5.5
	  	Payments and Modifications of Subordinated Debt	  	 	49	  
			
	 Section 5.6
	  	Consolidations, Mergers and Sales of Assets; Change in Control	  	 	50	  
			
	 Section 5.7
	  	Purchase of Assets, Investments	  	 	50	  
			
	 Section 5.8
	  	Transactions with Affiliates	  	 	50	  
			
	 Section 5.9
	  	Modification of Organizational Documents	  	 	51	  
			
	 Section 5.10
	  	Modification of Certain Agreements	  	 	51	  
			
	 Section 5.11
	  	Conduct of Business	  	 	51	  
			
	 Section 5.12
	  	Lease Payments	  	 	51	  
			
	 Section 5.13
	  	Limitation on Sale and Leaseback Transactions	  	 	51	  
			
	 Section 5.14
	  	Deposit Accounts and Securities Accounts; Payroll and Benefits Accounts	  	 	51	  
			
	 Section 5.15
	  	Compliance with Anti-Terrorism Laws	  	 	52	  
		
	 ARTICLE 6 - FINANCIAL COVENANTS
	  	 	52	  
			
	 Section 6.1
	  	Additional Defined Terms	  	 	52	  
			
	 Section 6.2
	  	Minimum Liquidity	  	 	53	  
			
	 Section 6.3
	  	Minimum Net Revenue	  	 	53	  
			
	 Section 6.4
	  	Evidence of Compliance	  	 	53	  


  
 iii 

MidCap / EndoChoice / Term Credit and Security Agreement 








 TABLE OF CONTENTS 

(continued) 
  

							
	 	  	 	  	Page	 
		
	 ARTICLE 7 - CONDITIONS
	  	 	53	  
			
	 Section 7.1
	  	Conditions to Closing	  	 	53	  
			
	 Section 7.2
	  	Conditions to Each Loan	  	 	54	  
			
	 Section 7.3
	  	Searches	  	 	55	  
			
	 Section 7.4
	  	Post Closing Requirements	  	 	55	  
		
	 ARTICLE 8 - REGULATORY AND LIFE SCIENCES MATTERS
	  	 	55	  
			
	 Section 8.1
	  	Representations and Warranties	  	 	55	  
		
	 ARTICLE 9 - SECURITY AGREEMENT
	  	 	57	  
			
	 Section 9.1
	  	Generally	  	 	57	  
			
	 Section 9.2
	  	Representations and Warranties and Covenants Relating to Collateral	  	 	58	  
		
	 ARTICLE 10 - EVENTS OF DEFAULT
	  	 	61	  
			
	 Section 10.1
	  	Events of Default	  	 	61	  
			
	 Section 10.2
	  	Acceleration and Suspension or Termination of Term Loan Commitment	  	 	64	  
			
	 Section 10.3
	  	UCC Remedies	  	 	64	  
			
	 Section 10.4
	  	[Reserved]	  	 	66	  
			
	 Section 10.5
	  	Default Rate of Interest	  	 	66	  
			
	 Section 10.6
	  	Setoff Rights	  	 	67	  
			
	 Section 10.7
	  	Application of Proceeds	  	 	67	  
			
	 Section 10.8
	  	Waivers	  	 	68	  
			
	 Section 10.9
	  	Injunctive Relief	  	 	70	  
			
	 Section 10.10
	  	Marshalling; Payments Set Aside	  	 	70	  
		
	 ARTICLE 11 - AGENT
	  	 	70	  
			
	 Section 11.1
	  	Appointment and Authorization	  	 	70	  
			
	 Section 11.2
	  	Agent and Affiliates	  	 	71	  
			
	 Section 11.3
	  	Action by Agent	  	 	71	  
			
	 Section 11.4
	  	Consultation with Experts	  	 	71	  


  
 iv 

MidCap / EndoChoice / Term Credit and Security Agreement 








 TABLE OF CONTENTS 

(continued) 
  

							
	 	  	 	  	Page	 
			
	 Section 11.5
	  	Liability of Agent	  	 	71	  
			
	 Section 11.6
	  	Indemnification	  	 	71	  
			
	 Section 11.7
	  	Right to Request and Act on Instructions	  	 	72	  
			
	 Section 11.8
	  	Credit Decision	  	 	72	  
			
	 Section 11.9
	  	Collateral Matters	  	 	72	  
			
	 Section 11.10
	  	Agency for Perfection	  	 	73	  
			
	 Section 11.11
	  	Notice of Default	  	 	73	  
			
	 Section 11.12
	  	Assignment by Agent; Resignation of Agent; Successor Agent	  	 	73	  
			
	 Section 11.13
	  	Payment and Sharing of Payment	  	 	74	  
			
	 Section 11.14
	  	Right to Perform, Preserve and Protect	  	 	75	  
			
	 Section 11.15
	  	Reserved	  	 	75	  
			
	 Section 11.16
	  	Amendments and Waivers	  	 	76	  
			
	 Section 11.17
	  	Assignments and Participations	  	 	77	  
			
	 Section 11.18
	  	Reserved	  	 	80	  
			
	 Section 11.19
	  	Reserved	  	 	80	  
			
	 Section 11.20
	  	Definitions	  	 	80	  
		
	 ARTICLE 12 - MISCELLANEOUS
	  	 	81	  
			
	 Section 12.1
	  	Survival	  	 	81	  
			
	 Section 12.2
	  	No Waivers	  	 	81	  
			
	 Section 12.3
	  	Notices	  	 	81	  
			
	 Section 12.4
	  	Severability	  	 	82	  
			
	 Section 12.5
	  	Headings	  	 	82	  
			
	 Section 12.6
	  	Confidentiality	  	 	82	  
			
	 Section 12.7
	  	Waiver of Consequential and Other Damages	  	 	83	  
			
	 Section 12.8
	  	GOVERNING LAW; SUBMISSION TO JURISDICTION	  	 	83	  
			
	 Section 12.9
	  	WAIVER OF JURY TRIAL	  	 	84	  
			
	 Section 12.10
	  	Publication; Advertisement	  	 	84	  
			
	 Section 12.11
	  	Counterparts; Integration	  	 	85	  
			
	 Section 12.12
	  	No Strict Construction	  	 	85	  


  
 v 

MidCap / EndoChoice / Term Credit and Security Agreement 








 TABLE OF CONTENTS 

(continued) 
  

							
	 	  	 	  	Page	 
			
	 Section 12.13
	  	Lender Approvals	  	 	85	  
			
	 Section 12.14
	  	Expenses; Indemnity	  	 	85	  
			
	 Section 12.15
	  	Reserved	  	 	87	  
			
	 Section 12.16
	  	Reinstatement	  	 	87	  
			
	 Section 12.17
	  	Successors and Assigns	  	 	87	  
			
	 Section 12.18
	  	USA PATRIOT Act Notification	  	 	87	  
			
	 Section 12.19
	  	Cross Default and Cross Collateralization	  	 	87	  


  
 vi 

MidCap / EndoChoice / Term Credit and Security Agreement